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Zusammenfassung 
Die vorliegende Arbeit hat die Anwendung von Polymerkapseln in diagnostischen und 
therapeutischen Fragestellungen in Säugerzellen zum Thema. Die Kapseln bestehen aus 
einer Kavität umhüllt von mehrern gegensätzlich geladenen Polyelektrolytschichten und 
haben eine Größe von zwei bis fünf Mikrometern. Für die diagnostischen Anwendungen 
wurden Kapseln für die Beobachtung des lysosomalen pH-Wertes von Krebszellen 
synthetisiert. Die Kavitäten der Kapseln wurde dafür mit einem fluoreszenten, pH-
abhängigen Farbstoff gefüllt, um das Signal optisch auszulesen. Die Dynamik des 
lysosomalen pH-Wertes unter äußerlicher Beeinflussung wurde vermessen. Aus den 
Ergebnissen ging hervor, dass die Kapseln für die intrazelluläre Langzeitmessung geeignet 
waren und Änderungen des pH-Wertes verfolgt werden konnten. Für therapeutische 
Aufgaben wurden bioabbaubare Kapseln mit biologisch aktiven Molekülen beladen. Zwei 
verschiedene Strategien wurden verwendet. Im ersten Fall wurde die Kavität der Kapseln mit 
Polyplexen aus DNA oder RNA und Polyetylenimin gefüllt, die weithin für die Einbringung 
von fremden Genmaterial in Zellen eingesetzt werden. Dies ist ein Beispiel für Gentherapie. 
Die Ergebnisse zeigten, dass die Integration des fremden Genmaterials mithilfe von Kapseln 
sehr effizient war und die eingekapselten Polyplexe weniger toxisch für die Zellen waren als 
freie Polyplexe. Die zweite Strategie war, funktionale Enzyme direkt zu integrieren. Dafür 
wurden Modelle für lysosomale Speicherkrankheiten eingesetzt. Patienten mit Morbus Fabry 
expremieren das Enzym α-Galactosidase A nicht oder nur unzureichend. Im Versuch wurden 
bioabbaubare Kapsel mit dem Enzym synthetisiert und den Modellzellen verabreicht. Diese 
Therapieform nennt man Enzymersatztherapie. Die intrazelluläre Enzymaktivität wurde 
mithilfe eines fluoreszenten Substrats von α-Galactosidase A bestimmt. Da das Produkt der 
Enzymreaktion nichtfluoreszierend ist, kann aus der intrazellulären Fluoreszenz auf die 
Aktivität des Enzyms geschlossen werden. Zuletzt wurden Diagnose und Therapie in einem 
Modell für Morbus Krabbe, einer weiteren lysosomalen Speicherkrankheit, vereint. Bei 
Krabbe-Patienten sammeln sich Sphingolipide und Cerebroside in den oligodendritischen 
Glia-Zellen an, da das Enzym Galactocerebrosidase, das diese Stoffe normalerweise abbaut, 
aufgrund eines Gendefekts nicht expremiert wird. Im Modell wurden die Zellen mit dem 
Sphingolipid Psychosin inkubiert, um die Krankheit zu simulieren. Galactocerebrosidase 
wurde den Zellen mithilfe bioabbaubarer Kapseln verabreicht. Die Funktionalität des Enzyms 
wurde mit einem Viabilitätstest verifiziert. Zwei Typen von Zellen, der Wildtyp, der das 
Enzym expremierte, und Knockout-Zellen, die das Enzym nicht expremierten, wurden 
verwendet. Die Viabilität der Zellen bei Zugabe verschiedener Konzentrationen von 
Psychosin wurde mit und ohne Kapselzugabe bestimmt. Es zeigte sich, dass die Kapseln 
einen gegensätzlichen Effekt auf die zwei Typen von Zellen ausübten. Knockout-Zellen 
erreichten eine höhere Viabilität nach Zugabe der Enzym-Kapseln, wohingegen Wildtyp-
Zellen eine leicht geringere hatten. Der diagnostische Part des Modells bestand in der 
Messung des lysosomalen pH-Wertes während der Inkubation mit Psychosin. Das 
zeitaufgelöste pH-Profil der beiden Zelltypen unterschied sich dabei. Daher kann die 
Entscheidung, ob Kapseln zur Therapie verabreicht werden sollten, von der Diagnose durch 
die pH-Messung abhängig gemacht werden. Dies kann man als in-vitro-Beispiel für 
Theranostik betrachten, der Kombination aus Therapie und Diagnose.  
Summary 
This thesis deals with the application of polymer capsules for diagnostic and therapeutic 
purposes in mammalian cells. The capsules comprise a multilayer shell of oppositely charged 
polyelectrolytes surrounding a cavity and have a size of two to five microns. Concerning 
diagnostics, capsules were produced to monitor the dynamics of the lysosomal pH in cancer 
cells. The cavities of the capsules were filled with a fluorescent, pH-sensitive dye for optical 
readout of the signal. The cells were monitored under physiological conditions upon induced 
pH imbalances. The results showed that the capsules were appropriate for intracellular long-
term measurements and could monitor changes of the pH. For therapy, biodegradable 
capsules filled with biologically active molecules were synthesized. Two strategies were 
employed. In one approach, the cavity was filled with polyplexes of DNA or RNA and 
polyethylenimine, which are used regularly for the delivery of foreign genetic material into 
host cells. This approach is an example for gene therapy. The results showed that delivery by 
the capsules was very efficient and the encapsulated polyplexes were less toxic for the cells 
than their free counterparts. The other strategy was to directly deliver functional enzymes 
into cells. For this approach, cell models representing lysosomal storage diseases were 
employed. One of these diseases is Fabry. Patients with Fabry disease are deficient of the 
enzyme α-galactosidase A. The enzyme was encapsulated in biodegradable capsules and 
given to the cells. This therapy form is called enzyme replacement therapy. The intracellular 
enzyme activity was determined by quantification of the intracellular level of a fluorescently 
labeled substrate of α-galactosidase A. As the products of the reaction were non-
fluorescent, the intracellular fluorescence could be used to quantify the intracellular activity 
of the encapsulated enzyme. Finally, therapy and diagnostics were combined in a model of 
Krabbe disease, another lysosomal storage disorder. In Krabbe patients, sphingolipids and 
cerebrosides accumulate in the oligodendritic glia cells of the patients, as due to a gene 
defect the enzyme galactocerebrosidase usually converting these agents is not expressed. In 
the model, the cause of the disease was simulated by incubation of oligodendritic cells with 
psychosine, which belongs to the group of sphingolipids. Galactocerebrosidase was 
encapsulated in biodegradable capsules and delivered to the cells. The functionality was 
tested by a viability assay. Two types of cells were used, wild-type cells expressing 
galactocerebrosidase and knockout cells, which did not express the enzyme. The viability of 
the cells in the presence of psychosine was determined with and without addition of 
galactocerebrosidase-filled capsules. The results showed that the effect of the capsules on 
the viability of the two different cell types was contrary. Whereas knockout cells gained 
higher viability when capsules were administered, wild-type cells suffered a loss in viability. 
The diagnostic part was characterized by monitoring the lysosomal pH upon incubation with 
psychosine. The dynamics of the lysosomal pH of the two types of cells turned out to be 
different. Each of the cell types could therefore be identified with a specific pH profile and 
the decision to treat cells with the enzyme-filled capsules can be based on the measured pH 
profile. This is considered an in vitro-example of theranostics, the combination of therapy 
and diagnostics. 
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1 Introduction 
1.1 Polyelectrolyte Multilayer Capsules in Biomedical Fields 
Polyelectrolyte multilayer capsules were first introduced in 1998 by the group of Helmuth 
Möhwald and since then gained increasing interest over the years, especially in biomedical 
fields.[1, 2] These capsules are fabricated using template particles, onto which polymers of 
alternating charge are deposited.[2] After dissolution of the template, stable hollow capsules 
remain. Capsules can be produced with a great variety of different polymers, including the 
possibility to produce both biodegradable and bio-stable capsules.[3-7] Biodegradable 
capsules are made of polymers that can be degraded inside living cells, for example by 
enzymes in the lysosomes.[3, 5] Furthermore, the capsules can be tuned in size from 30 nm up 
to several microns, opening the way for customization of the capsules according to the 
problem of interest.[8] In cell culture models, for example, a larg size of the capsules can be 
of advantage as they are easily observable with optical techniques. Small capsules in the size 
of nanometers are of interest for in vivo-experiments, where large capsules cannot be used 
as they may block capillaries. Capsules are taken up by almost all mammalian cells, both 
immortal cell lines and primary cells.[9-11] The uptake is triggered by phagocytosis and lipid-
rafts-mediated macropinocytosis and the final location of the capsules is in the 
heterophagolysosomes of the cells.[10] After cell division, the capsules are passed to the 
daughter cells.[3] The distribution, however, is asymmetric, i.e. they are not passed on in a 
fifty-fifty manner.[12, 13] Applications of capsules in biomedical fields are diverse and can 
generally be divided into delivery and sensing applications.[14, 15] Capsules can be filled with 
various cargoes for delivery, among them drugs, genetic material like DNA or RNA, or 
proteins.[4, 16-21] The experimental challenges lie in the difficulties to encapsulate certain 
cargoes in a sufficient way, but also in problems to release the cargo at the desired target 
site. Concerning release, one major challenge is to free the capsule content from the 
lysosome so that it becomes available to reach targets outside this vesicle. For sensing 
applications the capsules are filled with a sensor. This can be an ion-sensitive dye,[6, 22-24] but 
also more complex systems have been described, such as enzymes that convert a metabolite 
and a component that gives a signal quantifying the conversion.[25, 26] Finally, it should be 
mentioned that many other ways of synthesizing capsules apart from the LbL method are 
widespread.  The reader is referred to recent reviews on capsules as biological carriers.[8, 21, 
27]  
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1.2 Theranostics 
One of the future goals in medical treatment is so-called personalized medicine.[28] This term 
describes the idea to customize treatment of different patients based on their individual 
condition. The treatment should involve the identification of the molecular factors of the 
disease and from this the appropriate treatment and medication should be chosen. 
Moreover, this approach is expected to reduce unnecessary treatment, as ineffective drugs 
and therapies are to be prevented by the identification of the specific disease markers. In a 
further step, the outcome of the treatment should be monitored, so to be able to respond to 
side effects.[29] The major example where personalized medicine is expected to improve 
treatment is cancer.[30, 31] Theranostics is the term to describe the combination of therapy 
and diagnostics in one treatment.[32, 33] 
1.3 Scope of this Thesis 
In this thesis, the goal was to combine the needs of diagnostics and therapy using polymer 
capsules as carriers. Towards this goal, the starting point was the diagnostic tool. The 
intracellular ion homeostasis plays a crucial role for the cells and disturbances of it are often 
associated with diseases or with apoptosis of the affected cells.[34-37] Diagnosis here was 
based on capsules as intracellular optical pH sensors. There are numerous publications on 
optical sensors for intracellular ion sensing. However, very often there are also numerous 
shortcomings included.[38, 39] In many articles sensor systems are presented that show very 
good behavior in defined environment, for example buffers with varying concentration of 
the targeted ion. Yet, the claim that these sensors will work the same way intracellularly is 
often too strong as the intracellular environment is in many aspects different from a simple 
buffer solution. Hence, a study presenting a sensor system but no proof that the sensors 
work inside cells is incomplete and should be taken with a grain of salt. Studies including cell 
experiments often focus only on the proof that intracellular measurements are possible. 
Monitoring the behavior of the targeted ion concentration, however, is often excluded or 
only done over very short times.[40, 41] In the work described in section 3.1, the focus lay on 
the long-term monitoring of the dynamics of the lysosomal pH upon induced ion 
deregulation. pH was chosen for two reasons. First, pH is a ubiquitous quantity and relevant 
for many cellular processes. Second, optical sensing of other ions is not as easy and 
straightforward as might be expected. The fluorescent dyes available for intracellular sensing 
are usually pH-dependent in addition to their specific ion-sensitivity.[38] This problem is 
addressed in section 3.1, where the pH dependency of four commercial dyes is examined. 
Considering this, monitoring intracellular ion concentrations should be accompanied by 
observation of the local pH. The second objective of theranostics is therapy. For this 
purpose, the integration of genetic material, i.e. DNA and RNA, into eukaryotic cells was 
chosen as exemplary application, the so-called gene therapy. Transfection of cells with 
genetic material like DNA or RNA is a typical application in biological laboratories and for 
medical treatment purposes. Examples are transfection with green fluorescent protein (GFP) 
to mark cells,[42] but also knockout of genes such as in manuscript [A9] (cf. section 6.3), 
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where V-ATPases, which regulate the pH in vesicles like the lysosome, are knocked out or 
enhanced and the effect on the lysosomal acidification is measured. For the work described 
in section 3.2 and publication [A7][4], siRNA for knockout of GFP was used. By using capsules 
as carriers, certain advantages over the established methods can be obtained. These involve 
the protection of the nucleic acids against degradation before they reach their action site, 
the protection of the cell from adverse effects that can occur due to the transfection 
agent,[43] and also the possibility to perform transfection in serum-supplemented media.[44] 
In all cases, the advantages lie in the protective shield in form of the capsules. For the 
experiments, polyplexes with polyethyleneimine (PEI) and the nucleic acids, either DNA or 
siRNA, were synthesized and encapsulated in biodegradable capsules. By using this method, 
the properties of PEI for facilitating lysosomal escape of the nucleic acids could be utilized, 
while the toxic effects of PEI were diminished. The lysosomal escape is often ascribed to the 
so-called proton sponge effect,[45, 46] although this effect is still under debate. The proton 
sponge effect is stated to take place when polycations with buffering capacity, such as PEI, 
which at slightly acidic pH contains many deprotonated amine groups, buffer the pH in the 
lysosomes. The lysosomal pH hence does not decrease when proton pumps transfer protons 
from the outside into the lysosomes and thus influx of further protons takes place.[47] To 
ensure the charge and ion activity equilibrium across the lysosomal membrane, also chloride 
and water enter the lysosomes. This leads to swelling of the lysosomes and if the pressure 
rises high enough, the vesicles finally burst releasing their content to the cytosol.[48] In a first 
step for characterizing the delivery of genetic material, fluorescently labeled DNA was 
delivered to MDA-MB-231 cells and the distribution in the cells over time was observed. In a 
second step, silencing RNA (siRNA) was used to knock out GFP in GFP-transfected HeLa cells. 
The siRNA was also fluorescently labeled so it could be observed with the microscope. The 
quantification, however, was based on the GFP fluorescence of the cells. It could be shown 
that DNA and siRNA were set free from the capsules within a reasonable timeframe of less 
than 48 hours and that the knockout of GFP by siRNA was very efficient. Furthermore, the 
silencing could be performed in serum-containing media, which is a big advantage over 
standard protocols where transfection is done in serum-free medium,[44] which puts a lot of 
stress on the cells. In further experiments, another way of treatment, so-called enzyme 
replacement therapy (ERT) was employed. As mentioned already, the capsules are trafficked 
to the lysosomes of the cells after uptake. This paves the way for applications of capsules as 
carriers for the introduction of biologically active cargo into the lysosomes. There is a large 
family of diseases called lysosomal storage disorders (also lysosomal storage diseases, LSDs), 
which are characterized by defective enzymes in the lysosomes of one or more types of cells 
in the body.[49-51] Two diseases were picked for the treatment with enzyme-delivering 
capsules, Fabry disease and Krabbe disease. In case of Fabry, the enzyme α-galactosidase A 
(GLA) is defective throughout the body, mainly in the endothelial cells of blood vessels. For 
the in vitro-experiments, primary cells from mouse aorta of GLA-defective mice were 
used.[52, 53] The intracellular activity of the enzyme was determined. For this purpose, the 
cells were co-incubated with the encapsulated enzyme and a substrate. After 48 h of 
incubation, the substrate level inside the cells was measured and from this the efficacy of 
the delivery was obtained. The amount of substrate degradation was put into relation to the 
amount of delivered enzyme. In Krabbe disease, the enzyme galactocerebrosidase (GALC) is 
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defective in the oligodendrocytes of the patients, a type of glia cells in the brain. The 
experiments were performed with an oligodendritic cell line, MO3.13.[54, 55] In these cells, the 
enzyme GALC is still expressed in small amounts. Therefore, also knockout cells were used, 
where GALC was not expressed anymore. The cells are thus referred to as MO3.13 wild-type 
(MO3.13 WT) and MO3.13 knockout (MO3.13 KO) cells. GALC is responsible for the 
degradation of sphingolipids and galactosphingolipids. In Krabbe patients, these substances, 
especially psychosine and galactocerebroside, accumulate in the cells. Both are toxic for the 
oligodendrocytes. In the cell culture model, MO3.13 cells were incubated with psychosine to 
simulate the accumulation that happens in patients. The cytotoxicity of psychosine was also 
quantified with a viability assay to verify this. In this model, both diagnosis and therapy were 
performed to take the next step to theranostics. A time-resolved profile of the lysosomal pH 
during the accumulation of psychosine in the lysosomes was recorded for KO and WT cells 
for diagnosis of the effect of psychosine on the lysosomal pH. For therapy, the defective 
enzyme was delivered to the cells by capsules to inhibit the accumulation of psychosine. The 
effectivity of the delivery was quantified by a viability test by scrutinizing if cells suffered 
from psychosine also when GALC was provided by capsules.  
1.4 Goals 
In short, the following goals for this thesis can be defined: goal one was to establish a sensor 
system that was capable of diagnostic purposes in living cells. As the pH is a very important 
and furthermore a ubiquitous quantity in cells, it was chosen as parameter of interest. More 
specifically, the lysosomal pH was observed and the effect of external stimuli was quantified. 
Goal two addressed the applicability of capsules for therapy, i.e. the delivery of biologically 
active materials into living cells. Two different approaches were employed. One was to 
introduce siRNA into the cells to down-regulate the expression of the protein GFP, the other 
one was to directly deliver functional enzymes to the cells. The third goal was to perform 
diagnosis and therapy in one model and correlate the results. This was done in the Krabbe 
model, where the lysosomal pH was monitored in WT and KO cells, and the enzyme GALC 
was delivered to the cells.  
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2 Materials and Methods 
2.1 List of Chemicals  
Product (Abbreviation) Supplier Product  Number 
0.05 % Trypsin-EDTA Lifetech 25300-054 
BAC-SE Emp Biotech AF-0406-5 
2-N-(morpholino) ethansulfonic acid 
(MES) 
Sigma-Aldrich M8250 
Antibiotic-antimicotic (aa) Lifetech 15240-096 
Bovine Serum Albumin (BSA) Sigma-Aldrich A8806 
Ca(NO3)2 · 4H2O Sigma-Aldrich C1396 
CaCl2 · 2H2O Sigma-Aldrich 223506 
Calcium-Green-1 Lifetech C-3714 
Cd(C2H3O2)2 · 2 H2O Sigma-Aldrich 229490 
CoCl2 · 6 H2O Alfa Aesar 10692 
Commercial buffers pH 3 to 10 Sigma-Aldrich 38742 to 38749 
D-(+)-Glucose Sigma-Aldrich G8270 
Dextran sulfate sodium salt 
(6.5-10 kDa) (DexS) 
Sigma-Aldrich D4911 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich D4540 
Dulbecco’s Modified Eagle’s Medium 
(DMEM) 
Sigma-Aldrich D5030 
Dy-634-NHS-ester Dyomics 634-01 
Eagle’s Minimum Essential Medium 
(EMEM) 
Sigma-Aldrich M2279 
Ethylendiaminetetraacetic acid (EDTA) Sigma-Aldrich E5134 
Endothelial cell growth supplement 
(ECGS) 
Becton Dickinson 356006 
FeCl3 · 6 H2O Sigma-Aldrich 236489 
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Product (Abbreviation) Supplier Product  Number 
Fetal Bovine Serum (FBS) Biochrom S0615 
Fetal Bovine Serum (FBS) Lonza DE14-801F 
HCl (37 %) Roth 7476 
Heparin sodium salt Sigma-Aldrich H3149 
Hydrocortisone Sigma-Aldrich H0888 
KCl Sigma-Aldrich P9541 
L-Glutamine (L-Glu) Lifetech 25030-024 
L-Glutamine (L-Glu) Lonza 17-605E 
Mag-Indo-1 Setareh Biotech 6519 
MgCl2 Sigma-Aldrich M8266 
MgSO4 Sigma-Aldrich M2643 
N-(Ethoxycarbonylmethyl)-6-
Methoxyquinolinium Bromide (MQAE) 
Synthesized by Fabian Dommershausen, Koert Lab, 
FB Chemie, Philipps-Universität Marburg, Germany 
Na2CO3 Sigma-Aldrich S7795 
NaCl Roth HN00 
NaOH Roth 6771 
N-dodecanoyl-NBD-ceramide 
trihexoside (NBD-Gb3) 
Matreya 1631 
Non-essential amino acid solution 
(NE AA) 
Lonza 13-114E 
Penicillin/Streptomycin (P/S) Sigma-Aldrich P4333 
Phosphate buffered saline (PBS) Biochrom L1825 
Phosphate buffered saline (PBS) Lonza 17-516F 
Poly(allylamine hydrochloride) 
(56 kDa) (PAH) 
Sigma-Aldrich 283223 
Poly(sodium 4-styrenesulfonate) 
(70 kDa) (PSS) 
Sigma-Aldrich 243051 
Poly-L-Arginine hydrochloride 
(70 kDa) (pArg) 
Sigma-Aldrich P3892 
Potassium acetate Sigma-Aldrich 32309 
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Product (Abbreviation) Supplier Product  Number 
PrCl3 ·  x H2O Sigma-Aldrich 205141 
Psychosine Santa Cruz 
Biotechnology 
sc-202781 
Recombinant Human 
Galactosylceramidase/GALC, CF 
(Galactocerebrosidase, GALC) 
R&D Systems 7310-GH-005 
Replagal®  
(drug containing α-galactosidase A as 
active ingredient) 
Shire  
obtained from Abasolo Lab, Vall d'Hebron Institut 
de Recerca, Barcelona, Spain 
Resazurin Toxicity Assay Sigma-Aldrich TOX8-1KT 
RPMI medium HyClone SH30255.01 
SNARF® dextran (70 kDa) Lifetech D-3304 
SrCl2 · 6 H2O Sigma-Aldrich 255521 
Tris (hydromethyl) aminomethane 
(Tris) 
Sigma-Aldrich 154563 
Table 2.1 List of chemicals, suppliers, and order numbers. 
All chemicals were used as received. Water for experiments was purified with a Milli-Q 
Academic water purification system from Millipore (now Merck Millipore) and had a 
resistivity of 18 MΩ·cm.  
2.2 Capsule Synthesis 
2.2.1 Template Synthesis 
Polyelectrolyte multilayer capsules were synthesized by the co-precipitation method to form 
sacrificial CaCO3 templates followed by the LbL method to adsorb alternating layers of 
oppositely charged polyelectrolytes onto the templates.[2] Depending on the type of cargo, 
either Na2CO3 was mixed with the cargo solution first and then precipitated with CaCl2 to 
obtain CaCO3 particles containing cargo or vice versa, as can be found in the description of 
the different capsule syntheses. For the template formation, the first solution was mixed for 
30 seconds with the cargo solution prior to adding the second solution and mixing for 30 
seconds at a speed of 1000 rotations per minute (rpm) with a magnet stirrer. After 
formation of CaCO3 particles with entrapped cargo, the particles were spun down at 1000 
rpm with a centrifuge, the supernatant was removed and fresh Milli-Q water was added to 
rinse the particles from unreacted ions and cargo twice or three times.  
  
8 | P a g e  
 
2.2.2 Layer-by-Layer Adsorption of Polyelectrolytes 
Two different pairs of polyelectrolytes were used; for non-degradable capsules, polystyrene 
sulfonate (PSS, negatively charged, solutions of 2 mg/mL in NaCl (0.5 M), pH=6.5) and 
polyallanyl hydrochloride (PAH, positively charged, solutions of 2 mg/mL in NaCl (0.5 M), 
pH=6.5)) were used. For biodegradable capsules, dextran sulfate (DexS, negatively charged, 
solutions of 2 mg/mL in NaCl (0.5 M), pH=6.5)) and poly-L-arginine (pArg, positively charged, 
solutions of 1 or 2 mg/mL in NaCl (0.5 M), pH=6.5)) were adsorbed onto the templates. After 
the templates had been washed, they were resuspended in 1 mL of the positively charged 
polyelectrolyte solution and vortexed continuously for 15 minutes. Subsequently, the 
solution was centrifuged at 1000 rpm and washed twice or three times with Milli-Q water. 
Then, 1 mL of the negatively charged polyelectrolytes was added and the suspension was 
vortexed as before. This was repeated until the desired number of bilayers was adsorbed 
onto the templates. The CaCO3 core was removed with EDTA and the resulting hollow 
capsules were washed and re-suspended in water or buffer until further use.  
2.2.3 Synthesis of SNARF® Capsules 
SNARF® capsules were synthesized according to the procedure explained above. 615 µL of 
CaCl2 (0.33 M) in NaCl solution (0.5 M) were mixed with 770 μL of SNARF®-1 dextran (70 kDa, 
1 mg/mL in DMSO) for 30 seconds. Subsequently, 615 μL of Na2CO3 (0.33 M) in NaCl solution 
(0.5 M) were added quickly, and the solution was mixed for 30 seconds on a magnet stirrer 
at 1000 rpm. After resting for 2 minutes at room temperature, the resulting CaCO3 particles 
with entrapped SNARF® were washed twice with Milli-Q water. For the experiments with 
MCF-7 cells (cf. section 2.6), five bilayers of PSS and PAH were adsorbed to the cores, for the 
experiments with MO3.13 cells (cf. section 2.6), two bilayers were added. The template 
cores were removed with EDTA (0.2 M, pH=5 adjusted with HCl) by adding 1 mL EDTA 
solution to the particles and sonicating for 30 to 60 seconds until no further production of 
CO2 in form of gas bubbles could be observed. The capsules were washed three times with 
Milli-Q water and stored in water at 4 °C until use in experiments.  
2.2.4 Synthesis of α-Galactosidase A Capsules 
For the experiments, the Fabry drug Replagal®, which is a solution containing GLA as active 
ingredient, was used. Therefore, Replagal® is used as synonym for GLA in this thesis. The 
capsules were prepared as follows: 1 mL of Na2CO3 (0.33 M) in NaCl solution (0.5 M) was 
mixed with 1 mL of Replagal® solution (1 mg/mL) for 30 seconds prior to addition of 1 mL of 
CaCl2 (0.33 M) in NaCl solution (0.5 M) and mixing for 30 seconds at 1000 rpm. The resulting 
CaCO3 particles were washed and coated with 2 bilayers of DexS and pArg. After removal of 
the cores, the capsules were stored in water at 4 °C until use in experiments.   
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2.2.5 Synthesis of Galactocerebrosidase Capsules 
The synthesis of the cores was done with 50 µL of Na2CO3 (0.33 M) in NaCl solution (0.5 M), 
50 µL GALC (0.05 mg/mL in water), and 50 μL of CaCl2 (0.33 M) in NaCl solution (0.5 M). The 
templates were coated with 2 bilayers of DexS and pArg. After removal of the core the 
capsules were washed with Milli-Q water and kept in water at 4 °C until use in experiments.  
2.3 Cell Culture 
All cell lines used throughout the work for this thesis were of mammalian origin. With the 
exception of mouse aorta endothelial cells (MAEC, provided by Simo Schwartz and Ibane 
Abasolo from Vall d’Hebron Hospital, Barcelona, Spain), which are primary cells, all cell lines 
were immortalized commercial cell lines. MDA-MB-231 and MCF-7 cells were obtained from 
ATCC. Vero cells were provided by Jesús de la Fuente from the University of Zaragoza, Spain. 
Furthermore, for some experiments, genetically modified cells were used, in which certain 
proteins were expressed or silenced. This was the case for MO3.13 cells, where the enzyme 
GALC was silenced (referred to as MO3.13 KO cells then), and GFP-transfected HeLa cells. 
MO3.13 WT and MO3.13 KO cells were a gift from Marco Cecchini from Instituto 
Nanoscienze in Pisa, Italy. GFP-expressing HeLa cells were a gift from Christian Plank from 
Technische Universität München, Germany. All cells were kept in standard cell culture flasks 
or plates at 37 °C and 5 % CO2 and split twice or three times a week. For sub-culturing, the 
old medium was aspirated, the cells were rinsed with PBS, and Trypsin-EDTA 0.05 % was 
added for an appropriate time, which ranged from 1 to 10 minutes depending on the cell 
line, to detach the cells from the flasks. Then, two or three times the volume of Trypsin-
EDTA of complete growth medium was added in order to stop the effect of Trypsin-EDTA. 
The cell suspension was transferred into a centrifuge tube and centrifuged at a speed of 
1000 rpm for 5 minutes. The supernatant was decanted and the cells were re-suspended in 
fresh medium. The cells were then seeded in appropriate numbers in new flasks, or in cell 
culture dishes for experiments. MAEC, being primary cells, were more sensitive and 
therefore needed a slightly different treatment. The content of FBS was higher for low 
passages and the medium was supplemented with more additives to ensure healthy 
conditions for MAEC. In Table 2.2 the formulations of the cell media for the different cell 
lines used for this thesis are summarized. 
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Cell Line Basal Medium Additives (v/v) 
MAEC RPMI 1st and 2nd passage: 20 % hiFBS 
3rd and 4th passage: 15 % hiFBS 
5th and higher:          10 % hiFBS 
To all passages: 1 % L-glutamine, 1 % aa, 1 % NE AA, 
0.1 mg/mL heparin, 0.5 mg/mL ECGS, 0.001 mg/mL 
hydrocortisone 
HeLa GFP EMEM 10 % FBS, 1 % L-glutamine, 1 % P/S 
MCF-7 DMEM 10 % FBS, 1 % L-glutamine, 0.1% Insulin 1 % P/S 
MDA-MB-231 DMEM 10 % FBS, 1 % P/S 
Vero DMEM 10 % FBS, 1 % L-glutamine, 1 % P/S 
MO3.13 DMEM 10 % FBS, 1 % L-glutamine, 1 % P/S 
MO3.13 
differentiated 
DMEM 0.02 % FBS, 1 % L-glutamine, 1 % P/S 
Table 2.2 Media for the different cell lines. 
2.4 Viability Tests 
2.4.1 MTT Viability Tests of Psychosine in MO3.13 Cells  
For this test, help was obtained from Joanna Rejman. 
MO3.13 cells and MO3.13 KO cells were seeded in 96-well plates at a density of 5,000 cells 
per well. The cells were starved in culture medium with 0.2 % (v/v) FBS for 24 hours for 
differentiation. After that, the cells for capsule tests were incubated with 5 or 10 GALC 
capsules per cell or with 10 capsules only filled with amino dextran (70 kDa) for 24 hours. 
Then the cells were incubated with psychosine in starvation medium at various 
concentrations and incubated for 24 hours. The viability was scrutinized with the MTT test.  
2.4.2 Resazurin-Based Viability Tests of PEI and PEI Capsules 
MDA-MB-231 cells were seeded in 96-well plates at a density of 15,000 cells per well. The 
next day, the medium was aspirated and the cells were rinsed with PBS and incubated with 
PEI or PEI capsules at different concentrations, as described in the results, for 48 hours. 
Afterwards, the cells were rinsed with PBS and fresh medium containing 10 % (v/v) resazurin 
was added to the cells for 3 hours. At last, the fluorescence of each well was recorded with 
the plate reader of a fluorospectrometer. In the appendix, the test is described in detail at 
the example of metallic nanotubes and the corresponding metal ions, cf. section 5.3. The 
test with capsules was performed in the same way with the parameters mentioned above. 
The values for the PEI experiments were normalized with a linear function           
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between the minimum m and the maximum M of all experiments, i.e. data of capsules and 
free PEI. With the side conditions        and       , the two equations        
and        are obtained, from which the values of a and b were calculated. With the 
inverse of the function f, the values were normalized.  
2.5 pH Response Curves of Fluorescent Dyes 
The following is a slightly shortened version of the description presented in the supporting 
information of manuscript [A3][38] (cf. section 6.1). 
For the experiments with Mag-Indo-1 and Calcium-Green-1, Ca2+- and Mg2+-free buffers from 
Sigma-Aldrich were used and fine-adjusted with HCl or NaOH, respectively. 50 µg Mag-Indo-
1 were dissolved in 100 µL DMSO to prepare a stock solution of 0.5 mg/mL or 684 µM. 
Calcium-green-1 dextran was dissolved in water at a concentration of 1 mg/mL. From this, 
the molar concentration was calculated as cDextran= n/V = m/(MwV) = 1 mg/(70 kDa·1 mL) with 
the molar mass Mw. Taking into account that to each dextran molecule (70 kDa) 3.5 Calcium-
Green-1 fluorophores are bound, the concentration of Calcium-Green-1 in the solution is 
cCG1 = 3.5·cDextran =3.5 mg/(70 kDa·mL) = 50 µM. 1 M stock solutions of MgCl2 and CaCl2 were 
prepared in MilliQ water. Chloride-free buffers for experiments with MQAE and BAC-SE were 
prepared as follows: an alkaline buffer was prepared with 140 mM potassium acetate, 1 mM 
Ca(NO3)2, 2 mM MgSO4, 5 mM Glucose, and 20 mM tris(hydroxymethyl)aminomethane) 
(Tris). In parallel an acidic buffer was prepared similar to the alkaline buffer, but in which Tris 
was exchanged for 2-(N-morpholino)ethanesulfonic acid (MES) buffer. Buffers with different 
pH values were adjusted by mixing the acidic and alkaline buffers upon monitoring with a 
pH-meter (Satorius Professional Meter PP-50). 1 M KCl solution was prepared in Milli-Q 
water. 5 mg BAC-SE were dissolved in 1 mL DMSO to obtain a stock solution of 23 mM. This 
was further diluted in Milli-Q water for experiments. MQAE was dissolved in Milli-Q water to 
obtain a stock solution of 5 mM. Solutions of different pH and ion concentrations were filled 
into 96-well plates and fluorescence was recorded. The concentrations of the dyes and the 
corresponding ions are shown in Table 2.3. Solutions for the measurement were prepared by 
mixing 70 µL of buffer with 20 µL of salt solution of 5-fold concentration as stated in Table 
2.3 and 10 µL of the dye at 10-fold concentration as stated in Table 2.3 directly in the 96-well 
plates. 
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c(Calcium-Green-1) c(Mag-Indo-1) c(MQAE) c(BAC-SE) 
5 µM 68.4 µM 0.5 mM 100 µM 
    
c(Ca2+)[µM] c(Mg2+)[mM] c(Cl-)[mM] c(Cl-)[mM] 
0 0 0 0 
0.05 0.1 5 5 
0.1 0.25 10 10 
0.15 0.5 20 15 
0.5 1 40 20 
1 2 60 25 
5 4 80 30 
10 6 100 40 
25 8 150 50 
50 10 300 100 
100 50 500 150 
250 100  200 
Table 2.3 Concentrations of the dyes and the corresponding ions. 
2.6 pH Sensing in Living Cells with SNARF® Capsules 
2.6.1 pH Calibration Curves of SNARF® Capsules 
The calibration curves of the SNARF® capsules were obtained by taking images of the 
capsules in commercial buffers from pH 3 to pH 10 (cf. list of chemicals, Table 2.1), 
measuring the ratio of the fluorescence intensities in the green and the red channel, and 
fitting the values with a sigmoidal function (cf. Figure 2.1 and section 3.1.3) 
       
   
      
    
 
 
    
with fit constants a, b, c, and d. The batch of capsules for the experiments with MCF-7 cells 
was imaged with a widefield microscope, the batch for the experiments with MO3.13 cells 
with a confocal laser scanning microscope (CLSM).  
2.6.2 pH Sensing in MCF-7 Cells upon Addition of Monensin 
Course of Experiments 
MCF-7 cells were seeded in 8-well plates (Ibidi -slides) at a density of 15,000 to 25,000 cells 
per cm2 in culture medium and incubated overnight at 37 °C and 5% CO2. After 24 hours, the 
medium was exchanged and SNARF® capsules were added to the cells at a concentration of 
20 to 40 capsules per seeded cell. The cells were observed with a widefield microscope 
equipped with an automated stage in time intervals of two to four hours. 15 to 30 positions 
were chosen and observed during the whole experiment. After at least 12 hours of 
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incubation with capsules, the medium was aspirated, the cells were rinsed with PBS, and 
fresh medium containing 20 µM monensin was added to the cells. The cells then were 
observed for four hours in time intervals of one hour. Subsequently, the monensin-
containing medium was aspirated, the cells were rinsed with PBS, and fresh medium was 
added. The cells were then observed again in intervals of 2 to 4 hours until the end of the 
experiment. 
Image Processing and Data Presentation 
The goal was to obtain a time series of the lysosomal pH of the cells. For each experiment 
the capsules in each image were detected and a region of interest (ROI) was drawn around 
the area of the capsule in the image of the overlay of the transmission and the fluorescence 
channels. The fluorescence intensity of both channels was measured and the ratio was 
plotted versus time. 
2.6.3 pH Sensing in MO3.13 Cells upon Addition of Psychosine 
Course of Experiments 
These experiments were carried out on a CLSM with automated stage and autofocus and an 
incubation chamber to keep the cells at 37 °C and 5 % CO2 over the course of the 
experiments. This made it possible to take time series of a number of positions of the sample 
automatically, typically 8 to 16. Additionally, tile scans were performed which means that 
neighboring squares of 512 x 512 pixels were imaged automatically. Usually images of 4 tiles 
were taken for each position. MO3.13 WT or MO3.13 KO cells were seeded in 8-well plates 
at a density of 1.5·104 cells per cm2. After 24 hours, five capsules per seeded cell were added 
and the cells were deprived of serum for 24 hours yielding differentiated cells. Then, the 
cells were incubated with psychosine-containing, serum-free medium at a concentration of 2 
or 10 µM, or no psychosine in case of the controls. The acquisition time varied between 15 
and 24 hours with time intervals of 10 or 15 minutes between the points in time.    
Image Processing and Data Presentation 
The ratio of the green and the red channel was obtained as described above. This time, the 
intensity ratio was converted into a pH value by use of the inverse function of the calibration 
curve of the capsules. The average of the pH values of all internalized capsules of one 
experiment was built for every point in time. As the curves obtained in this manner show 
large variations among neighboring points in time, a lowpass filter in form of the “moving 
mean” of the time series was calculated and plotted instead. For the moving mean, instead 
of the value of the point in time tn, the average of the value tn and the neighboring values, in 
this case tn-2, tn-1, tn+1, and tn+2, was calculated and plotted. To obtain a complete curve the 
first value is the same as in the mean curve, and the second value was calculated as average 
of the first three values. Similarly, the last two values were obtained. Figure 2.1 shows the 
calibration curve and, as example, the mean and moving mean of one experiment with 
MO3.13 KO cells and 10 µM psychosine.  
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Figure 2.1 Evaluation of capsule pH values. a) Calibration curve of the SNARF® capsules. The fit was done with the 
function f and revealed the values a-d. b) Mean and moving mean for one experiment with psychosine. The ratio values 
of the fluorescence channels (indicated as I640 for the red fluorescence peak of SNARF® and I580 for the yellow-green 
fluorescence peak of SNARF® in the calibration curve) are converted into pH values using the inverse function of the 
calibration curve.   
 
2.6.4 Determination of Intracellular α-Galactosidase A Activity  
These experiments were conducted at Vall d’Hebron Institut de Recerca, Barcelona, Spain, 
under guidance of Maria-Eugenia López Sánchez. The amount of Replagal® in capsules was 
determined by Western Blot by Natalia García Aranda. 
2.6.4.1 Isolation of Endothelial Cells from Mouse Aorta 
This was not part of the work for this thesis. The cells were already obtained and frozen in 
the past by the group of Ibane Abasolo and could be used directly for the experiments. 
However, the procedure of isolation is summarized shortly here for completeness. 
Mice bearing the Fabry enzyme defect are sacrificed and the aorta is removed, cleaned, and 
cut into rings of 2 mm thickness. These rings are placed onto collagen-coated culture dishes 
and supplemented with MAEC growth medium containing 20 % FBS (cf. Table 2.2). The cells 
now detach from the rings and spread in the dishes automatically. After 5 to 10 days the ring 
is removed and cells can be collected for experiments or grown further until confluence is 
reached. The procedure is explained by Shu et al. in their publication “An in vitro model of 
Fabry disease”.[53]  
2.6.4.2 Preparation of NBD-Gb3 Medium  
The substrate for Replagal® in the MAEC assays was the fluorescent N-dedecanoyl-NBD-
ceramide trihexoside (NBD-Gb3) as depicted in Figure 2.2. The sugar rings are removed by 
Replagal® and the remaining molecule can be further processed until the fluorescence is 
lost. This fluorescence loss is quantified and used as measure for the intracellular activity of 
Replagal®.  
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Figure 2.2 NBD-Gb3 structure formula. NBD-Gb3 is a fluorescent molecule. Replagal® removes the sugar rings 
and inhibits the accumulation of NBD-Gb3 in the lysosomes. The remaining molecule can be further 
processed and fluorescence is lost. 
To make the substrate available to the enzymes in the lysosomes, it needed to be prepared 
in order to make uptake possible. NBD-Gb3 needs a carrier to enter the cells which here was 
bovine serum albumin (BSA). The medium with the substrate was prepared as follows. A 2 % 
solution of BSA in NaCl solution (9 mg·mL-1) was prepared. NBD-Gb3 was dissolved in DMSO 
at a concentration of 4 mM. 10 µL of the solution was heated 10 minutes at 60 °C and 
vortexed from time to time. 130 µL of the 2 % BSA solution was added dropwise and the 
solution was shaken at 37 °C for 20 minutes. Afterwards, another 140 µL of 2 % BSA solution 
were added and the solution was mixed. The solution was filtered through a column 
(Sephadex G25, VWR) to remove unreacted NBD-Gb3. For cell experiments, the solution was 
diluted 500-fold in complete growth medium. As the reaction yield may differ among 
batches of NBD-Gb3 medium, the results of the cytometry experiments were always 
compared to a positive control, which represented the maximum fluorescence possible for 
the respective batch.  
2.6.4.3 Conduction of Cell Experiments 
MAEC were seeded in standard 24-well cell culture plates. 105 cells were seeded in 0.5 mL of 
growth medium appropriate for the given cell passage for 24 hours. Then the medium was 
exchanged for medium containing NDB-Gb3 and Replagal® or Replagal®-containing capsules, 
respectively. 48 hours later, the cells were rinsed with PBS and trypsinized. The trypsin was 
removed by centrifugation and the cells were re-suspended in 350 µL of ice-cold PBS and 
stored at 0°C until use for cytometry.  
2.6.4.4 Evaluation 
The events were plotted as scatter plot with side scattering (SCC) versus forward scattering 
(FSC). From this plot the cells were gated for the first time to exclude events of small size 
which were too small to be cells, cf. Figure 2.1. From these events, only those were chosen 
where the fluorescence signal was within gate 2. This gate was adjusted from the negative 
control, i.e. cells neither incubated with NBD-Gb3 nor Replagal® or Replagal® capsules. The 
gate was set in such a way that 2 % of the control cells were inside gate 2.   
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Figure 2.1 Example plots of the gating for the evaluation of the flow cytometry experiment. a) Events are plotted as 
scatter plot with side scattering versus forward scattering. Gate 1 excludes events of elements which are smaller than 
cells. b) The gated cells are plotted as scatter plot with the collected fluorescene versus side scattering. Cells are gated 
again, this time according to their fluorescence signal.  
The positive control was done with cells incubated with NBD-Gb3, but without Replagal® or 
Replagal® capsules. Cells without Replagal® treatment cannot metabolize NBD-Gb3, and 
therefore, they set the maximum percentage of fluorescent cells. The results of the cells 
treated with Replagal® or Replagal® capsules are put in relation to the positive control to 
determine the efficacy of the treatment (cf. section 2.6.4.2). The efficacy was finally plotted 
against the mass concentration of the administered Replagal® either as solution or in 
capsules.  
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3 Results 
3.1 Ion Sensing with Fluorophores, Stimulation and Sensing 
of pH in Cells 
Work described in this section was used for the manuscript of [A3][38] and publication [A6][6] 
(cf. section 6). The data showing pH dependences of fluorescent dyes were recorded and 
evaluated by the author. Data in publication [A6] were obtained by more than one person. 
All data described in this thesis, however, was recorded and evaluated by the author as well 
as additional data used for [A6] although not presented here. 
3.1.1 pH Sensing with Fluorescent Dyes 
In the context of medical or pharmaceutical purposes, monitoring the internal properties of 
a cell is of highest interest, as many diseases are triggered by malfunctions of cells. In many 
cases, the homeostasis of the cells is influenced and alterations of intracellular properties 
can occur. One of the most fundamental properties in this manner is the pH. The activity of 
enzymes, for example, is dependent on the pH value and deviations from the appropriate pH 
lead to low activity and can in the worst case harm the enzyme irreversibly. Furthermore, pH 
gradients across cellular membranes play an important role as they ensure that the cell can 
extract energy from transport processes across membranes. pH monitoring in living cells can 
help to study proliferation, apoptosis, and endocytosis, among others.[56-59]  Moreover, there 
are many examples of diseases where the pH regulation in the affected cells or tissue is 
disturbed.[60, 61] Monitoring pH can therefore be used to identify affected cells or vice versa 
tell, if a certain drug is capable of stopping the pH regulation disturbance. A straightforward 
way is to use cell-permeant forms of a dye, e.g. acetoxymethyl ester derivates. These dyes 
are electrically neutral and are taken up by cells via osmosis. Either they show a spectral shift 
upon change of pH or the emission intensity alters. As the cellular fluids are very complex, 
there are many ways in which the dye can be influenced, e.g. by binding to proteins.[62] 
Therefore, to measure accurate pH values, the dye must be calibrated intracellularly. The 
most common way to do this is the use of nigericin, a K+/H+ ionophore.[63] After treatment 
with nigericin, the intra- and extracellular pH value equilibrate and the intracellular pH can 
be adjusted by change of the extracellular pH. However, there are some problems 
associated with these kinds of measurements. During long-time measurements, the cells 
sequester parts of the dye, which leads to lower signal although no actual change of pH may 
have happened. Fading, also called photobleaching, is another problem in long-time 
experiments. In this case, repeated illumination leads to lower signal due to reaction of the 
dye with radicals, e.g. reactive oxygen species, into non-fluorescent molecules.[64, 65] 
Furthermore, a ratiometric measurement is preferred as it excludes sources of errors such as 
local gradients of the concentration of the dye, fluctuations of the illumination intensity over 
time, different exposure times, etc.[66, 67] For ratiometric measurements, however, a second 
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dye is needed as a reference where the ratio of the local concentrations of the two dyes is 
constant and the ratio of the intensities is pH-dependent, at least in the interesting pH 
range, which is around 4.5 to 8 for cells.  
3.1.2 pH Dependence of Organic Fluorophores 
Apart from protons, the most critical ions in cells are Na+, K+, Ca2+, Mg2+, and Cl-. The 
concentrations of Na+, K+, and Cl- are, for example, of special importance for muscle cells and 
neurons as the formation of action potentials is dependent on them. Ca2+ is important for 
the release of neurotransmitters and muscle contraction and can serve as cofactor for 
enzymes. Mg2+ also is a cofactor for many enzymes. The use of ATP as energy source for the 
cell is, for example, only possible if magnesium is bound to the ATP. There are many organic 
fluorophores available to sense and measure intracellular concentrations of the mentioned 
ions. However, many of the dyes available tend to be pH-sensitive in addition to their 
specific ion and may be sensitive to other ions.[68] For example, the potassium- and sodium-
sensitive dyes PBFI and SBFI, respectively, show crosstalk with the correspondent other 
ion,[23, 38] and the Mg2+-sensitive dye Mag-Indo-1 can also be used for sensing Ca2+. In Figure 
3.1, the pH dependence of the chloride-sensitive dyes MQAE and BAC, the calcium sensor 
dye Calcium Green-1, and the magnesium sensor dye Mag-Indo-1 are depicted. In all cases, 
the fluorescence intensity is clearly dependent on pH. In the plots of the chloride-sensitive 
dyes, intensity values rise especially for low pH values, whereas for higher values, from pH 6 
to 10, the profile only slightly changes for constant chloride concentration. For the other two 
dyes, the fluorescence intensity is clearly dependent on pH as well. This means in principle 
that measurements with all these dyes need to be supported also by pH measurements to 
obtain clear results on changes of concentrations of the desired ions.  
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Figure 3.1 Response curves of ion-sensitives dyes to the respective ion and pH. a) Fluorescence intensity of MQAE against 
Cl
-
 and pH. b) Fluorescence intensity of BAC in dependence of Cl
-
 and pH. c) Fluorescence intensity of Calcium-green-1 
against Ca
2+
 and pH. d) Fluorescence intensity of Mag-Indo-1 in dependence of Mg
2+
 and pH. In all cases the fluorescence 
intensity is dependent on pH in addition to the respective ion. The figure has been taken from publication [A3].
[38]
 
3.1.3 Intracellular pH Sensing with Capsules 
One application of capsules is their use as intracellular sensors. Thereby, advantage is taken 
of the porosity of the capsules, as small ions can freely diffuse through the capsule walls,[69] 
whereas the dye can be bound to bigger molecules such as dextran to keep it trapped inside 
the cavity. The use of capsules or other carriers has some advantages over the free dye. As 
the probe is confined to a small volume, the local concentration of the dye does not 
influence the measurement. For the free dye, problems can occur when the concentration of 
the dye is not evenly distributed as then the signal obtained is dependent on the 
concentration of the dye and on the concentration of the analyte.[70] Moreover, the capsules 
protect the dye from unspecific binding, sequestering, and degradation inside the cells.[22] 
Vice versa, the capsule also protects the cell from the dye. This opens the possibility to use 
molecules, which intrinsically are toxic for the cells or have other undesired effects. To 
perform intracellular sensing with capsules, they were filled with the pH-sensitive dye 
SNARF® bound to dextran. This dye has two emission maxima, one at 580 nm, and one at 
640 nm. The maximum at 580 nm grows with smaller pH, whereas the one at 640 nm grows 
with higher pH. The ratio of both maxima can be used to obtain a calibration curve of the 
dye. In Figure 3.2, the calibration curve for one batch of SNARF® capsules is depicted. The 
capsules can be used as sensors roughly from pH 6 to 9, as above and below the slope 
vanishes and hence the ratios cannot be related to a specific pH value anymore.  
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Figure 3.2 Calibration curve of SNARF® capsules from widefield microscopy images. Capsules were suspended in 
commercial buffers from pH 3 to 10 and the ratio of the fluorescence intensities was measured. The figure has been 
adapted from publication [A6].
[6]
 
3.1.3.1 Lysosomal pH Measurement in MCF-7 Cells with SNARF® Capsules 
The SNARF® capsules were used as intracellular reporters for the lysosomal pH of MCF-7 
breast cancer cells. Capsules in the extracellular medium served as control capsules to 
confirm that changes of the color of the capsules did not take place automatically as an 
intrinsic feature of the capsules. In Figure 3.3, curves of intra- and extracellular capsules are 
plotted as function of time. The red line displays extracellular capsules and the green one 
internalized capsules. The ratio of the red and green intensity is plotted, which means that 
higher values correspond to higher pH. The green line stays constant throughout the 
measurements. The red one starts from a higher value, but after 10 hours, the value reaches 
its baseline, although the pH in the extracellular medium is kept constant throughout the 
experiment. The drop of the ratio of the red curve can be ascribed to photobleaching. After 
10 hours, the bleaching does not influence the ratio anymore. In the green curve, no sign of 
photobleaching is observable. The reason is that SNARF® bleaches stronger in alkaline than 
in acidic conditions.[71, 72] 
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Figure 3.3 MCF-7 cells were incubated with SNARF® capsules and the fluorescence intensity ratio was monitored over a 
period of 50 hours. Intracellular capsules (green curve) show that the intracellular pH does not change during that time. 
Extracellular capsules start from a high value but then tend to be constant. The drop within the first 10 hours is ascribed 
to photobleaching. Error bars indicate standard deviations. The figure has been adapted from publication [A6].
[6]
 
3.1.3.2 Stimulation of the Lysosomal pH of MCF-7 Cells and Detection with SNARF® 
Capsules 
The capsules were used now to monitor the lysosomal pH under influence of substances that 
are reported in the literature to influence the lysosomal or generally the cellular pH. The 
substances tested were amiloride, bafilomycin A1, chloroquine, and monensin. The 
mechanisms influencing the pH were of different nature. In this section, only the example of 
monensin will be described. Details for the other substances can be found in the publication 
and its supporting information.[6] Monensin is a Na+ ionophore, which means that it can bind 
to sodium ions and transport them through cell membranes. It is not specific to sodium ions 
but can bind also to potassium and other monovalent cations.[73] However, in cells it plays an 
important role as Na+/H+ antiporter. This means that it transports sodium ions through 
membranes in one direction and protons in the other direction. Thereby, it abolishes sodium 
and pH gradients in the cells.[74] In Figure 3.4, the plot of one monensin experiment is 
displayed. The yellow bar indicates the period when monensin was added. The red curve 
again shows photobleaching in the beginning (cf. Figure 3.3). The green curve has a baseline 
slightly above one, but when monensin is added the ratio rises to that of the extracellular 
capsules very fast, meaning that the lysosomal and the extracellular pH equilibrate during 
the presence of monensin. The peak keeps a high level during the presence of monensin. As 
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soon as there is equilibrium of pH and sodium ions across a membrane, a further increase of 
the pH value is not possible. This means that the equilibrium was reached within one hour. 
The fast decrease of the green curve after the washing supports this. By rinsing the cells, the 
effect of monensin is completely diminished within one hour. 
 
 
Figure 3.4 Fluorescence ratio of internalized (green curve) and extracellular (red curve) capsules over time. The yellow 
bar indicates the time when monensin was present. The intracellular values clearly rise during the presence of monensin 
showing a rise in pH. After the cells have been rinsed the ratio and thus the pH drops to its normal value. The inset shows 
the structure formula of monensin. Error bars indicate standard deviation. The figure has been adapted from publication 
[A6].
[6]
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3.2 Capsules for Intracellular Delivery of Genetic Material 
The results were used for publication [A7][4] (cf.section 6). The author did all quantitative 
evaluation of images leading to the results depicted in Figure 3.6, Figure 3.8, and Figure 5.2 
as well as the cytotoxicity assays shown in Figure 3.9.  
3.2.1 Introduction  
Despite the established methods, there is need for other or improved means of delivery of 
the genetic material to cells. Viral vectors usually show a high transfection rate and are 
therefore the preferred vectors. They, however, raise concerns because of mutagenesis, i.e. 
the possibility that the viral vectors trigger mutations of the genome, and immunogenicity, 
i.e. the possibility that viral vectors induce an unwanted immune response.[75-77] This is the 
reason why, so far, only one gene therapy has been approved in Europe, namely Glybera® 
from uniQure.[78, 79] Non-viral vectors such as lipoplexes and polyplexes, in contrast, show 
only small transfection rates. Microinjection does not allow for high numbers of transfected 
cells, as the transfection is very time-consuming and not automatable. Furthermore, it does 
not allow for in vivo-transfection, which is also true for electroporation. Thus, other carries 
are of interest both for in vitro- and in vivo-transfection. A bio-compatible carrier is desired, 
which protects the genetic material against degradation before it reaches its target, 
facilitates cell internalization, and enables controlled release of the genetic material.[80] 
Biocompatible capsules have been synthesized by many groups and subsequent release into 
the cytoplasm has been achieved for different cargo, such as proteins, DNA, or RNA.[3, 9, 17, 18, 
81, 82]   
3.2.2 Delivery of DNA 
This study was a comparative study where the delivered amount of DNA was quantified for 
different delivery systems. Cells were incubated with plain DNA, PEI/DNA polyplexes, 
PEI/DNA polyplexes encapsulated in biodegradable capsules, and PEI/DNA polyplexes 
encapsulated in non-degradable capsules. Standard transfection protocols with polyplexes 
are performed in serum-free growth medium.[44] Here, a comparison for media with and 
without serum was performed. The amount of DNA for each of the experiments was 
equalized so that a comparison based on the administered amount of DNA was possible. In 
Figure 3.5, images of HeLa cells at different points in time and for the different ways of 
delivery are shown. The images show cells incubated without serum. The DNA was labeled 
with the fluorophore Cy5 and is colored in violet and PEI was labeled with FITC and is colored 
in green. The result of the overlay of violet and green is white. In the images, one can see 
that cells with plain DNA and PEI/DNA polyplexes show no fluorescence signal at any point in 
time. With both capsule types, the cells show fluorescence signal but only cells incubated 
with biodegradable capsules show fluorescence in the cytosol, whereas in non-degradable 
capsules the signal is confined to the area of the capsules. The PEI, however, is distributed in 
the cytosol also in case of non-degradable capsules. Note that the amount of PEI/DNA 
polyplexes is very small compared to what is stated in standard protocols. This was due to 
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the small amounts needed for the delivery by capsules and the fact that the comparison was 
based on the amount of DNA added to the cells. Furthermore, the cells begin to become 
round at later times as the serum-free medium stresses them.  
 
Figure 3.5 MDA-MB-231 cells were incubated with free DNA, DNA/PEI polyplexes, biodegradable (DexS/pArg)5 capsules 
with embedded PEI/DNA, and non-degradable (PSS/PAH)5 capsules with embedded PEI/DNA. After different incubation 
times t, as indicated in the top panel, cells were imaged. The transmission channel shows the cells, and the green and 
violet channels show the emission of the FITC labels and Cy5 labels of PEI and DNA, respectively. Images from serum-free 
experiments are shown.  The scale bar corresponds to 20 m. The figure has been taken from publication [A7].
[4]
 
The delivery efficacy was quantified by image analysis. The area of each cell was determined 
from the transmission channel and the mean fluorescence intensity in that area was 
measured. Fluorescence from the area of the capsules was not included. The mean 
fluorescence of the cells was averaged and plotted as column diagrams in Figure 3.6. The left 
graph corresponds to serum-free incubation and the right graph to cells in serum-containing 
medium. The amount of DNA delivered was highest for biodegradable capsules and already 
took place within less than 24 hours of incubation. DNA transport was not observable for 
free DNA or PEI/DNA polyplexes in serum-free medium, which is also visible in the images in 
Figure 3.5. However, non-degradable capsules could deliver a small but observable amount 
in serum-free medium. In serum-containing medium, free DNA and PEI/DNA polyplexes 
show a small effect. Nevertheless, here, as well as in serum-free medium, the biodegradable 
capsules have a much higher efficacy. Moreover, the amount delivered DNA with 
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biodegradable capsules is clearly higher in serum-containing medium than in serum-free 
medium.  
 
Figure 3.6 From the microscopy data as presented in Figure 3.5, for each cell in each recorded image the integrated 
fluorescence intensity IDNA was determined. The integrated fluorescence intensity corresponds to the area of the cell 
(determined from the transmission channel) times the mean fluorescence intensity from the Cy5 channel in that area. 
Fluorescence originating from the capsules was not considered, but only fluorescence located in the cytosol. The mean 
fluorescence intensities, as observed for the different ways  of delivery, are displayed for incubation in a) serum-free and 
in b) serum-containing media together with the corresponding standard deviations. For each data point at least 30 cells 
were analyzed. The figure has been taken from publication [A7].
[4]
 
Cells deprived of serum will suffer from stress, which in turn influences the metabolism. 
Therefore, transfection in serum-containing medium is clearly preferred. Here, it could be 
shown that transfection with biodegradable capsules offers a possibility to do that and the 
capsules provide protection for the DNA in the extracellular medium.  
3.2.3 Delivery of siRNA with Capsules for Knockout of GFP 
In the section above, the amount of delivered DNA was measured and quantified. In a 
further step, silencing RNA (siRNA) was used to transfect cells and to determine the efficacy 
of transfection with biodegradable capsules. For this purpose, GFP-expressing HeLa cells and 
siRNA capable of knocking out GFP were used. The cells were kept in serum-free medium for 
these experiments. The comparison here was made only between cells incubated with 
biodegradable siRNA-containing capsules and polyplexes. In Figure 3.7, images of the cells 
are shown. In this case, PEI was labeled with Dy-651 and colored in violet and siRNA was 
labeled with AF-546 and colored in red. GFP is depicted in green. The left panel shows cells 
incubated with polyplexes and the right one cells incubated with polyplex-containing 
biodegradable capsules. The cells incubated with polyplexes keep their green fluorescence 
over the entire time, while in the images of cells incubated with capsules the fluorescence is 
lost after 30 hours in the cells marked with asterisks. After 20 hours, the cells with capsules 
clearly show distribution of PEI (violet) in the cytosol. The insets labeled with the number 
sign (#) in the polyplex panel show that there is siRNA present in the cells (red label). These 
images were enhanced in contrast to make the red fluorescence visible.  
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Figure 3.7 GFP-expressing HeLa cells were incubated with free (left column) and encapsulated (right column) PEI/siRNA 
polyplexes. Live images of the same cells were taken over time t. Besides the transmission channel showing the cells, 
also GFP (green), AF-546 labeled siRNA (red), and DY-651 (violet) labeled PEI are displayed.  The straight arrow indicates 
a homogenous cytosolic distribution of PEI, whereas the dashed arrow shows a punctuate distribution. Cells marked with 
asterisks have clearly lost their GFP fluorescence. The insets (#) correspond to images of the polyplexes. For clarity, these 
insets were enhanced in contrast in order to show the presence of the siRNA inside the cells. The scale bars correspond 
to 10 m. The figure has been taken from publication [A7].
[4]
 
From images as presented in Figure 3.7, the fluorescence intensity in the cells was 
measured. In the transmission channel, the area of each cell was determined and the mean 
GFP intensity was measured. To calculate the mean of these cells, only cells in between the 
0.25- and the 0.75-quantile were used to exclude outliers. Cells dividing, for example, have a 
much higher mean intensity as the cell contracts to a spherical form. In Figure 3.8, the mean 
intensity was plotted against time for cells incubated with polyplexes, cells incubated with 
capsules, and untreated control cells. The amounts of siRNA added to the cells were 
comparable, 6.4·10-3 µg via capsules and 10·10-3 µg via polyplexes added to 2·104 seeded 
cells in 300 µL of medium. The graph clearly shows that encapsulated polyplexes decrease 
the GFP fluorescence after 30 hours of incubation. On the contrary, both polyplexes and 
control cells do not show any effect. It has to be noted that an amount of 400·10-3 µg under 
the same conditions was sufficient to knock out GFP successfully. This can be found in the 
appendix in section 5.1.  
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Figure 3.8 GFP-expressing HeLa cells were incubated with free encapsulated PEI/siRNA polyplexes. The total amount of 
siRNA and PEI was 6.4·10
-3
 µg and 25·10
-3
 µg for capsules and 10·10
-3
 µg and 12.5·10
-3
 µg for polyplexes, respectively. 
Images were taken at different points in time t (cf. Figure 3.7) and the mean integrated fluorescence density of GFP, i.e. 
the area of each cell times its mean fluorescence intensity, is displayed. The error bars represent standard deviations of 
the mean. The figure has been taken from publication [A7].
[4]
 
These results mean that encapsulated polyplexes are much more efficient for the delivery of 
siRNA into cells than plain polyplexes. Furthermore, the advantages mentioned in the 
beginning of the section, protection of the siRNA against degradation, high biocompatibility, 
and controlled release of the cargo can be utilized.  
3.2.4 Cytotoxicity of PEI Polyplexes and Encapsulated PEI 
One concern not dealt with yet is the toxicity of PEI for cells, which has been described 
regularly for PEI polyplexes.[43, 46, 83] The capsules offer a way to circumvent this problem as 
they not only facilitate protection of siRNA against degradation but also protection for the 
cells from PEI. This was verified by a resazurin-based toxicity assay. The toxicity of PEI and 
PEI in biodegradable capsules as tested. The results are depicted as a function of added mass 
of PEI to make the experiments comparable. A linear function between the minimum and 
the maximum value was used to normalize the values (cf. section 2.4.2). Note that the value 
for zero PEI could not be plotted due to the logarithmic scale but lies in the same range as 
the smallest plotted value.   
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Figure 3.9 Reduction of cell viability caused by encapsulated and non-encapsulated PEI. The normalized cell viability in 
terms of resorufin fluorescence intensity I versus the amount of added PEI mPEI is displayed. The average of six (PEI 
capsules) and three (PEI solution) independent measurements is displayed. Higher amounts of encapsulated PEI could 
not be measured as there is a threshold at which the capsules themselves can induce toxicity if added in too high 
quantities to the cells
[84]
. The error bars represent standard deviations of the mean. The figure has been taken from 
publication [A7].
[4]
 
The value where 50 % of the cells had died was (0.80 ± 0.02) µg, as obtained from fitting 
with the sigmoidal function 
     
         
   
 
  
 
      . 
For the capsules, larger amounts of PEI than plotted were not added to the cells because at 
some point the capsules themselves may introduce adverse effects,[85] and also the cells do 
not have the capability to take up arbitrarily high numbers of capsules. Nonetheless, the 
graphs show that the toxicity of encapsulated PEI is much less than that of free PEI. The 
number of capsules added to the experiments corresponding to Figure 3.7 and Figure 3.8, 
respectively, was 20 capsules per seeded cell, which accords to 25 ng in the whole well. In 
the toxicity test, this accords to 0.1875 ng, as only 1.5·104 instead of 2·104 cells were seeded 
per well. At this amount, however, the viability of the cells is not affected. This means that 
the capsules protect the cells from the PEI of the encapsulated polyplexes. 
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3.3 Capsules for Sensing and Enzyme Delivery in Lysosomal 
Storage Disease Models  
The work presented in this section was used for the preparation of the manuscript [A8] (cf. 
section 6). Work done by the author includes all capsule preparations, all pH time series 
from the experiments to the evaluations, preparation of cells for cytometry measurements, 
and parts of the cytotoxicity experiments. Cytometry runs and processing of the data were 
done under guidance of Maria-Eugenia López Sánchez. Western Blots were taken out by 
Natalia García Aranda. Help for MTT-assays was obtained from Joanna Rejman.  
3.3.1 Introduction 
Lysosomal storage diseases result from the deficiency of certain enzymes in the lysosomes of 
cells. So far, round about 50 LSDs are known. Each single disease is very rare in the 
population, but taken together make for a rate of 1 in 4000-8000 live births.[51] Approved 
treatment is only available for six of these diseases so far and relies on so-called enzyme 
replacement therapy, in which the patients are administered the defective enzyme via 
infusion.  
3.3.2 Fabry Disease 
One of these six diseases where treatment is available is Fabry disease. Patients with Fabry 
lack the enzyme GLA. This enzyme is responsible for the degradation of 
globotriaosylceramide (Gb3). There are two drugs approved for treatment, Replagal® from 
Shire and Fabrazyme® from Genzyme. However, there is need for improvement of these 
treatments for several reasons: first, so far the defective enzyme is injected as solution into 
the blood stream, which means that the enzyme is unprotected against degradation. This 
degradation already can happen in the body outside the cells, but also inside the cells the 
enzyme can be degraded before it begins its work in the lysosome.[86] The advantage of 
capsules is therefore the protection of the drug against degradation in the body. Second, 
Replagal® enters the cells through receptor-mediated uptake by mannose-6-phosphate 
receptors. These receptors, however, may not be expressed homogeneously in all relevant 
organs of the patient, leading to imbalanced distribution of Replagal® in the body and thus 
ineffective treatment of the patient.[49] This can be evaded by use of capsules as shell, as 
their uptake is independent of receptors. Third, many patients begin to express antibodies 
against Replagal® and treatment becomes ineffective or inefficient.[49, 87] The mechanism 
behind the immune response is the production of antibodies binding to Replagal® which can 
influence, among others, receptor binding and subcellular trafficking, which means that the 
enzymes might not reach the lysosomes anymore.[87]    
3.3.2.1 Determination of Replagal® Content of Capsules by Western Blot 
Determination of capsule content is, in general, a difficult task. Absorption spectroscopy, for 
example, does not work properly as the capsules themselves usually absorb and scatter light 
much stronger than the cargo. Measuring the content of all washing solutions and 
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subtracting the value from the amount used for synthesis is also highly error-prone. As the 
cargo in this case is a protein, Western Blot was used to determine the content of the 
capsules. The capsules were put in a vertical gel and an electric field was applied. In the 
electric field, the enzyme was released from the capsules and ran in the gel. The exact 
mechanism why the capsules break and release their content is not clarified yet and to the 
best of the author’s knowledge Western Blots with polyelectrolyte capsules to determine 
the loading level have not been published so far. As the polyelectrolytes of the capsules are 
not covalently bound to each other, the electric field might rupture the capsules and 
subsequently, the content could be released. After gel electrophoresis, the proteins were 
transferred to a membrane where antibodies to mark the protein could be applied. In Figure 
3.10 b) the calibration curve of one Western Blot is depicted, as obtained from the Replagal® 
standards in a). The area of the bands was measured as shown below the bands. From the 
calibration curve, the amount of Replagal® in the capsules could be obtained through the 
area of the Western Blot bands of the capsules. The amount of Replagal® in the capsule 
suspension found in case of the depicted data was 161.7 µg·mL-1. The concentration of the 
capsule suspension was 4·108 capsules per mL. Therefore, the average amount per capsule 
was approximately 400 fg.    
 
 
Figure 3.10 Results of the Western Blot. The bands as obtained for Replagal® from 300 ng down to 25 ng and from the 
capsule solution diluted 1/40, 1/60, or 1/80 can be seen in a) From the area of the bands of the Western Blot in a) 
(arbitrary units), the data points for the plot in b) were obtained. The data for 250 ng and 300 ng was neglected, as the 
values were too small due to saturation of the camera. The data was fitted with a line A=k·mReplagal® of intercept zero and 
slope k. From this line the amount of Replagal® in the capsules was determined.  
3.3.2.2 Intracellular Effect of Replagal® and Replagal® Capsules 
The Replagal® capsules were tested for their intracellular effectivity with MAEC. GLA was 
knocked out in these mice to simulate Fabry disease. To determine the intracellular activity 
of the Replagal® capsules, the cells were co-incubated with the capsules and the Replagal® 
substrate NBD-Gb3. The substrate is fluorescent while the product after conversion by 
Replagal® is non-fluorescent. Therefore, the intracellular activity of the capsules or free 
Replagal® can be obtained from the fluorescence of NBD-Gb3 in the cells. Concerns that the 
substrate is converted already in the cell medium before take-up by the cells can be ruled 
out as the enzyme only works well at acidic pH and thus only when it has reached the late 
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endosomes or lysosomes in the cells. The efficiency of the capsules compared with Replagal® 
was determined by the fluorescence loss of NBD-Gb3. In Figure 3.11, the fluorescence loss is 
plotted against the mass concentration of Replagal®, which was calculated from the amount 
of Replagal® determined by Western Blot. The amount administered with capsules was 
higher than that of the Replagal® solution. The curves show that the Replagal® solution has a 
higher efficacy, since already with a concentration of 1 mg·mL-1 a fluorescence reduction of 
more than 90 % was obtained, while the capsules do not reach such a high level, but only 
about 80 %. Furthermore, the Replagal® concentrations needed in case of capsules are 
higher than those in case of the Replagal® solution. 
 
Figure 3.11 Fluorescence reduction of NBD-Gb3 in MAEC as determined with flow cytometry. The plot depicts the loss of 
fluorescence as function of the administered concentration of Replagal®, either as solution or as capsule suspension. The 
figure has been adapted from manuscript [A8]. 
3.3.3 Krabbe Disease 
Krabbe disease, also called globoid cell leukodystrophy, is an inherited neurological disorder. 
Knowledge about the disease is limited and so far no cure but only palliative and symptom-
related treatment is available.  Symptoms occur at the age of 3 to 6 months and involve 
fevers, limp stiffness, and decelerated mental and motor development among others. Later 
blindness and deafness can appear. The disease is triggered by a dysfunction of the 
oligodendrocytes of the patients. Oligodendrocytes are a type of brain cells, which provide 
the axons of neurons with an electrically insulating myelin sheath that also serves as 
scaffold. When the oligodendrocytes produce myelin, side products such as psychosine or 
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other sphingolipids, and galactosylceramides are produced, which are metabolized by GALC. 
This enzyme is located in the lysosomes of the cells. In Krabbe disease, however, the 
oligodendrocytes lack this enzyme, and therefore, sphingolipids and galactosylceramides 
accumulate in the lysosomes. This accumulation leads to cell death, and subsequently, the 
axons are not provided their myelin sheath. The lack of insulation leads to slower signaling 
which can be measured in a nerve conduction study.[88] A simple model of Krabbe disease 
can be obtained from the MO3.13 cell line.[54, 55] These cells are immortalized 
oligodendrocytes. When incubated with psychosine they internalize and store it in 
lysosomes. For the studies, the wild-type (MO3.13 WT) was used as well as cells where the 
enzyme GALC was knocked out (MO3.13 KO). The KO cells represent dysfunctional 
oligodendrocytes in the brain of Krabbe patients whereas the WT serve as control.  
3.3.3.1 pH Sensing in MO3.13 Cells 
So far, there is not much knowledge about the influence of psychosine and other 
sphingolipids on the pH of oligodendrocytic cells and especially on cells lacking GALC. In this 
work, SNARF® capsules were used to monitor the pH to obtain a time-resolved pH-profile of 
the lysosomes during the accumulation of psychosine in both KO and WT MO3.13 cells. In 
Figure 3.12, images of cells incubated with 2 µM psychosine are shown. The capsules have 
already been taken up and appear in yellow due to the acidic environment. Images of both 
WT and KO cells are depicted and “PSY” indicates cells incubated with psychosine whereas 
“Control” shows cells kept in psychosine- and serum-free media. After 20 h of incubation, 
the cells in all the four conformations appear healthy and no sign of apoptosis is visible.  
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Figure 3.12 MO3.13 cells incubated with psychosine at a concentration of 2 µM. Images of the points in time indicated at 
the top are shown. “PSY” indicates the panels with cells incubated with psychosine, whereas “Control” indicates the cells 
in medium not supplemented with psychosine. From the images it can be seen that the cells are viable and healthy 
throughout the experiment whether psychosine had been added or omitted. SNARF® capsules in all images are yellow 
indicating the acidic pH-environment of the lysosomes. The scale bar represents 10 µm. 
Images like these were evaluated to obtain the time-resolved pH profile of the cells during 
the presence of psychosine. In Figure 3.13, the results are plotted as “moving mean” of a 
value and its four next neighbors. The blue lines represent the cells incubated with 
psychosine, the red lines the controls without psychosine. The graphs show that both the 
wild-type cells in a) as well as the knockout cells in b) show small variations but no significant 
changes of pH during the presence of psychosine.  
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Figure 3.13 MO3.13 cells treated with 2 µM psychosine (blue line) and controls without treatment (red line). a) Wild-type 
cells as well as b) knockout cells do not show significant response in the lysosomal pH during incubation with 2 µM of 
psychosine. The figure is taken from manuscript [A8]. 
Figure 3.14 contains images of MO3.13 cells incubated with 10 µM of psychosine at different 
points in time. The marking is similar to the images above. Cells incubated with psychosine 
show round shapes after 600 minutes, which is a sign of apoptosis. Both WT and KO cells 
show this behavior. In the KO cells, no significant color change is detectable, which is also 
true for both WT and KO controls.   
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Figure 3.14 MO3.13 cells incubated with psychosine at a concentration of 10 µM. Images of the points in time indicated 
at the top are shown. “PSY” indicates the panels with cells incubated with psychosine, whereas “Control” indicates the 
cells in medium not supplemented with psychosine. From the images it can be seen that both the wild-type and the 
knockout cells suffer from psychosine as cells become round, which is a sign of apoptosis. SNARF® capsules in all images 
are yellow indicating the acidic pH-environment of the lysosomes. The scale bar represents 10 µm. 
Again, the moving mean of a value and its four next neighbors was plotted versus time. As 
before, the blue lines in Figure 3.15 represent the psychosine-treated cells and the red ones 
the control cells. In the graphs, a significant difference between WT and KO cells is 
observable. While the KO cells in b) do not show pH changes, the WT cells in a) show a clear 
rise in pH during the presence and accumulation of psychosine. Note that the images for the 
two graphs in a) were not taken at the same time and therefore with cells of a different 
passage, which explains the difference of the 0 hours value. In the other experiments, the 
psychosine-treated and the control cells were taken from the same culture flask and 
therefore show no difference in their respective 0 hours value. In c) the color change of one 
capsule in a WT cell is shown. The two images were taken within a period of 20 minutes. The 
color changes from green to red, which means that the local pH rose between those two 
images.  
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Figure 3.15 MO3.13 cells MO3.13 cells treated with 10 µM psychosine (blue line) and controls without treatment (red 
line). a) Wild type cells show a significant rise of lysosomal pH during treatment with 10 µM psychosine whereas the 
control cells keep the lysosomal pH constant. b) In contrary, knockout cells show no significant difference in lysosomal 
pH whether treated with psychosine or not. c) Example of a capsule, where the color changes from green to red in a 
MO3.13 wild-type cell. The scale bar corresponds to 10 µm. The figures in a) and b) are taken from publication [A8]. 
 
3.3.3.2 Delivery of Galactocerebrosidase to MO3.13 Cells 
Krabbe disease arises due to lack of GALC and so far, there is no drug to cure the disease. 
Other LSDs like Fabry or Gaucher can be treated by enzyme replacement therapy where the 
missing enzyme is delivered to the patients by infusion. Here the idea was to introduce the 
lacking enzyme GALC into the cells by capsules and scrutinize if the delivered enzyme could 
reduce the toxic effects of psychosine.  As seen from the images in section 3.3.3.1, cells of 
the wild type as well as KO cells treated with 10 µM of psychosine show signs of apoptosis 
after longer incubation times, i.e. the cells appear spherical. This was quantified further by 
MTT cytotoxicity assays. 5 or 10 GALC capsules, and in case of KO cells also 10 empty 
capsules per seeded cell were added to the cells together with the serum-free medium. 
Control cells without capsules were treated similarly. Afterwards, psychosine was added in 
serum-free medium at different concentrations from 0 to 20 µM. The results are found in 
Figure 3.16. The blue and black curves show the cells treated with capsules, the red curves 
the cells without capsules. The 100 % value was always assigned to cells without capsules 
and without psychosine, i.e. the 0 µM value of the red curves. In KO cells, the red curves 
show the same trend in both diagrams, and the black curve in b), which represents empty 
capsules, shows the same behavior. KO cells incubated with GALC-containing capsules show 
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high viability both with 5 and with 10 GALC capsules per seeded cell. The viability, however, 
is higher for cells treated with 5 capsules. With 10 capsules, the cells show a small loss in 
viability with rising psychosine concentration and generally lower viability. In WT cells, a 
contradictory behavior is observed, as shown in c). The untreated cells show high viability 
independent of the concentration of psychosine, whereas cells incubated with capsules 
show clearly reduced viability, which means that the capsules have an adverse effect on the 
WT cells. 
 
 
Figure 3.16 MTT assays of MO3.13 KO cells. The viability V after 24 hours is plotted versus the concentration of 
psychosine. The red curves represent cells without capsules whereas the black curves represent cells treated with a) 5 
GALC capsules per cell, b) 10 GALC capsules per cell, and c) 10 empty capsules per cell. The error bars represent standard 
deviations. The figure has been taken from publication [A8]. 
Note that values larger than 100 % are a phenomenon often observed in cells treated with 
substances that do not harm them at these concentrations. The reason is the enhanced 
metabolism due to stress because of the added substance. The second thing to note is that 
the viability of WT cells at 10 µM is not reduced although the images of WT cells treated 
with psychosine show signs of apoptosis, i.e. the round shape, cf. Figure 3.14. This can be 
explained because the cells are still viable although they began with apoptotic behavior and 
therefore the MTT test does not detect reduced metabolism.  
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4 Discussion  
The topic of this thesis was the application of polymer capsules in mammalian cells for 
diagnosis and therapy, the combination of which is called theranostics. The goal was to have 
a sensor, which reads out the condition of a certain type of cell, and to apply an appropriate 
treatment based on the diagnosis. In a first step a diagnostic capsule was synthesized and 
tested. Knowledge of intracellular ion distributions and concentrations is of high value for 
the diagnosis of diseases. Especially pH plays a prominent role, and was thus chosen as 
parameter for the experiments. In general, the analysis of the entire intracellular ion milieu 
is of relevance for the health condition of cells. However, the intracellular measurements of 
other ions such as sodium, potassium, chloride, calcium, or magnesium, which are the most 
important ions for the cells, are problematic. The available ion-sensitive dyes usually are not 
only sensitive to the specific ion of interest but also show sensitivity to other ions. Problems, 
for example, occur for dyes used to measure potassium or sodium, as they are usually 
sensitive to the respective other ion.[22] The same is true for calcium and magnesium. 
However, in cells, the concentrations of potassium and sodium, or calcium and magnesium, 
are usually very different, so that the crosstalk between these ions can often be neglected. 
For Na+, K+, and Cl-, capsules have been produced by encapsulation of the dyes SBFI, PBFI, 
and MQAE.[22] Another severe problem though is crosstalk with pH. As shown in section 
3.1.2, the optical signal of the dyes considered there is influenced massively by pH. This 
means in principle that determination of ion concentrations with these sorts of dyes is 
pointless unless the local pH is measured in addition. The first step towards theranostics was 
to prove the applicability of pH sensitive capsules for diagnosis. This was done in the 
experiments for publication [A6].[6] The intracellular pH was influenced externally by addition 
of pH-active substances. SNARF® capsules were used as lysosomal sensors to monitor 
changes of pH upon stimulation with these substances. In the results section, only monensin 
was presented. The reader is referred to the paper for detailed information about the other 
substances, amiloride, bafilomycin A1, and chloroquine. Monensin caused the lysosomal pH 
to rise to a level comparable to that of the extracellular medium. This was explained by the 
H+/Na+ antiporter property of monensin that leads to dispelling of pH gradients across 
membranes. The effect was highly reversible as the pH dropped to the previous level when 
monensin was removed again. The effects of the other substances showed different pH 
profiles, as can be found in Figure 5.1 in the appendix. Bafilomycin A1 showed a slower 
increase and the pH level was staying high upon removal of the external stimulus. 
Chloroquine induced a fast rise of the pH comparable to monensin, but after removal of 
chloroquine from the extracellular medium, the pH kept an elevated level as in the 
treatment with bafilomycin A1. This means that the measurement of the pH can be used to 
discriminate which of the substances was added, in other words, the reason for the pH 
changes can be diagnosed in this way. Amiloride, though, did not show influence on the 
lysosomal pH, and therefore amiloride treatment cannot be detected through the pH profile, 
as it is not different from untreated cells. For the therapeutic task, two systems were 
employed. The first was to introduce siRNA into the cells to knock down GFP. The second 
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system was the direct integration of functional enzymes. The first belongs to the spectrum of 
gene therapy, whereas the second one constitutes an example of enzyme replacement 
therapy. The challenge thereby was the encapsulation of the biologically active molecules 
into the capsules and the save delivery into the cells, i.e. after uptake, the cargo needed to 
still be functional. Starting with the delivery of genetic material into cells, biodegradable 
capsules were used as carriers for fluorescently labeled DNA to examine the efficiency of 
delivery, and for siRNA to perform transfection. The DNA experiments showed the potential 
of capsules to introduce DNA into cells and subsequently release it to the cytosol. The results 
were compared to standard PEI/DNA polyplexes often used for transfection experiments. It 
could be shown that the capsules had a higher delivery rate than PEI/DNA polyplexes, and 
furthermore, the delivery could be performed in serum-supplemented medium. This is a big 
advantage over standard protocols, as deprivation of serum results in stress for the cells. 
Especially, if the cells are not very robust, for example in case of primary cells, the possibility 
to transfect cells in serum-containing medium is of importance. The release of DNA or siRNA 
to the cytosol happened automatically instead of having to be triggered by an external 
stimulus. Compared to non-encapsulated PEI/siRNA polyplexes, the transfection efficacy in 
terms of time needed for transfection was enhanced; the effect of siRNA was observable 
already after 20 hours rather than 48 hours, which is the time normally stated for 
transfection in standard protocols.[44] Another point addressed in this work was cytotoxicity. 
Polyplexes made of PEI are known to be toxic for cells, and hence, the PEI concentration has 
to be kept low, which, however, is a limiting factor for applications of PEI polyplexes. The 
PEI-filled capsules had reduced adverse effects compared to the same amount of PEI added 
in non-encapsulated way. PEI was used for the synthesis of polyplexes as it facilitates 
lysosomal escape of the genetic material. This feature is ascribed to the proton sponge 
effect. The capsules therefore have the advantage that higher amounts of PEI can be used 
without the adverse effects, while at the same time offering enhanced proton sponge effect 
and subsequently increased transfection efficacy. Taken together, it could be shown that the 
capsules have a great potential for gene therapy as they facilitate enhanced uptake and thus 
enhanced delivery rates compared to standard transfection agents, and furthermore, the 
cells do not need to suffer from low serum levels. This feature is especially important for 
in vivo-experiments, where the serum levels cannot be regulated externally. Concerning the 
delivery of functional enzymes to cells, one problem occurs which is the so-called lysosomal 
escape dilemma. This term describes the difficulties to make cargo in the lysosome available 
outside of this vesicle.[89] Therefore, delivery of enzymes was performed in models of LSDs to 
make use of the fact that capsules are automatically trafficked to the organelle of interest, 
the lysosome. The challenge of delivery of enzymes to the cells was to deliver functional 
enzymes and to verify the effectivity and to quantify the efficacy. The experiments were 
performed with cells representing models of the diseases Krabbe and Fabry. Two different 
ways of verification of the functionality of delivered enzymes were employed. In case of 
Fabry, the goal was to measure the intracellular activity of Replagal® delivered to the cells. 
To do so, the cells were co-incubated with the encapsulated enzyme and the fluorescently 
labeled substrate Gb3. The activity of the delivered enzyme was determined in terms of 
fluorescence reduction of the substrate. The capsules used for these experiments were 
biodegradable, so the enzyme could be released inside the lysosomes. The results clearly 
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showed that the enzyme delivered by capsules had activity inside the cells. Furthermore, a 
reduction of about 80 % of fluorescence of NBD-Gb3 could be obtained. The optimum of 
100 % was hereby defined by a negative control where no substrate was added before. 
Compared to Replagal® solution, however, the efficiency was smaller, i.e. the amount of 
Replagal® needed when capsules were used was higher than in the free enzyme solution. 
Nonetheless, the results can be seen as proof of concept for the delivery of defective 
enzymes to the lysosomes of cells and future research might lead to better results. 
Concerning Krabbe disease, the MO3.13 cell line can be used as simple model to study basic 
features of the disease. With the use of KO cells, the absence of the enzyme GALC can be 
modeled. Incubation with psychosine simulates the condition of accumulation of 
sphingolipids and cerebrosides in the oligodendrocytes of Krabbe patients. MO3.13 cells 
incubated with high concentrations of psychosine showed apoptosis as the internalized 
psychosine is toxic for them. Therefore, the effectivity of delivery of GALC by biodegradable 
capsules could be verified by viability assays. The test was performed both with WT cells and 
KO cells. The findings of the MTT cytotoxicity assays showed that the delivery of GALC to KO 
cells by capsules was successful and that psychosine did not have an adverse effect on cells 
provided with the enzyme. On WT cells, psychosine did have less adverse effect due to the 
presence of intrinsic GALC. Once the cells were treated with capsules though, psychosine 
induced an adverse effect on them. This means that treatment with capsules only makes 
sense in case of KO cells. This is an example where theranostics plays an important role; with 
a preliminary diagnosis test verifying total absence of the enzyme, the applicability of 
enzyme replacement therapy can be assured. One possibility for diagnosis can be obtained 
from pH measurements. The pH of the MO3.13 WT and MO3.13 KO cells was measured in 
the presence of psychosine and two different effects were found. In the WT cells, i.e. the 
cells containing a fraction of GALC, the pH rose in the presence of psychosine. On the 
contrary, the pH in KO cells did not change in the presence of psychosine. With help of these 
findings, it is possible to decide if a given sample of MO3.13 cells is of WT or KO type and 
based on this, one can decide if treatment of the cells with GALC capsules is possible or not. 
Concerning the goals of the thesis, the following could be achieved. The usefulness of 
capsules as diagnostic tool could be shown. When the pH profile of the lysosomal pH is 
known, the substances bafilomycin A1, chloroquine, and monensin can be distinguished, i.e. 
a diagnosis which of them has been added to the cells is possible. The applicability of 
capsules as carrier of therapeutics, either in form of nucleic acids or in form of enzymes, was 
demonstrated. In case of siRNA, the successful knockout of GFP was obtained and moreover 
the capsules were more efficient compared to the standard protocol. The delivery of 
functional Replagal® by capsules was also successful, as intracellular activity could be 
observed. However, the results of Replagal® solution showed a higher metabolic rate for the 
conversion of Gb3 and smaller amounts of Replagal® were needed than in the assays with 
encapsulated Replagal®. The capsule treatment is therefore less efficient than Replagal® 
solution. The combination of diagnostics and therapy was undertaken in the Krabbe model. 
It could be shown that the pH profile can be employed to determine if cells are of KO type or 
WT. The decision whether to treat cells with GALC-filled capsules or not therefore can be 
made based on the diagnosis obtained by the pH capsules. This can be seen as an 
in vitro-example for theranostics.    
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Outlook 
So far, capsules and other carriers are used individually, i.e. only one type of capsule or 
carrier is employed. With the possibility to modify the capsules in various ways and label 
them differently, the next step is to use different capsules simultaneously to monitor 
different analytes in the cells or to sense and deliver at the same time. Ultimately, the goal is 
to produce multifunctional capsules for sensing of different analytes or even capsules for 
both delivery and sensing. Cystic fibrosis (CF), also called mucoviscidosis, is a disease that 
could serve as model for this research. In CF the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene responsible for the expression of a chloride channel is expressed 
wrongly. The most common dysfunctional version of the gene leads to the misfolding 
mutation ΔF 508. This misfolding results in low chloride levels inside endothelial cells. The 
possibility to introduce RNA into cells by capsules as shown in this thesis, but also in other 
publications[19, 81] paves the way to deliver messenger RNA (mRNA) of the chloride channel 
into cells to trigger the correct expression of the channel. A chloride-sensitive capsule could 
then be employed to monitor the changes of chloride levels in the cells to verify the 
expression of the chloride-channels. Other methods to verify the expression of the ion 
channel like Western Blot require disrupting the cells to detect the protein of interest in the 
resulting suspension. In the way described here, the protein could be detected non-
invasively in living cells. Another possibility to make use of the results obtained in this thesis 
is to make the step from in vitro- to in vivo-experiments. For this purpose, the capsules 
should have a size of some 100 nm as otherwise capillaries may be blocked. The fabrication 
of nanocapsules as small as 100 nm or less has been demonstrated already although the 
synthesis is different from the one used in this thesis. Current methods to produce enzyme 
nanocapsules can be found in a recent reviews by Shimanovich et al.[27] and Cui et al.[8] 
Animal models for Krabbe and for Fabry disease are readily available. A similar disease as 
Krabbe is found in the twitcher mouse.[90] In this mouse, the deficiency of GALC and 
subsequent accumulation of sphingolipids and cerebrosides in the oligodendrocytes occurs 
naturally. Similarly, a mouse model of Fabry disease can be employed.[52, 91] Difficulties of 
Replagal® treatment, as already outlined in section 3.3.2, include degradation of the drug in 
the blood stream, imbalanced distribution within the body and hence inefficient treatment, 
and immune responses. Capsules serve as protective shield for the drug in the blood stream 
as proteins and big molecules cannot pass through the capsule walls. Uptake of free 
Replagal® by cells is mediated by mannose-6-phosphate receptors. As these receptors are 
distributed unevenly among cells in the body, the treatment can be affected as Replagal® 
will accumulate in cells where there are receptors, whereas cells without receptors will not 
be targeted. Capsules, however, are taken up receptor-independently, and thus also cells 
without these receptors will be targeted. Moreover, if capsules are modified by magnetic 
nanoparticles in their walls, the distribution of the carriers can be controlled by magnetic 
field gradients.[92, 93] Finally, also the combination of the hitherto Replagal® treatment with 
magnetic carriers may improve the treatment, as the carriers could be directed to organs 
where receptors are not sufficiently expressed, whereas free Replagal® will be internalized 
by receptor-expressing cells as before. 
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5 Appendix 
5.1 Results of Bafilomycin A1, Chloroquine, and Amiloride 
For completeness, the results of the other agents used for publication [A6] are depicted in 
Figure 5.1.  The figure of monensin in b) and the control in e) were shown in section 3.1.3. 
Bafilomycin A1 (a) induces a rapid increase of pH and the pH level stays high after rinsing. 
Monensin induces a rapid increase, but after rinsing, the pH drops to the starting level. After 
incubation with chloroquine (c), the pH rises quickly to high levels, and after rinsing, the pH 
drops slowly to the starting level before addition of chloroquine. Amiloride (d) does not 
influence the lysosomal pH.    
 
  
Figure 5.1 Results of the treatment of MCF-7 cells with different agents. a) Bafilomycin A1 (600 nM), b) Monensin (20 
μM), c) Chloroquine (100 μM), d) Amiloride (1 mM). In e) no agent was added. The ratio of red to yellow fluorescence 
(I640/I580) origination from capules inside the lysosome (drawn in green) and control capsules in the extracellular medium 
(drawn in red) is plotted versus time. Error bars represent standard deviations. The figure has been adapted from 
publication [A6]. 
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5.2 GFP Knockout with PEI/siRNA Polyplexes 
In the knockout experiments, a comparison of polyplexes and capsule-embedded polyplexes 
was performed based on the amount of siRNA. Here, the results of an experiment with a 
high amount of siRNA delivered with polyplexes are shown for completeness to prove the 
possibility to knock out GFP with PEI/siRNA polyplexes. In Figure 5.2, the curves from section 
3.2.3 are shown together with data of an experiment of PEI/siRNA polyplexes with a much 
higher amount of siRNA, namely 400·10-3 µg instead of 10·10-3 µg. The decrease of GFP 
intensity is clearly visible showing that the polyplexes work in principle. 
 
 
 
Figure 5.2 Normalized GFP intensity IGFP against time. The time-dependent change of GFP for PEI/siRNA polyplexes 
containing 10·10
-3
 μg or 400·10
-3
 μg siRNA per experiment, as well as for encapsulated PEI/siRNA with a final amount of 
6.4·10
-3
 µg siRNA per experiment are depicted. Intensities are normalized to their respective 0 hours value. Error bars 
represent standard deviations of the mean. The figure has been taken from the supporting information of publication 
[A7].
[4]
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5.3 Cytotoxicity of Metallic Nanotubes 
The author did this work for a co-operation with a group from the University of the Basque 
Country. Ricardo Sanchéz Pinedo from the Spanish group synthesized the nanotubes, 
whereas the author did all cytotoxicity measurements described in this section. The results 
were published in the PhD thesis of Ricardo Sanchéz Pinedo.[94] For details of the nanotube 
synthesis, the reader is referred to this PhD thesis. 
Conduction of the Experiments 
Cytotoxicity of nanotubes (NTs) and ions was measured according to the following protocol: 
Vero cells were seeded in 96-well plates at a density of 10,000 cells per well and were grown 
for 24 hours in cell growth medium. Then, the cells were rinsed with PBS and medium 
containing NTs or ions at appropriate concentrations was added to the wells. Concentrations 
were adjusted in a way that a wide range of concentrations was covered. The cells were 
incubated at 37 °C and 5% CO2 atmosphere for 24 hours. After that, the cells were rinsed 
with PBS and a freshly prepared solution of medium containing 10% resazurin was added to 
the wells. The cells were incubated for 3 hours at 37°C and 5% CO2. Non-fluorescent 
resazurin is oxidized by living cells to fluorescent resorufin. Therefore, the fluorescence 
intensity is a measure of the viability of the cells. After incubation, the fluorescence emission 
spectrum of the solution was recorded. Hereby, the wells were excited at 560 nm and 
fluorescence emission was recorded from 572 nm to 650 or 700 nm. The recorded spectra 
I(c,) for cells incubated with Cd2+ ions at different concentration are shown as example in 
Figure 5.3. The intensities of 685 to 700 nm (or 640 nm to 650 nm) were averaged and 
subtracted as background from the average of 580 to 585 nm, which was the maximum of 
the emission spectrum. The background-corrected, averaged intensities I(c) were plotted 
versus the concentration, as shown as example in Figure 5.3b. The concentration-dependent 
fluorescence intensities I(c) were then fitted with the sigmoidal function  
     
         
   
 
  
 
      . 
c0 is the concentration, at which the viability of the cells was reduced to half of its activity. In 
Figure 5.3, the fluorescence spectra of cells incubated with Cd ions is shown, which serves as 
positive control of the resazurin assay. In a) the entire spectra are displayed, whereas in b) 
the background-corrected averages of the maxima are plotted. From the fit, the 
concentration c0 at which half of the cells have died was obtained. 
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Figure 5.3 Fluorescence spectra of cells incubated with different concentrations of Cd
2+
 ions and the resazurin assay. a) 
Raw data given as recorded fluorescence spectra I(c, ). b) Background-corrected average intensities I(c) as derived from 
the raw data. A fit and the derived c0 value are shown. 
As sample, Pr0.6Sr0.4Fe0.8Co0.2O3 NTs and, as control, salts containing the metal ions out of 
which the NTs were composed were used. Three different methods for the synthesis of the 
NTs were used, which were named LiO 10, LiO 80, and Sg 80. NTs were mixed with medium 
at a concentration of 1 mg·mL-1 and stirred overnight at room temperature with a magnet 
stirrer to obtain a homogenous suspension. It has to be noted that the NTs did not dissolve 
in aqueous solution. Besides this procedure over 1 day, the NTs were also left for 8 days or 3 
weeks, respectively, in growth medium, before the suspensions were added to the cells. In 
this way, leaching of ions from the NPs over time was investigated. Salts containing Co2+, 
Fe3+, Pr3+, Sr2+, and Cd2+ were directly dissolved in cell growth medium. In case of Pr3+, the 
concentrations were estimated, as the manufacturer did not provide the water content of 
the salt PrCl3xH2O. The fluorescence spectra I(c) obtained for the salt solutions are displayed 
in Figure 5.4. The fluorescence spectra I(c) obtained for NTs are displayed in  Figure 5.5.  
 
Figure 5.4 Background-corrected average fluorescence intensities I(c) of cells incubated with different metal salts and the 
resazurin assay. a) and b) display 2 sets of experiments. The mean values are based on 8 values. 
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Figure 5.5 Background-corrected average fluorescence intensities I(c) of cells incubated with and without nanotubes 
(batches LiO10, LiO80, Sg80) and the resazurin assay. a) Nanotubes were suspended in medium 1 day prior to addition to 
the cells. b) Repetition of experiment as described in a). c) Nanotubes were suspended in medium 8 days prior to 
addition to the cells. d) Nanotubes were suspended in medium 3 weeks prior to addition to the cells. The error bars are 
the standard deviations. The mean values are based on 2 values. 
Except for Cd2+ at high concentrations, none of the metal ions showed reduced cell viability 
under the used conditions (cf. Figure 5.4). For the NTs, some reduced viability was observed 
at high concentrations (cf. Figure 5.5). In case NTs were longer incubated in medium (before 
addition of cells), there is a tendency that the NTs cause more cytotoxic effects to cells. This 
is likely to be due to increased leaching of ions from the NTs to the solution. In order to 
compare the effects of NTs and free ions, the data was normalized. Normalization, as 
displayed in Figure 5.6, was done by calculating the amount of each ion in one NT and 
converting all concentrations to mg·mL-1. The molecular weight MW of Pr0.6Sr0.4Fe0.8Co0.2O3 
NTs is 224 g·mol-1. The molar masses of O, Pr, Sr, Fe, and Co are 16, 141, 88, 56, and 59 
g·mol-1, respectively. Thus, x = 21 %, 38%, 16%, 20%, and 5% of the mass of NTs is composed 
out of O, Pr, Sr, Fe, and Co, respectively. In order to calculate the effective mass 
concentration c*[mg·mL-1] of ions in reference to the NTs, the content x of ions per NT was 
used as c*[mg·mL-1] = c[M]MW/x. In this way, an ion, which is only present at fraction x in 
the NTs, accounts for an x-fold higher effective NT concentration. To give an example, for 
Pr3+ the concentration c = 100 M corresponds to c* = 37 mg·mL-1 as calculated in the 
following:    
  
  
    μ   
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The normalized concentrations of the ions are plotted in Figure 5.6, which allows for 
comparison with the viability results obtained with the NTs. In the overlap of both graphs, 
which reaches up to 0.1 mg·mL-1 depending on the specific ion, the data consistently does 
not show reduced viability of cells.  Only for NT-concentrations of 1 mg·mL-1, the intensity 
values decrease significantly. The contents of Pr, Sr, Fe, and Co in 1 mg NTs are 377, 156, 
199, and 53 µg, respectively. Note, that these amounts are only set free, if the NTs were fully 
disintegrated.  
 
Figure 5.6 Background-corrected average fluorescence intensities I(c*) and I(c) of cells incubated with different metal 
salts and NTs and the resazurin assay. a) Normalized ion data from Figure 5.4 a) (without Cd
2+
) b) NTs in suspension for 3 
weeks (data from  Figure 5.5 d)). 
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5.4 List of Abbreviations  
ATCC American Type Culture Collection 
CCD Charge-Coupled Device 
CF Cystic Fibrosis 
CFTR Cystic Fibrosis Transmembrane Conductance Regulator 
CLSM Confocal Laser Scanning Microscope 
Cy5 A fluorescent dye  
DNA Desoxyribonucleic Acid 
ERT Enzyme Replacement Therapy 
FITC Fluorescein isothiocyanate 
FSC Forward Scattering 
GALC Galactocerebrosidase 
GFP Green Fluorescent Protein 
GLA α-Galactosidase A 
KO Knockout 
LbL Layer-by-Layer 
LSD Lysosomal Storage Disease (Disorder) 
MAEC Mouse Aorta Endothelial Cells  
mRNA Messenger RNA 
MTT assay Viability Test based on the chemical MTT 
NT Nanotube 
PBFI A fluorescent potassium-sensitive indicator 
RNA Ribonucleic Acid 
ROI Region of Interest 
rpm Rotations per Minute 
SBFI A fluorescent sodium-sensitive indicator 
SCC Side Scattering 
siRNA Silencing RNA 
WT Wild-Type 
ΔF508 A gene mutation responsible for occurrence of Cystic Fibrosis 
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6 Publications 
This thesis is a cumulative dissertation and therefore the publications constituting it are 
shortly summarized here and the contribution of the author is described. The contributions 
of the author to the research papers used for this thesis are also described in the results part 
at the beginning of each section. 
6.1 Reviews 
[A1][95] C. Carillo-Carrion, M. Nazarenus, S. Sánchez Paradinas, S. Carregal-Romero, M. Jesús 
Almendral, M. Fuentes, B. Pelaz, P. del Pino, I. Hussain, M.J.D. Clift, B. Rothen-Rutishauser, X. 
Liang., W.J. Parak, Metal ions in the context of nanoparticles towards biological applications, 
Curr. Opin. Chem. Eng. 2014, 4, 88 (Paper attached) 
In this review, the interactions of nanoparticles and ions in biological context are discussed. 
Three major topics are pointed out; unintended modification of the particles such as 
corrosion and dissolution of the particles, intended modification of the particles with certain 
ions for new applications, and nanoparticles for the detection of ions, for example inside 
cells. 
The author did literature research, corrections and amendments of the text, and the 
editoring of the manuscript before final submission.   
[A2][39] M. Nazarenus, Q. Zhang, M.G. Soliman, P. del Pino, B. Pelaz, S. Carregal-Romero, J. 
Rejman, B. Rothen-Rutishauser, M.J.D. Clift, R. Zellner, G.U. Nienhaus, J.B. Delehanty, I.L. 
Medintz, W.J. Parak, Interaction of Colloidal Nanoparticles with Mammalian Cells: What 
Have We Learned Thus Far? Beilstein J. Nanotechnol. 2014, 5, 1477 (Paper attached) 
In this review, the principles of interaction between cells and colloidal nanoparticles are 
outlined. The focus is put on the fundamentals of interactions rather than special 
phenomena. Critical assessment of effects on colloidal particles taking place in biological 
media, such as agglomeration and formation of a protein corona on the particles, and the 
consequences for uptake by cells is presented. The problem how to compare the results of 
studies with different methodologies is addressed.  
The author did a large part of the literature research, included the contributions of the 
different authors into coherent text and did the editing before submission. He as well did 
part of the revision before final acceptance.   
[A3][38] K. Kantner, S. Ashraf#, S. Carregal-Romero, C. Carrillo-Carrion, M. Collot, P. del Pino, 
W. Heimbrodt, D. Jimenez de Aberasturi, U. Kaiser, L. I. Kazakova, M. Lelle, N. Martinez de 
Baroja, J. Montenegro, M. Nazarenus, B. Pelaz, K. Peneva, P. Rivera Gil, N. Sabir, L.M. 
Schneider, L. I. Shabarchina, G.B. Sukhorukov, M. Vazquez, F. Yang, W.J. Parak, 
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Particle-Based Optical Sensing of Intracellular Ions at the Example of Calcium - What are the 
Experimental Pitfalls?, Small. DOI: 10.1002/smll.201402110 (paper attached) 
# alphabetical order 
This review deals with intracellular ion sensing. The intracellular location and trafficking of 
colloidal nanoparticles are discussed. The difficulties arising due to crosstalk of emission of 
different fluorophores as well as the influence of pH on fluorophores are addressed.  
Experimental data is shown to underline the problematic.  
The author recorded and evaluated the data of crosstalk of ion-sensitive dyes with pH and 
wrote the part of the supporting information describing these experiments in detail.  
[A4][96] P. del Pino, X. Jiang, D. Valdeperez, M. Nazarenus, Z. Wang, F. Stellacci, W.J. Parak, 
Nanomaterials for Smart Food Packaging and Quality Control, Part. Part. Syst. Charact. 2014, 
DOI: 10.1002/ppsc.201400192 (paper attached) 
Future perspectives for the use of nanomaterials in food science, especially for smart ways 
of packaging, are presented in this review. Possible ways of quality control and enhancing 
sustainability of food utilizing nanotechnology are described.  
The author did literature research, wrote the part of the manuscript describing dual-readout 
particles, and did the editing before the first submission. 
6.2 Book Chapters 
[A5][97] P. Rivera Gil, M. Nazarenus, W.J. Parak, Composite Colloidal Nanosystems for 
Targeted Delivery and Sensing, in Bioinspired and Biomimetic Systems for Drug and Gene 
Delivery, Gu, Z., Ed.; Wiley-VCH: Weinheim, 2015; p.61-81 (galley proofs attached) 
In the chapter of this book, the applicability of capsules in drug delivery and sensing, which 
are the main topics also of this thesis, is presented. In the part about sensing, the data for 
the chapter includes the main results of publication [A6]. Furthermore the internalization 
and intracellular location of capsules are shown and an outlook on delivery of genetic 
material is given and ways of release inside the cells are described.  
The author’s contribution was part of the data for pH sensing and proofreading of the 
manuscript.  
6.3 Research Papers 
[A6][6] P. Rivera Gil, M. Nazarenus, S. Ashraf, W.J. Parak, pH-sensitive capsules as 
intracellular optical reporters for monitoring lysosomal pH changes upon stimulation, Small 
2012, 8, 943 (paper attached) 
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This paper showed the applicability of capsules as intracellular long-term pH probes. The 
cells were stimulated with four different substances, amiloride, bafilomycin A1, chloroquine, 
and monensin. The effect on the lysosomal pH was examined. The results of monensin are 
presented in this thesis as it was the author’s suggestion to examine the effect of monensin.   
The author did a major part of the experiments and evaluations of all the different 
substances. Furthermore he wrote part of the supporting information, and established the 
evaluation method.  
[A7][4] C. Ganas, A. Weiß, M. Nazarenus, S. Rösler, T. Kissel, P. Rivera Gil, W.J. Parak, 
Biodegradable capsules as non-viral vectors for in vitro delivery of PEI/siRNA polyplexes for 
efficient gene silencing, J. Control. Release 2014, 196, 132 (paper attached) 
In this paper, biodegradable capsules were used to deliver siRNA into living cells to perform 
down-regulation of GFP. The results showed a better efficacy for delivery of genetic material 
with capsules compared to that of the polyplexes used regularly. Furthermore, the toxicity of 
the capsules was scrutinized and compared to that of standard PEI polyplexes. 
The author did all evaluations of the experimental data presented in the paper, i.e. image 
processing and quantification of the data. The cytotoxicity experiments were performed by 
the author.  The author helped with the manuscript and wrote part of the supporting 
information and did part of the revision after the peer-review process. 
[A8] M. Nazarenus, M. López Sánchez, N. García, J. Rejman, I. Abasolo, P. Rivera Gil, W.J. 
Parak, Polymer capsules as theranostic delivery and analysis vehicle for universal in vitro 
screening assays in the case of lysosomal storage diseases, in preparation (draft attached) 
In this paper, capsules were used for pH sensing and enzyme delivery. Cell culture models of 
the lysosomal storage diseases Krabbe and Fabry were employed to show the applicability of 
capsules as carrier for enzyme delivery. In these diseases, certain enzymes are deficient. The 
capsules were used to deliver the deficient enzymes to the cells and intracellular activity 
could be verified. In case of Krabbe disease, also the lysosomal pH was monitored in a long-
term manner. A difference was found between cells expressing the enzyme and enzyme-
deficient cells.  
The author did all capsule syntheses and recorded and evaluated all pH sensing experiments. 
Furthermore, part of the flow cytometry experiments was done by the author under 
guidance. Help was obtained for MTT cytotoxicity assays and Western Blots. The author 
wrote part of the manuscript and the major part of the supporting information, and did the 
editing. 
[A9] M.M. Ferraro, M. De Luca, R. Hartmann, P. Rivera Gil, A. Klingl, M. Nazarenus, A. 
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with metal ions in biological media is discussed. Metal ions in
the context of nanoparticles are relevant because of completely
different reasons. First, considering unwanted effects, upon
corrosion/dissolution some particular inorganic nanoparticles
can release metal ions and cause toxicity, such as in the case of
Cd2+, Zn2+, and Ag+. Second, intentional modification of
nanoparticles with particular metal ions can provide contrast
for imaging applications, such as Gd3+ ions for magnetic
resonance imaging. Third, nanoparticles themselves can be
used for the detection of metal ions, even inside cells. Thus,
there are several unwanted/intended scenarios where the
interplay between nanoparticles, metal ions, and biological
systems is of paramount importance.
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Introduction
Most inorganic nanoparticles (NPs) contain metals, be
they in the form of elemental metals (e.g. Au [1,2,3], AgCurrent Opinion in Chemical Engineering 2014, 4:88–96 [4], Pt [5], Pd [6], Co [7,8]), metal alloys (e.g. FePt [6],
CoPt [9]), metal oxides (e.g. Fe2O3 [10], Fe3O4 [11],
CoFe2O4 [12], TiO2 [13]), or other metal compounds
(e.g. CdSe [14], PbS [15], InP [15]). Such NPs are being
explored for their potential use in life science due to their
functional properties, which can be very different from
those of typical organic molecules [16]. The functional
properties are defined by the material of the NPs, as well
as their size and shape. Important classes of functional
NPs comprise fluorescent NPs, plasmonic NPs, and mag-
netic NPs. (i) Fluorescent NPs can be made of semicon-
ductor materials such as CdS and CdSe, so-called
quantum dots (QDs) [14]. In comparison to organic
fluorophores, QDs suffer less from photobleaching and
thus can be observed over extended periods of time.
Fluorescence has also been reported for ultra small metal
NPs (Au, Ag), so-called metal clusters [17,18,19,20,21],
which, however, concerning the physical origin of their
fluorescence, must not be confused with QDs. Lantha-
nide-containing NPs are another newly emerging system,
which also promise better and more stable optical proper-
ties [22]. (ii) Plasmonic NPs have been widely used for
optical read-out [23], photothermal heating, and other
related applications [24]. Most often, plasmonic NPs are
composed of noble metals (in particular Au and Ag), but
recently also plasmonic semiconductors have been
reported [25–27]. (iii) Magnetic NPs can be used for
directing NPs via magnetic field gradients, for imaging
applications, or for the creation of heat (hyperthermia),
just to give a few examples [28,29,30,31]. They can be
composed of elemental metals (e.g. Co), metal alloys (e.g.
CoPt), or metal oxides (e.g. Fe2O3).
In case such NPs (partly) dissolve upon corrosion/oxi-
dation, metal ions are released into the surrounding
medium. Biological media, however, also contain metal
ions. Ions such as Na+, K+, Ca2+, and Mg2+ are basis of cell
culture media (in particular Na+ at physiological concen-
trations of about 150 mM NaCl). Dynamic differences in
intracellular and extracellular Na+, K+, Ca2+ concen-
trations regulate cellular communication, such as the
formation of action potentials in neurons or muscles
[32]. In addition, a gradient of metallic ions is directly
related to cell migration and/or transportation. Biological
media may also contain contaminants, such as Hg2+,
which are uptaken unintendedly by organisms. In thewww.sciencedirect.com
Metal ions in the context of nanoparticles toward biological applications Carrillo-Carrio´n et al. 89following sections, we will discuss three scenarios
describing the mutual interaction of these metal ions
with NPs, which all have implications on life-science
motivated experiments involving NPs.
Nanoparticles can release metal ions and thus
cause toxic effects
Metal-containing NPs can corrode/oxidize in biological
media, which results in release of metal ions to the solution,
cf. Figure 1. While this effect is negligible for Au, it plays an
important role for less stable NP materials such as Ag and
CdSe [33,34,35]. NPs present in cell culture are inter-
nalized by cells, typically through endocytosis upon multi-
point contact with the cell membrane [36,37]. Even though
one can distinguish clearly between different pathways
[38] NPs generally end up in lysosomal compartments [39],
which are highly acidic. Acidic media enhances oxidation
of NPs [40] and thus, it is assumed that in those compart-
ments the release of metal ions from NPs internalized by
cells is increased. Although ion-release from NPs in bio-
logical media can be partly reduced by appropriate surface
coatings [41], for many types of NPs release of ions to their
environment is a matter of fact. While NPs clearly have
potential for use in medical applications, diagnosis, and
treatment, their potential toxicity to the environment upon
chemical or biochemical conversion has to be considered
[42,43,44]. One might easily be mistaken by ascribing
toxicity of certain NP materials only to the metal ions
released from them. Surely, for example Ag+ (as released
from Ag NPs) and Cd2+ (as released from CdSe NPs) can be
toxic depending on the exposure route and the concen-
tration [45,46,47]. But is toxicity induced by Ag and CdSe
NPs only caused by their released ions? Unfortunately, it isFigure 1
(ii)
(iii)
(i)
Current Opinion in Chemical Engineering
Scheme of the interrelations between metal-containing NPs and metal
ions in solution. (i) Metal ions (depicted in green) can be released from
the NP to the medium upon corrosion/oxidation of the NP. Metal ions
from solution (depicted in blue) can enter into the NP and substitute the
original ions. (ii) Metal ions (depicted in red) can be attached via
chelators to the surface of NPs. (iii) Upon binding of metal ions from the
solution (depicted in violet) to the NP a signal is generated, which can be
used to sense the ions.
www.sciencedirect.com complicated to strictly address this question, as the NPs
and their released metal ions cannot be separated exper-
imentally. Whenever there are NPs prone to corrosion
inside biological media, there automatically will be
released ions around. While naturally one can assess
toxicity of ‘‘only’’ metal ions (most trivial by incubating
cells with the respective salt), one has to take into account
that in these experiments biodistribution will be different
from ions released from NPs [48]. While the cellular
membrane is more or less impermeable to certain metal
ions (in case there are no specific ion transporters) NPs are
generally incorporated into intracellular vesicular compart-
ments (in particular the lysosome), where, due to acidic
conditions, ions are released. Thus, ions released from NPs
are in general located at different locations than ions added
as salts to the cell culture medium. Even when there is no
doubt about the relevance of the dissolution and shedding
of toxic ions to the toxicity of metal-containing NPs, there
are also several studies in which NP toxicity could not be
completely explained by their liberation of ions [49,50].
Thus, in general, both the NPs themselves, and ions
released from them can contribute to toxic effects. Nel
et al. [51] demonstrated for 24 different metal oxide NPs
that their toxicological potential at cellular and animal level
depends on their conduction band energy levels. Among
the materials, the overlap of the conduction band energy
levels with the cellular redox potential (4.12 to 4.84 eV)
was strongly correlated to the ability of Co3O4, Cr2O3,
Ni2O3, Mn2O3, and CoO NPs to induce oxygen radicals,
oxidative stress, and (pro-) inflammation. As the band gap is
in general a bulk property these toxic effects can be
ascribed to the NPs as an intact entity. In contrast, for
other particles such as Ag, CuO, ZnO, or CdSe NPs, their
solubility and subsequent release of ions upon oxidation
has been found to be a major contribution to their toxicity
[51]. Metal ions (i.e. Zn2+, Cu2+, Cd2+ or Ag+) shedding
during intracellular dissolution induces lysosomal damage,
calcium flux, mitochondrial perturbation, generation of
reactive oxygen species (ROS), alteration of the cytoske-
leton, oxidative stress, excitation of pro-inflammatory
responses, and cell death [52–54]. Because nanosized
particles have a large specific surface area to interact with
solvent molecules, NPs show faster dissolution than their
respective bulk materials. This higher solubility (i.e. ion
release) is a possible reason to explain the higher toxicity
observed for ZnO and CuO NPs compared to microparti-
cles or bulk materials of the same composition [54]. Still,
more studies are required for investigating the respective
contributions of NPs and their released ions to toxic effects,
though, as mentioned above, it is experimentally compli-
cated to separate both entities.
Further understanding of the mechanisms would allow
for synthesizing more biocompatible NPs. This concept
has been called ‘‘safe-by-design’’ strategy and has been
pioneered by Nel et al. [55]. Four ‘‘safe-by-design’’
strategies have been proposed: (i) covering the NPs withCurrent Opinion in Chemical Engineering 2014, 4:88–96
90 Nanotechnologypolymers to prevent direct interaction with biomolecules,
(ii) doping metal or metal oxide NPs to change the
electronic structure and prevent dissolution of toxic con-
stituents [56,57], (iii) covering the NPs with a shell to
prevent dissolution and release of metal ions from the
core [35,41,58], and (iv) passivation of surface defects
to prevent the generation of reactive oxygen species. We
conclude that contamination of biological liquids by the
release of metal-ions from NPs is at least partly respon-
sible for certain toxic effects of metal-containing NPs,
and is thus an undesired effect. Though this is typically
true for most envisaged medical (in vivo) applications,
such as controlled delivery, imaging, or diagnosis, the
antibacterial properties of certain inorganic NPs, like
those made of silver, and the corresponding ions (e.g.
silver nitrate) have been widely employed for thousands
of years. One of the pathways typically associated with the
antibacterial properties of inorganic NPs is indeed release
of toxic ions [59] and thus, for certain applications,
corrosion of the inorganic core may turn into an asset.
It is therefore mandatory to understand the chemical and
biochemical behavior of metal-containing NPs in bio-
logical environments to make correct interpretations of
observed effects [60].
We just briefly want to mention that, vice versa, also metal
ions in media can contaminate NPs. Hg2+ ions present in
media can contaminate CdTe NPs by forming an alloy
(CdxHg1xTe NPs) with optical properties different from
those of the original CdTe NPs [61]. Exchange of metal
ions in NPs by metal ions in solution has also been used
intentionally to create new NP materials. Inorganic NPs
can act as templates which upon mixing with atomic ions
from different elements, can be used to produce new
materials of great potential for biological applications
[62]. Processes such as Kirkendall effect and the galvanic
replacement can be used for producing materials of
superior complexity (e.g. porous, hollow, multicomponent
materials, etc.) which can be used for specific purposes
[63,64]. For example, incubation of CdSe NPs in a
solution of Ag+ ions results in substitution of Cd2+ in
the NPs via a cation exchange reaction and thus in the
formation of Ag2Se NPs [65]. Moreover, in addition to
corrosion, these processes might play an important role in
the fate of inorganic NPs inside living animals, or even in
the environment.
Metal ions attached to nanoparticles as
contrast agents
Whilst in the previous section the presence of metal ions
released from the NP material was in general considered a
drawback (except for antibacterial properties), in certain
cases it can be also beneficial to link metal ions to the
surface of NPs, cf. Figure 1. Several metal ions are useful for
providing contrast in in vitro and in vivo imaging. Gd3+-
based complexes such as Gd–DTPA (Gd3+ chelated by
diethylenetriaminepentaacetic acid) and Gd–DOTACurrent Opinion in Chemical Engineering 2014, 4:88–96 (Gd3+ chelated by 1,4,7,10-tetraazacyclododecane-1,4,
7,10 tetraacetic acid) are, for example, widely used as
alternative magnetic resonance imaging (MRI) contrast
agents to generate the unambiguous positive contrast
(hyper-intensity) [66]. Even though various paramagnetic
ions (e.g., Mn2+, Fe3+, Eu3+) were considered as paramag-
netic centers for MRI, Gd3+has received the most attention
due to its unique features. It has a very high value of
magnetic moment because of the seven unpaired electrons
in the ‘‘+3’’ oxidation state and a much longer electronic
relaxation time (109 s) than other lanthanides such as
Dy3+, Eu3+, and Ho3+ (1013 s) [67]. However, Gd-based
complexes have short residence time and cannot pass easily
through the cell membrane, which leave them residing
within the extracellular space where they usually interact
with blood so that they have some limitations as molecular
probes for longer time tracking. To overcome these limita-
tions, a new strategy of linking Gd3+ ions to NPs has
recently been introduced and is nowadays under intense
study [68]. The attachment of Gd3+ ions to the surface of
NPs offers several advantages for MRI: (i) The relaxivity of
Gd3+ is enhanced by increasing the molecular weight of the
agent by attaching them to larger molecules such as
proteins or NP scaffolds, giving rise to higher sensitivity
as contrast agents [66]. For example, Gd3+ ions encapsu-
lated in single-walled carbon nanotubes showed a surpris-
ing increase in the relaxivity of the Gd3+ ions by nearly 40-
fold [69]. (ii) Longer circulation times and different biodis-
tribution according to their size [68]. The size of NPs is the
main factor controlling their physiological characteristics,
such as blood half-life and biodistribution. Small NPs with
an effective size in the range of 10–100 nm have a longer
plasma-circulation time, because they are small enough to
slow down activation of the mononuclear phagocyte sys-
tem, mostly evade the reticuloendothelial system (RES),
and reduce immediate opsonization. Studies carried out
with ultrasmall superparamagnetic iron oxide (USPIO; less
than 50 nm) showed that, unfortunately, they are yet big
enough to slow down the excretion by the liver [68]. (iii)
Improved cellular uptake either via active or passive tar-
geting [70]. Passive targeting leads to enhanced accumu-
lation of NPs in tumor sites via the enhanced permeability
and retention (EPR) effect, as result of the combination of
an increased permeability of tumor blood vessels and a
decreased rate of clearance caused by the lack of functional
lymphatic vessels in the tumor [71,72]. These findings
support the use of NPs in tumor diagnosis and therapy
as carriers, because they passively accumulate in solid
tumors after their intravenous administration. In addition,
the uptake can be modulated by controlling the size and
surface chemistry (charge and specific ligands) of the NPs.
Concerning attachment strategies, Gd3+ ions have been
linked to different kinds of NPs, such as silica NPs [73,74],
dendrimer-based NPs [75,76], lipid-based NPs [77,78],
chitosan NPs [79], iron oxide NPs [80,81,82], gold NPs
[82,83,84], nanodiamonds [85], and QDs [82,86–90].
Linkage is often realized by means of chelators such aswww.sciencedirect.com
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Gd3+. The chelator then is linked to the NPs through either
covalent linkage, such as amide bonds [79,82], sulfide
bonds [83,84], streptavidin–biotin interaction [89], or by
non-covalent linkages, for example by incorporating the
chelator into micelles [86,87,89,90], lipid bilayers [78], or
polyelectrolyte cappings [83,84]. In similar strategies the
linkage of metal ions to the surface of NPs can also provide
contrast for other imaging modalities, such as single photon
emission computed tomography (SPECT). In this case,
radioactive isotopes of certain ions, such as 111In3+ can be
added to the surface of the NPs [82]. Also, lanthanides
such as Eu3+ and Tb3+ have been linked to the surface of
QDs in order to achieve particular optical properties [91].
These examples demonstrate that it is useful to chemically
link certain metal ions to the surface of NPs, in order to
provide them with additional functionality. Naturally this
linkage should be stable, thus preventing release of the
metal ions from the chelators.
Detection of metal ions with nanoparticles
While so far the origin of the discussed metal ions was the
NPs themselves (corrosion of NP materials and linkage of
metal ions to the NP surface), NPs also can be used to
detect metal ions in solution: in test tube, in vitro, and in
vivo. The NP-based sensors can be divided into two main
categories, depending on the role of the NP. (i) NPs can act
merely as a chemically inert platform (carrier), which is
loaded with the actual sensing components, or (ii) NPs can
act as active sensing unit. At any rate, the sensing mech-
anism requires some kind of interaction (preferably se-
lective) between the metal ions and the NPs, resulting in
measurable signal changes, cf. Figure 1. For intracellular
detection, optical read-out is a frequent choice since
alternative techniques such as electrochemical electrodes
are more cumbersome to apply inside cells [92]. In case of
charged surface NPs, it is also important to note that the
conditions at the NPs surface are different from bulk, as
there will be a higher and lower concentration of ions with
the opposite and the same sign of charge around the
nanoparticles compared to bulk, respectively [93–95]. This
fact has profound effect on ion-sensitive NPs, and there-
fore, it has to be taken into account in the design of the
sensing systems by using appropriate calibration curves.
Several analytical strategies for NP-based ion-sensing are
used. (i) Plasmonic NPs (in particular Au) have been
widely used for the development of colorimetric sensors
for metal ions detection via an ion-chelation induced
agglomeration process. Upon NP agglomeration, color
changes (in the case of Au NPs from red to blue) can be
employed for visual sensing of the ions. This method has
been used, for example, for the detection of Pb2+, Cd2+ and
Hg2+ [96–98]. (ii) Fluorescent NPs such as QDs and
nanoclusters (NCs) can report metal ions via changes in
their fluorescence. The simplest ion sensing strategy is
based on fluorescence quenching when the ions are elec-
trostatically adsorbed on the surface of the QDs/NCs, or bywww.sciencedirect.com means of a specific ligand (e.g. ion chelators, peptides). The
detection of different metal ions such as Hg2+, Cu2+, Zn2+,
Ag+, has been reported following this strategy [99,100].
However, the maximum potential of QDs relies on the
development of multiplexing assays for the simultaneous
determination of several ions by using different-sized QDs.
A multiplexed analysis of Hg2+ and Ag+ ions by nucleic acid
functionalized CdSe/ZnS QDs has been reported [101].
Besides QDs and NCs, other NP-based sensors are being
used as well, such as the PEBBLE (probes encapsulated by
biologically localized embedding) system, in which ion-
sensitive dyes are linked to a carrier matrix. PEBBLE
sensors have been developed for example for the detection
of Ca2+, K+, Na+, Mg2+, Zn2+, Cu2+, and Fe3+ [102,103–
110]. In these systems, the readout involves mainly optical
detection, absorption, or fluorescence, depending on the
ion-sensitive dye used. There are several advantages of
PEBBLE sensors as follows: (i) The matrix protects the
cell from the dye and the dye from the cell components. In
other words, the matrix provides a protective coating for the
indicator dyes, avoiding responses of interferences such as
protein binding and/or membrane/organelle sequestration
in the biological sample. The nanosensor matrix also
provides protection to the cellular contents, enabling the
use of dyes that would usually be toxic. (ii) The PEBBLE
creates a separate sensing phase (the PEBBLE matrix)
distinct from the cellular environment which allows that
multiple dyes and ionophores can be combined within this
sensing phase to create complex sensing schemes. These
complex sensing schemes can include reference dyes for
allowing ratiometric sensing/imaging, or ionophore/chro-
moionophore combinations for the use of highly selective,
non-fluorescent ionophores. However, there are still sev-
eral challenges for NP-based sensing of metal ions. One
major problem is that the selectivity of many ligands or
fluorophores to the target ion is sometimes not as high as
required. Another problem for the application of NP-based
sensors, in particular in cells, is that colloidal stability needs
to be provided. This problem is particularly evident for the
detection principles in which read-out depends on direct
binding of ions to the NP surface, which limits employing
coating strategies for enhanced colloidal stability. Most
difficult to solve is that, in theory, NP-based sensors should
be ‘‘silent observers’’, measuring the ion concentrations
without interfering with normal cell behavior. However, as
we have discussed in the first part, the NPs can cause toxic
effects, for example by the release of toxic ions, as happens
with QDs, and thus, the ions release influences the cellular
environment.
Conclusions
In this review we have discussed three different topics,
which at first glance seem to be unrelated: (i) Toxic
effects upon corrosion of metal-containing NPs, (ii) modi-
fication of NPs with metal-ions for improved contrast
properties concerning imaging applications, and (iii)
detection of metal ions with NPs. However, as we haveCurrent Opinion in Chemical Engineering 2014, 4:88–96
92 Nanotechnologydemonstrated, these three topics are conceptually linked,
involving metal ions either in the NPs or in solution. The
ideal metal-containing NP should preserve its integrity
even under the harsh conditions of biological environ-
ments (e.g. presence of binding ligands, low pH, and
proteases in the lysosome), preventing release of metal
ions both from the NP material (corrosion/oxidation) and
from the surface (e.g. from chelators). In case metal ions
from solution are to be detected, however, these ions
should bind only reversibly to the NP surface in order to
warrant multiple uses.
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Abstract
The interfacing of colloidal nanoparticles with mammalian cells is now well into its second decade. In this review our goal is to
highlight the more generally accepted concepts that we have gleaned from nearly twenty years of research. While details of these
complex interactions strongly depend, amongst others, upon the specific properties of the nanoparticles used, the cell type, and their
environmental conditions, a number of fundamental principles exist, which are outlined in this review.
Introduction
There is a multitude of reports about the interaction of colloidal
nanoparticles (NPs) with mammalian cells [1], as this topic is
important for analyzing intended (e.g., medical applications
[2-4]) and non-intended (e.g., contamination [5-7]) exposure of
NPs to humans. However, there is a great number of available
NPs made of many different materials [8-10] with a wide range
Beilstein J. Nanotechnol. 2014, 5, 1477–1490.
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Figure 1: An overview of the “zoo” of different NPs concerning their composition, functionality, and fields of application. Reproduced with permission
from [11]. Copyright (2011) American Chemical Society.
of different functionalities, cf. Figure 1. For a classification of
NPs according to their composition, functionality, and fields of
application we refer to a recent review [11]. To complicate the
situation, most NPs do not consist of only one substance, but
typically are hybrid materials, involving surface coatings and
other modifications [12], cf. Figure 2 [13]. Even a homoge-
neous NP formed out of only one material will turn effectively
into a hybrid NP, when it is brought into contact with any bio-
logical system (e.g., biological media) because of an organic
coating that will form on the surface of the NPs [14]. This all
illustrates that virtually no two types of NPs are the same and
their inherent structure, properties, and constituent materials
will contribute to the way in which they are taken up by cells.
For example, a 20 nm diameter polymeric dendrimer may be
very flexible, whereas a 20 nm metal NP may not, which leads
to different interaction with cells. Furthermore, all of these
different NPs can be exposed to different cells (e.g.,
macrophages, endothelia, and tumor cells) under different expo-
sure scenarios (in vitro and in vivo), which as a consequence
culminates in a large, but diverse body of work reported in the
literature [15-17]. Due to this overwhelming amount of data, it
is not easy to obtain a comprehensive overview. Many studies
focus on the details of particular systems, but those can dramati-
cally vary from case to case, and even conflicting trends are
reported [17]. In addition, results will depend on the cellular test
model used. In order to simplify the discussion, this review
focuses on in vitro interaction of NPs with adherent,
mammalian, immortalized cell lines. This avoids for example
the problem of having to discuss how NPs reach and penetrate
tissue, which makes in vivo scenarios more complicated than in
vitro test systems. Despite these issues, it is still possible to
discern some general trends, as described within this review.
However, a limitation to having general trends equates to being
permissive of some specific details, though common agree-
ments reported here are clearly not trivial. It also automatically
involves the possibility that studies exist, which under particu-
lar experimental conditions claim the opposite to the general
statements. The most important of these trends will be
discussed. In this regard, the current review will focus on
physicochemically defined NPs, i.e., solutions of monodisperse
NPs with a defined ligand shell attached, and without residual
“left-over” impurities of the NP synthesis [13,18].
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Figure 2: Hybrid nature of typical NPs, comprising different structural
compartments. Reproduced with permission from [13]. Copyright
(2013) American Chemical Society.
Review
How do particles enter cells and where do
they go?
Virtually all cell lines internalize NPs, which are dispersed in
the growth medium [19]. Uptake of different NPs by different
cell lines, however, can vary significantly in biological kinetics
[20-22] (this is also true for larger microparticles [23]). This is
particularly important to keep in mind for specific (i.e.,
targeted) NP uptake, in which NPs modified by ligands (such as
folic acid), which bind to appropriate receptors on the cell
surface (such as folate receptors [24]), are specifically internal-
ized [25]. Ligand-mediated uptake (which depends also on the
ligand “valence”, i.e., the number of ligands per NP, their
density, and their orientation [26]) is faster and more efficient
than non-specific (i.e., not receptor-mediated) uptake [27,28],
although also plain or non-targeted NPs will be incorporated by
cells. Thus, an important parameter to compare amongst
studies, in which specific uptake is reported, is the time scale
used within the experimental approach. While after short times
of exposure huge differences in the amount of incorporated NPs
can exist (e.g., between ligand-modified and plain NPs), those
differences typically become less significant after longer expo-
sure times [29], e.g., by the presence of the protein corona [30],
as will be discussed later in more detail. Thus, statements which
claim that only specifically modified NPs, but not non-modi-
fied NPs are taken up by cells, have to be regarded highly criti-
cally and put into the correct context of the reported time-scale.
In fact, differences in uptake are not digital (i.e., "yes" or "no"),
but rather are based on different kinetics. However, non-adhe-
sive cell lines, i.e., cell suspensions, can be different and exam-
ples in which no significant internalization of NPs happened are
reported [31]. Coming back to adhesive cell-lines, the first step
in NP internalization obviously is the contact of the NP with the
cell plasma membrane. This is a concentration-dependent
process, which for high NP concentrations no longer
scales linearly with concentration (i.e., saturation effects may
occur). The first association of a non-targeted NP with a cell
surface is usually electrostatic. Positively charged NPs are, for
example, believed to interact with surface-displayed heparan
sulfate proteoglycans [32,33]. As a rule of thumb, NPs which
strongly interact with the cell plasma membrane, be it by
ligand–receptor-mediated or by charge-mediated adhesion, are
also internalized more efficiently [34]. Non-fouling polyeth-
ylene glycol (PEG)-modified NPs, for example, stick less to the
cell plasma membrane and are, therefore, incorporated by cells
less efficiently than other NPs [35-37] (this is also true in vivo
as manifested by enhanced retention times [38]). It is clear that,
while there are a number of portals through which NPs can gain
entry into the cell, they all have as the common denominator the
cell plasma membrane. Thus, the NP either must translocate
(diffuse) directly across the cell plasma membrane entering the
cytosol, or it must be internalized via any of the several routes
of cellular endocytosis. While some evidence exists to support
the direct membrane translocation of a select number of NP ma-
terials (typically partly hydrophobic and very small, as
discussed later) the overwhelming evidence to date supports
endocytosis as the common route of NP uptake. Thus, once NPs
are associated to the outer cell plasma membrane they are typi-
cally internalized by endocytosis [39,40]. While a variety of
different endocytotic pathways exist, which can be quite
different in detail (to appreciate the complexity of endocytosis,
we refer the reader to the review by Iversen et al. [41], cf.
Figure 3), all of them have in common that the NPs are
surrounded by membrane. Pinching-off of the membrane-
surrounded NPs from the cell plasma membrane leaves the NPs
incorporated into intracellular vesicles. These vesicles undergo
a cascade of intracellular trafficking steps passing the NPs to
more and more acidic vesicles [42,43], which also comprise
enzymes specialized in digesting nutrition (and thus also parts
of the NPs are digested in the lysosome [44,45]). In other
words, after incorporation, the majority of NPs is not “free” in
the cytosol, but inside intracellular vesicles (cf. Figure 4). Inside
those intracellular vesicles the NPs are in an environment
(acidic pH, enzymes) completely different from that in the
cytosol (cf. Figure 5). Endocytosis and the endosomal escape
dilemma have to be taken into account in particular concerning
the delivery applications of NPs, in which the goal is to deliver
something to the cytosol. Getting stuck inside intracellular vesi-
cles is redundant to the purpose of these applications. However,
in contrast to endocytosis as described so far, studies exist in
which it is claimed that NPs can directly translocate through the
cell membrane, thus indicating alternative pathways for NPs to
penetrate the cell plasma membrane [46,47]. Besides other
possible mechanisms, passive diffusion through (transient)
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Figure 3: Scheme depicting the different mechanisms of cellular endocytosis. Reproduced with permission from [41]. Copyright (2011) Elsevier.
Figure 4: Fluorescence microscopy image showing the granular struc-
ture of internalized NPs inside A549 lung cancer cells (two types of
iron oxide NPs with different surface chemistry, labelled with different
fluorophores (green and magenta)) after 24 h of incubation at a
concentration of 1 µg/mL, which are located in individual vesicles.
Nuclei are stained with DAPI (blue) and the cell membrane with Wheat
Germ Agglutinin (red). Note that due to limited lateral resolution of
optical microscopy the spots most likely do not correspond to indi-
vidual NPs, but to several NPs, which are entrapped inside intracel-
lular vesicles. The scale bar represents 5 μm. Adopted with permis-
sion from [65] und Creative Commons Attribution 4.0 International
Public License.
membrane pores and passive uptake by van der Waals or steric
interactions (subsumed as adhesive interactions) have been
suggested [48]. Still, it is always important to interpret such
studies critically [49]. Most of the time studies involve an
Figure 5: a) A microparticle has been internalized by an A549 lung
cancer cell into an intracellular vesicle (here the lysosome [165]) and is
thus clearly localized. The microparticle is filled with a pH-sensitive
fluorophore (SNARF, from Invitrogen, now LifeTech) linked to dextran
and the acidic pH of the lysosome is reported by the yellow fluores-
cence. b) After release of the pH-sensitive fluorophore linked to
dextran to the cytosol (by photothermal heating), the
fluorophore–dextran conjugates are freely dispersed, without any
visible granular structure. Due to the neutral pH in the cytosol the fluo-
rescence of the fluorophore–dextran conjugates has changed to red.
The scale bar corresponds to 10 μm. Adopted with permission from
[166]. Copyright (2012) Elsevier.
analysis of intracellular NP distributions, i.e., they rely on
images showing NPs distributed in the cytosol. Additionally,
these studies often rely on the observation that cellular NP entry
still occurs below physiological temperatures (e.g., 4 °C), at
which endocytosis and the active transport machinery are abro-
gated. However, without probing also for vesicular membranes
around the NPs it is complicated to claim that the NPs in fact
have passed the cell plasma membrane as "naked" NPs, without
having ever been inside any intracellular vesicle. Clearly, there
are a lot of indications (e.g., simulations) that NPs can enter
cells through transient pore formation, in particular very small
NPs [50,51]. Still, in many publications experiments do not
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unequivocally demonstrate this pathway, though it surely exists.
One possibility of experimental modification would involve, for
example, pH-sensitive fluorophores (such as SNARF [52,53])
attached to the surface of the NPs, which can distinguish
between the neutral cytosol and highly acidic intracellular vesi-
cles [54]. In a similar direction the reductive capacity of
glutathione (the cytosolic concentration of which is between 5
and 10 mM) may be used to displace a fluorescence resonance
energy transfer (FRET) acceptor on the surface of the NP as
confirmation of a successful NP localization to the cytosol [55].
Such experiments are in particular important for distinguishing
between direct translocation to the cytosol versus endocytotic
uptake followed by endosomal release. In fact, while there is
clear experimental proof that NPs can be transported to the
cytosol, the most straightforward pathway is uptake through
endocytosis followed by release from the intracellular vesicles
to the cytosol [56-58] (and not the diffusion through (transient)
membrane pores). Endosomal release is, for example, a scenario
which has been unraveled in detail for NPs coated with certain
cell penetrating peptides (CPPs) [59-62]. Thus, while NPs can
be free in the cytosol, this clearly does not automatically
involve that they are membrane-permeable and not endocy-
tosed. As pointed out above, observations based on merely
measuring intracellular NP distributions are not sufficient for
making profound statements about the uptake pathway. On the
other hand it is safe to say that different intracellular locations
for NPs exist. NPs have been reported in different intracellular
organelles such as mitochondria, the nucleus, and free in the
cytosol [63,64]. Most of the time such intracellular distribu-
tions are analyzed with transmission electron microscopy
(TEM), in which also the structure of the intracellular
organelles can be resolved (cf. Figure 6), or with fluorescence
microscopy, in which the intracellular organelles have been
co-stained with a fluorescent marker [65-67]. However, these
data have to be interpreted carefully. In particular, such data
should always include a quantitative distribution analysis,
which is highly time-consuming. Even plain NPs without any
particular surface capping can be found free in the cytosol [68],
however, only to a very low extent. Thus, images in which NPs
are shown in some particular intracellular organelles are only of
limited value if the fraction of NPs that resides in these
organelles is not quantified. Quantification, however, is not as
trivial as it seems, and there is a need for better quantitative
techniques for the future. While TEM offers the lateral resolu-
tion to visualize individual NPs, typically only a limited amount
of cell sections (i.e., thin slices cut from cells) can be observed
and thus for an absolute quantification, which is highly time-
consuming, stereological tools need to be employed [68,69].
Also in case of TEM studies knowledge and understanding of
cells under TEM conditions is essential. Fluorescence, on the
other hand, can be recorded quantitatively by assuming that the
Figure 6: Intracellular compartments after internalization of PEG-
coated gold NPs as visualized with TEM. The NPs (which are individu-
ally resolved due to the high lateral resolution of TEM) are located
within a lysosome (arrows I) and in the cytosol (arrow II). m and n
demark the nucleus and mitochondria, respectively. The scale bar
corresponds to 500 nm. Adopted from with permission from [68]. Copy-
right 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
emission intensity is proportional to the number of NPs.
However, fluorescence can be partly quenched in certain
organelles (for example at low pH), and it is impossible to
resolve individual NPs due to the limited lateral resolution of
optical microscopy [70]. In addition, as mentioned before, NPs
can be partly degraded after having been internalized [71,72]
and thus, in case fluorescently labeled NPs are used, it is
required to prove that the fluorescence (or any other) label is
still attached to the NPs inside the cells. Otherwise the recorded
intracellular distribution of fluorescence may originate from
detached labels and thus would not reflect the distribution of the
NPs [73]. Summarizing available data suggests that, while
translocation from intracellular compartments to the cytosol and
from there to other cellular organelles is possible, translocation
efficiencies still are moderate at best. In addition, NPs free in
the cytosol may later end up again in intracellular vesicles
through auto-phagocytosis [74]. Thus, for many applications,
such as intracellular sensing or drug delivery, translocation of
NPs to the cytosol after spontaneous endocytotic uptake
remains a major challenge. External stimuli may be helpful in
this direction [75]. In order to close this section it is also impor-
tant to think about what happens after endocytotic uptake. It is,
for instance, often overlooked that there is an eventual loss of
the total NP load per cell as a result of mitotic division, NP
exocytosis, and NP transcytosis [76]. This is largely due to the
fact that in most experimental systems the primary issues
addressed are uptake efficiency of the NPs and subsequent
intracellular fate. These parameters are typically asked over the
time course required for NP internalization and subcellular
localization, and are not tracked over long time courses. It is
generally accepted that NPs are partitioned during cell division,
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in which they are passed to the daughter cells [76,77]. Such
dilution effect of NP labels is in particular important for studies
involving NPs as long-term tracers. Here, the relevant question
arises whether upon cell division NPs are passed 50/50 to each
daughter cell. Summers et al. have done both a theoretical [78]
and experimental assessment [79] showing that, while parti-
tioning of endosomes to daughter cells is symmetric, the
number of NPs per endosome is a distribution and therefore NP
partitioning to daughter cells is asymmetric. Thus, after several
division cycles the NP distribution will not necessarily be
representative for the fate of the original “mother” cells
anymore. NPs also can be excreted to the extracellular medium,
which represents an additional source of NP dilution effects.
While endocytosis of NPs has been investigated heavily there
are only a limited number of reports investigating exocytosis of
NPs [80-82]. Excretion of NPs in exosomes (i.e., membrane
surrounded vesicles), however, clearly affects the long-term
cellular loading with NPs. In addition, for some particular cells,
transcytosis has also been reported, i.e., that NPs are passed
from one cell to another one [83].
What are the critical parameters involved in
in vitro nanoparticle internalization?
As mentioned before, virtually all NPs are spontaneously inter-
nalized by adherent cells, mainly cell lines, that are usually
grown on a certain support and covered with cell culture
medium under static conditions. In this case, NPs in the medium
can directly access cells, and issues like tissue penetration,
which need to be considered in in vivo experiments, can be
neglected. The kinetics of internalization can depend strongly
on the physicochemical properties of the NPs, the type of cells,
and other parameters. Cellular uptake studies of NPs require as
much characterization of the NP materials as currently possible.
Concerning the NPs, this is, unfortunately, hampered by our
incapability to synthesize “defined” NPs. For quantitative
studies NPs and their bioconjugates should be as monodisperse
as possible with regard to all relevant parameters, such as
charge and size, well-defined and well-characterized. Moreover,
in the case of bioconjugates, the biological molecule, be it
protein or drug, should be attached to the NP with control over
orientation [84,85], density, affinity, and number or ratio per
NP [85]. Although these goals are extremely hard to achieve,
the more they can be fulfilled, the less heterogeneity is present
in the NP material and the easier the results (i.e., the correlation
between the properties of the NPs and the observed interaction
of NPs with cells) can be interpreted [13,18,86]. With limita-
tions, a correlation of the spontaneous endocytotic uptake of
NPs to the physicochemical properties of the NPs can be found.
One, however, has to be aware that many physicochemical
properties of NPs, such as size, shape, charge, and colloidal
stability are highly entangled [14]. The physicochemical prop-
Figure 7: TEM images of a) dispersed and b) agglomerated Au NPs.
The scale bars correspond to 100 nm. Adopted with permission from
[30]. Copyright 2014 Royal Society of Chemistry.
erties are not intrinsically associated with the NPs, but result
from the interaction of the NPs with the surrounding particular
medium [87]. The colloidal stability is presumably the most
influential parameter. NPs with low colloidal stability will
agglomerate and thus, originally "small" NPs will transform
into agglomerates, resulting in large particles presented to the
cells (cf. Figure 7). However, “colloidal stability” is not a
defined physicochemical entity such as size, but needs to be put
in context with the measurement protocol, such as the tendency
to agglomerate. Any correlation to the size of the NPs without
any previous demonstration of colloidal stability in the incuba-
tion medium has to be seen very critically. Loss of colloidal
stability during incubation also complicates dosimetry. If NPs
are quantified in numbers, is an agglomerate of NPs considered
to be one particle or the number of NPs in the agglomerate
[14]? Agglomeration can have direct consequences on cellular
uptake [62]. If the cell cultures are turned upside-down, i.e., the
cells are hanging in the culture medium, NP agglomerates that
have precipitated at the bottom would not reach the cells and
thus the effective NP concentration would be dramatically
reduced [88]. In contrast, in conventional geometry, in which
the culture medium is on top of the cells, a reduced colloidal
stability leads to the precipitation of NP agglomerates onto the
cells and, thus, to enhanced uptake, which can influence the cell
viability negatively [89]. Such different exposure scenarios are
highly relevant for the prediction of NP interactions, for
instance, in the human body or in ecotoxicology. Some NPs
have been mistaken to elicit limited to no adverse effects upon
zebrafish assays, as they had precipitated to the bottom, and
thus, the fish had not been directly exposed to them. After
correct solubilization, however, the same NPs turned out to be
highly detrimental to zebrafish health [90]. Colloidal stability
does not only interfere with size but also with other parameters
such as shape. An agglomerated bundle of sharp NPs may no
longer be "sharp". Thus, colloidal stability is the paramount
parameter to consider for all correlations between the NP–cell
interactions and the physicochemical properties of the NPs.
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Reports, in which no characterization of colloidal properties has
been performed, therefore have to be regarded very critically.
Unfortunately, many NPs are not colloidally stable in cell
culture media [91]. The reason is that many NPs are stabilized
by charge (in contrast to stabilization through steric repulsion).
Salt (in particular NaCl, which always is present at high
concentration) in the media screens the NP charge and thus can
cause agglomeration [92]. Consequently, data which demon-
strate that NPs are colloidally stable in water do not provide any
proof that the same NPs also will be stable in cell culture media.
Besides salt, proteins are another key compound of (serum-
containing) cell media. As discussed later in more detail,
proteins adsorb to the surface of NPs, forming the so-called
protein corona [93,94], which in fact can increase or reduce
colloidal stability [95,96]. Thus, characterization of colloidal
stability and other physicochemical properties of NPs needs to
be carried out under the same conditions under which later on
cells are incubated with the NPs (i.e., in the respective cell
culture media [86,97,98]). Obviously, NPs also should be
appropriately purified [99], as otherwise effects from impuri-
ties rather than from the NPs themselves cannot be excluded.
Unfortunately, for unstable NPs (e.g., for NPs to which the
organic surface capping is only loosely attached) purification
can trigger a loss of colloidal stability and thus agglomeration
[14]. As lack of colloidal stability can overrule the other para-
meters, the following discussion about dependencies of other
parameters is done assuming colloidally stable NPs. Uptake of
NPs into the cells clearly depends on the size of the NPS. In
general, smaller NPs are incorporated by cells faster than bigger
ones, though there is some kind of size limit, i.e., the trend does
not continue down to ultrasmall NPs [40,100]. As mentioned,
upon endocytosis NPs are first wrapped by cellular membrane.
Due to intrinsic stiffness and other parameters for membrane
bending the radii of curvature cannot become infinitely small,
and thus, there is an optimal NP size [101,102]. Excluding
ultra-small NPs (smaller than 2–3 nm), smaller NP (smaller
than 20–25 nm) are internalized readily in endosomes with most
rapid kinetics [103]. Larger NPs (smaller than 60–70 nm) are
internalized with lower kinetics to the extent that they are
largely associated to the cell membrane over the time courses
that see an intake of smaller NPS [62]. This has also been
shown in fixed, permeabilized cells (to eliminate cell uptake
machinery and pathways) to directly assess the size restrictions
of plasma and intracellular membrane barriers on NP passage
[104]. In contrast, ultrasmall NPs may be small enough to
become membrane-permeable and thus bypass endocytotic
uptake. Size-dependent uptake has also been reported for in
vivo scenarios [105]. However, in particular for statements
concerning size-dependent internalization, the experimental size
determination of NP is important. Unfortunately, this is not a
straightforward task, as different techniques measure different
types of sizes. TEM only provides the geometric size of the NP
core which has sufficient contrast, but organic surface cappings
are typically not included [14]. In solution there is adsorption of
counter ions to the NP surface [106,107] and organic surface
coatings can swell, which results in hydrodynamic diameters
larger than the core diameters as determined with TEM. There
are several techniques for determining the hydrodynamic diam-
eters of NPs [108], of which dynamic light scattering (DLS)
might be the most common approach. All techniques have their
limitations, and it is always helpful to know the measuring prin-
ciple they are based on. DLS, for example, is based on calcu-
lating autocorrelation functions of the light-scattering signal of
the solution. In order to obtain quantitative values, these auto-
correlation data need to be fitted with a model, which is, for
example, often done by assuming free diffusion of three NP
species of different size. Thus, the results are based on the
model (which is hidden as "black-box" in the software). To give
an example, in case three species are assumed one always will
obtain three peaks in the size distribution spectra, even though
the sample may contain more different NP species. From the
model, diffusion coefficients are yielded as fit parameters,
which can be converted to hydrodynamic diameters by the
Stokes–Einstein relation. As NPs of larger size also scatter light
much more than smaller NPs, the results for DLS-derived size
distributions also are quite different depending on whether
number or intensity distributions are reported. Thus, simply
taking the mean hydrodynamic diameter as displayed by
commercial set-ups is prone to errors [109]. Calibration stan-
dards of NPs of known size are always a good help to bench-
mark size measurements and it is highly beneficial to apply
several techniques in parallel [108-110]. By applying existing
techniques correctly, the hydrodynamic diameters of NPs can
be determined with remarkable accuracy, in particular if rela-
tive size changes are determined. Detection can be sensitive
enough to resolve size-changes due to the attachment of indi-
vidual macromolecules to the NPs [84,85,111,112]. Besides
size, also shape has been proven to modulate the NP uptake of
cells. In general, elongated, sharp NPs (i.e., NPs with a prolate
spheroid shape) enter cells better than flatter NPs (i.e., NPs with
an oblate spheroid shape). This however does no longer hold for
very long fibers with high aspect ratios [100]. Flattening of NPs
has been used, for example, to reduce NP uptake by cells in a
way that flat NPs just adhere to the plasma cell membrane like a
“backpack”, without being internalized, in contrast to spherical
NPs that are readily incorporated [113,114]. Concerning a third
parameter, charged NPs usually are internalized more effi-
ciently than neutral ones, presumably due to enhanced charge-
mediated adhesion to the outer cell membrane. Note that the
charge pattern of the plasma cell membrane is patchy, and thus,
while the overall net charge of cells is negative, there are plenty
of positively charged domains. However, due to the overall
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negative net charge, positively charged NPs are typically incor-
porated more efficiently by cells than negatively charged ones
[65,97,115-119]. Indeed, the current consensus is that positive
charges on NPs, such as those provided by the TAT peptide or
surface functionalization, interact initially with the negatively
charged heparan sulfate proteoglycan groups on the exterior of
the cells. This allows them to then be present on the plasma cell
membrane as endocytosis starts. Thus, while details may be
very complex, clearly some tendencies for which physicochem-
ical parameters enhance the spontaneous endocytosis of NPs
can be given. In general, small, elongated, and positively
charged NPs are incorporated preferentially to big, flat, and
uncharged NPs. Dependency on other physicochemical parame-
ters such as stiffness [120] has not been investigated exten-
sively yet.
The role of the protein corona
In serum-containing media or inside cells all different types of
biologically relevant molecules adsorb to the surface of NPs.
i) Ions such as H+, Na+, K+ or Ca2+ in the case of negatively
charged NPs, or Cl− in the case of positively charged NPs
adsorb to the NPs. As a consequence of counter ion adsorption
the local ion concentration around the NPs surface is different
from the bulk [54,87,106,107]. ii) Also nucleic acids, such as
mRNA or siRNA, which are negatively charged due to their
phosphate groups attach to positively charged NPs [121,122].
iii) Lipids present in membranes or second-messenger lipids
wrap around NPs driven by hydrophilic/hydrophobic inter-
action and often result in formation of micelles [123,124].
iv) Thiols, present in glutathione or reduced proteins bind to the
surface of noble metal NPs, in particular to Au NPs [125,126].
v) Proteins, in general, tend to adsorb to surfaces, which is also
true on the nanometer scale. Adsorption of albumin is, for
example, an integral part of opsonization [127,128]. The
proteins adsorbed to the surface of NPs are typically termed
protein corona [93,94]. The protein corona has a significant
impact on how NPs interact with cells and thus will be
discussed in the following in more detail. NPs can, in principle,
be synthesized in water without any organic surface coating, for
example by laser ablation [129-131]. However, also to NPs just
stabilized by their surface charge (which can be directly on the
inorganic surface) proteins will adsorb in serum-containing cell
media and in this way can provide additional colloidal stability
[129]. Therefore, there are no "naked" NPs in serum-containing
cell culture media and inorganic NP cores are always
surrounded by an organic coating [14]. Adsorbed proteins can
significantly alter the surface properties of NPs and are of key
importance in defining the biological identity of NPs [132,133].
The corona formed around NPs is what the cell will “see”
primarily, though certainly also the original properties of the
underlying NPs determine interactions with the cells [97]. In
general, adsorbed proteins "smear out" differences in the
surface chemistry between different NPs. Thus, typically two
different types of NPs show more pronounced differences in
their interaction with cells in case exposure is done in serum-
free media (i.e., without proteins) rather than in serum-
containing media [97]. The effect of ligands immobilized on the
surface of NPs designated for ligand–receptor-mediated uptake
is diminished by the protein corona, which partly overcoats the
ligands [134]. However, due to the fact that specific targeting
still is possible [84], enough ligands still are biologically active.
For highly defined NPs, such as nearly monodisperse NPs over-
coated with a shell of an amphiphilic polymer [135], the corona
formed by special model proteins can be surprisingly well orga-
nized. By using fluorescence correlation spectroscopy (FCS),
Röcker et al. investigated the adsorption of human serum
albumin onto FePt NPs and found clear evidence that the
proteins formed a monolayer on the surface of the NP [136].
Additional FCS studies by using other important serum proteins
invariably confirmed the formation of monolayer. The thick-
ness of the monolayer could be related to the molecular dimen-
sions of the adsorbed protein determined by X-ray diffraction.
All proteins studied were found to adsorb in a specific orienta-
tion determined by local charge distributions on the protein
surface [20,137,138]. However, adsorption of proteins to the
surface of NPs is not only driven by the basic physicochemical
properties of the NP such as size, shape, surface charge, but also
by other parameters such as the incubation temperature [139].
While model systems involving only one type of NPs and one
type of protein help to analytically quantify protein adsorption,
such as by determining binding constants [30,136], the bio-
logical reality is more complex. Serum-containing cell culture
media comprise hundreds of different proteins. To make it
worse to analyze, protein adsorption is also a dynamic process.
Thus, proteins which are initially bound to the NP surface can
later be replaced by others [140,141], which also is referred to
as the Vroman effect [142]. It has been shown, for example, that
surfactant lipids bound on multiwall carbon nanotubes are
replaced with blood plasma proteins after a subsequent incuba-
tion [143]. Mass spectrometry is an invaluable tool for quanti-
fying the amounts of different adsorbed protein species
[140,141]. The dynamic exchange of proteins, induced by their
different adsorption kinetics and affinities to the NP surface is
reflected in the discrimination between "soft" and "hard" corona
[144,145]. The initial, soft corona is formed by the most abun-
dant proteins, which are then replaced by the high-affinity
proteins to yield the hard corona. It has been suggested that
differences for different protein species can be characterized by
their dissociation constants [30]. In a simple model the dissocia-
tion constant tells which protein concentration is required to
saturate half of the NP surface with proteins under equilibrium
conditions [30]. With simple treatments such as the Hill Model
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[146] one may characterize the protein corona around NPs with
only a few parameters, which would be a great help in
comparing results obtained with different systems, thus
allowing for a more comprehensive understanding. While the
protein corona around NPs has been heavily investigated these
data ultimately are only relevant for the first interaction of NPs
with cells. After spontaneous endocytosis NPs are inside intra-
cellular vesicles. This imposes a completely different environ-
ment than that of the extracellular medium, in particular low
pH, presence of endo-/lysosomal enzymes, and different
reducing agents [147]. Thus, after NP uptake the protein corona
around NPs may change significantly. The original proteins can
be displaced by other intracellular proteins, and even more
severe, part of the original protein corona may be digested
enzymatically [44,45,148,149]. Changes of the protein corona
in turn may also alter the physicochemical properties (such as
colloidal stability) of the NPs [96]. In this manner, for a full
understanding of NP interaction with cells along the pathway of
NP uptake the physicochemical characterization of NPs should
also be done intracellularly, which, however, is complicated.
This opens up a window for future research efforts.
Toxic effects of NPs
NPs clearly can trigger toxic effects in cells such as cytotoxi-
city, oxidative stress, (pro-)inflammation, and genotoxicity
[150-152]. While again the detailed mechanisms are very com-
plex and by far not understood in a comprehensive way, yet
again there are certain characteristic features [153]. Toxic
effects can result from the NPs themselves (e.g., by their
catalytic surface or by their organic coating, such as in the case
of cetyltrimethylammonium bromide (CTAB), a surfactant
commonly used to synthesize gold nanorods) or by ions
released from the NPs [154,155]. Ion release from certain ma-
terials such as Ag, ZnO, or CdSe is in particular triggered by the
highly acidic pH in endo-/lysosomal compartments [156]. In
both cases adverse biological effects are typically correlated
with the production of reactive oxygen species (ROS)
[157,158]. Also membrane damage plays a decisive role. In
case of dissolvable NPs, the extent to which toxicity originates
from the NPs themselves and to which extent from released ions
is still subject to an intense scientific debate. Unfortunately, it is
experimentally complicated to separate both effects. Even if
before exposure all free ions were removed from the NP solu-
tion, inside cells new ions would be released. Thus, it is virtu-
ally impossible to have cells exposed exclusively to NPs
without free ions [87]. One may argue that on the other hand
cells could be exposed just to the free ions. While this is true,
exposure to free ions will result in different intracellular ion
distributions than the one obtained by ions which have been
released from the NPs intracellularly, which again complicates
direct comparison. Physicochemical properties can be, in some
way, correlated with NP toxicity. In other words, reporting toxi-
city without accompanying in-depth NP characterization is not
very useful concerning a detailed understanding of the mecha-
nism. Surface coatings and impurities in the NPs can play an
important role. Thus, also the coatings alone, as well as poten-
tial impurities need to be investigated towards potential toxic
effect in control experiments. If only the physicochemical prop-
erties of “pure” NPs are considered, NPs with low colloidal
stability have bigger effective sizes, thus are internalized to a
larger extent, and thus typically have a greater adverse bio-
logical impact [154]. In order to account for concentration
effects, it is advisable to correlate toxicity with particle internal-
ization by using adequate methods. Enhanced uptake is one
major reason (amongst others) why positively charged NPs
(which are incorporated to a higher extent) elicit an increased
adverse cellular effect compared to negatively charged ones
[97,117,118]. This opens a dilemma. While in general, positive
charge is better for enhanced uptake, too much positive charge
becomes so toxic that it outweighs the added benefit of
enhanced uptake. Thus, for delivery applications an optimum
between both effects has to be found. This opens up another
important point about the biological impact of NPs that merits
discussion. There is a big difference between the use of NPs for
cellular labeling or biosensing studies in research, as opposed to
any therapeutic (in vivo) utility, and the two should never be
thought of together or directly compared. It was, for example,
recently shown that semiconductor quantum dot NPs (QDs)
were unable to elicit a more negative biological effect when
used for cellular labeling than a panel of dyes commonly used
for the same intrinsic purposes [159]. Along with this, often
transformed and immortalized cell lines are used in biological
research, meaning that they are essentially cancerous. Thus,
what appears to be adverse biological impact in these experi-
ments has to be qualified with this context in mind. For cellular
labeling, perhaps, there is the need for a particular experiment
that should drive the issue of toxicity. If the use is specifically
for in vitro labeling, tracking or sensing, there are multiple
studies that have shown that over the time course required to
perform such studies, the impact on cellular viability/prolifera-
tion at appropriate NP concentrations is minimal and is often
comparable to or even less impactful than the use of traditional
materials designed for the same purpose [159]. In this case
“chronic toxicity” does not play a role, as the experiment is
terminated before such an effect may occur. In contrast, for in
vivo delivery one has to consider that NPs will remain in the
organism over extended periods of time [160], and thus, bene-
fits of treatment have to be weighted with long-term toxic
effects [161]. Consequently, toxicity of NPs always has to be
seen in the context of the applications the NPs are used for, but
furthermore, the potential accidental exposure beyond the appli-
cation has to be considered and its risk has to be assessed. In the
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context of this review we have focused on in vitro studies. The
advantage of such studies is the easy screening capability and
the possibility to monitor in detail biomolecular pathways and
changes in gene expression as a measure of a possible bio-
logically adverse response. In case NP toxicity is investigated in
a comprehensive study, however, involvement of in vivo exper-
iments is crucial.
Conclusion
Due to their interesting functional properties, numerous applica-
tions of NPs exist, e.g., plasmonic NPs [2,75], magnetic NPs
[162,163] or fluorescent NPs [164]. For optimizing NP prop-
erties for biological applications, an understanding of their
interaction with mammalian cells needs to be gained. However,
the interaction of NPs with cells is complex due to the many
different types of NPs, cells, and exposure scenarios being used
within the field. Still, one may make an attempt to reduce
details to very general statements, in order to highlight some
essential elements, which was the motivation for this review.
Endocytosis is the common route of NP uptake. NPs which
strongly interact with the cell plasma membrane are also inter-
nalized more efficiently. Hereby differences in uptake are not
digital (i.e., "yes" or "no"), but rather are based on different
concentration-dependent kinetics. After internalization NPs
inside intracellular vesicles are in an environment (acidic pH,
enzymes) completely different from that in the cytosol and the
extracellular space, which can modify their properties. The
translocation of the NPs from these vesicles to the cytosol is a
current challenge, which is referred to as endosomal escape
dilemma. Uptake studies best should involve a quantitative
distribution analysis. While endocytotic uptake of NPs has been
extensively investigated, the eventual loss of internalized NPs
as a result of mitotic division, NP exocytosis, or NP transcy-
tosis on the other hand has not been comprehensively studied
yet. Cellular uptake studies of NPs require as much characteri-
zation of the NP material as currently possible. However, many
physicochemical properties of NPs such as size, shape, charge,
and colloidal stability are highly entangled, which complicates
analysis. Analysis of physicochemical properties should be
always performed in the incubation medium in which the
uptake of NPs by cells is studied. The incubation medium can
for example modify the colloidal stability of the NPs. Colloidal
stability does not only interfere with size but also with other
parameters such as shape. In general, small, elongated, and
positively charged NPs are incorporated preferentially to big,
flat, and uncharged NPs.
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Particle-Based Optical Sensing of Intracellular Ions at the 
Example of Calcium – What Are the Experimental Pitfalls?
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 Colloidal particles with fl uorescence read-out are 
commonly used as sensors for the quantitative 
determination of ions. Calcium, for example, is a 
biologically highly relevant ion in signaling, and thus 
knowledge of its spatio-temporal distribution inside cells 
would offer important experimental data. However, the 
use of particle-based intracellular sensors for ion detection 
is not straightforward. Important associated problems 
involve delivery and intracellular location of particle-
based fl uorophores, crosstalk of the fl uorescence read-out 
with pH, and spectral overlap of the emission spectra 
of different fl uorophores. These potential problems are 
outlined and discussed here with selected experimental 
examples. Potential solutions are discussed and form a 
guideline for particle-based intracellular imaging of ions. 
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 1.  Introduction 
 There is a large variety of ion-sensitive fl uorophores avail-
able, which change their fl uorescence intensity in the presence 
of the respective ion. [ 1–7 ] With such fl uorophores intracellular 
ion concentrations could, in principle, be determined, which 
would be an interesting tool for cell biology. [ 8–16 ] Ions play 
an important role in biology, for example, in signaling. This 
comprises signal propagation via action potentials in neurons, 
for example, which is governed by local switching on and off 
of Na + and K + currents. Another important ion related to 
cellular signaling is Ca 2+ , which plays an important role in 
muscles. Having local ion-sensitive probes would allow the 
spatio-temporal observation of such signaling dynamics. 
 Most ion-sensitive fl uorophores are based on organic 
molecules, [ 1,2,5–7 ] but there are also intrinsically fl uores-
cent (nano-)particles with sensitivity to certain ionic spe-
cies. [ 17–20 ] Ion-sensitive particles can be composed of a 
carrier particle functionalized with ion-sensitive organic 
fl uorophores. The particle acts as a carrier for a read-out in 
the form of (organic) ion-sensitive fl uorophores. This is pos-
sible by embedding the organic fl uorophores in the volume 
of a porous particle matrix, [ 21–23 ] by encapsulating them in a 
porous particle shell, [ 24–26 ] or by linking them to the particle 
surface. [ 27–29 ] Ideally, the carrier particle would not inter-
fere with the photophysical properties of the attached fl uo-
rophore. However, in the case of metal particles, quenching 
effects of the fl uorescence of organic fl uorophores close to 
the particle surface are possible. Also in case of very high 
packing densities of the fl uorophores on the particle surface, 
self-quenching effects may occur. In some scenarios as, for 
example, for fl uorescence resonance energy transfer (FRET), 
interactions of the organic fl uorophore with the particle car-
rier is wanted in order to tune the photophysical properties 
of the attached fl uorophores, which will be described below. 
Alternatively, intrinsically ion-sensitive fl uorescent particles 
such as quantum dots (QDs) can be sensitive to ions. [ 102 ] In 
this case, the particle has a double function, acting as sensi-
tive fl uorophore and a carrier at the same time. In the fol-
lowing sections, all of these different geometries will be 
referred to simply as particles. These particles can range from 
the nanometer to the micrometer scale. [ 30 ] Besides acting as 
carriers, charged particles can intentionally or unintentionally 
modify the ion response, as their typically charged surface 
forms a nano-environment in the proximity of the particle 
surface that is different from the bulk. [ 27,31–34 ] 
 A particulate form of ion-sensitive fl uorescence sensor 
offers several potential advantages. Concerning the signal-
to-noise-ratio of the read-out, the emission intensity of ion-
sensitive particles can be very high (in the case of intrinsically 
fl uorescent particles such as QDs, this is due to their high 
absorption cross-section; [ 35,36 ] in the case of organic fl uoro-
phores, it is due to the linkage of several fl uorophores per par-
ticle). [ 37–39 ] Next, the interaction with their environment, such 
as with cells, is predominantly governed by the physico-chem-
ical properties of the particle surface. As particles sensitive to 
different ions can have the same physico-chemical properties, 
they also will have the same interaction with cells. In contrast, 
as organic fl uorophores sensitive to different ions typically 
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have very different molecular structures and thus different 
physico-chemical properties (their polarity can range from 
hydrophilic to hydrophobic, for example), they will interact 
differently with cells. The pathway of cellular uptake of fl uo-
rescent particles can therefore be quite different from plain 
organic fl uorophores. Playing with the size of the particle that 
acts as the carrier (nano- or microparticles), the location of 
the sensor inside the cells can be designed and thus informa-
tion about the ion concentrations in different cellular regions 
can be obtained. While nanoparticles are preferentially 
located in endolysosomal compartments, microparticles can 
also be found in phagolysosomal vesicles, which allows the 
design of ion-sensitive particles depending on the location of 
the ion of interest. Due to potentially different intracellular 
locations and also because of the protection by the particle, 
particulate fl uorophores may be less degraded by intracel-
lular enzymes, and also cause less toxic intracellular effects (in 
particular when their sensing part is directly located on the 
particle surface). Concerning multiplexed sensing, the possi-
bility of working with detection schemes involving temporal 
or spatial discrimination can circumvent the problem of spec-
tral overlap and, thus, different ion-sensitive fl uorophores can 
be detected in parallel. [ 40,41 ] Naturally, besides these advan-
tages there are also problems associated with particle-based 
intracellular ion-sensing, which will be highlighted in the fol-
lowing sections based on experimental examples. While the 
given analysis holds true in a general way for small biologi-
cally relevant ions such as Na + , K + , Cl − , H + , the statements 
above are illustrated by selected experimental data. For rea-
sons of homogeneity, the experimental data are presented for 
the case of Ca 2+ -sensing, though results would be similar for 
other ions. The technical details for the experiments can be 
found in the Supporting Information. 
 2.  Upon Cellular Internalization, Particle-
Based Sensors are Typically Located Inside 
Intracellular Acidic Vesicles 
 The classical entry of particles into cells is via endocytosis. 
While endocytosis can involve a lot of different pathways, [ 42–45 ] 
it results in a localization of the particles in acidic intracellular 
vesicles (endosomes, lysosomes). [ 25,46–49 ] In such a scenario, the 
particles would sense the ion concentrations inside these vesi-
cles, but not in the cellular cytosol. [ 8,50 ] For many applications, 
sensing of ion concentrations in the cytosol would be favorable. 
Administration of particles by microinjection or electropora-
tion allows the placing of particles in the cytosol, though these 
techniques are clearly invasive and would have severe limita-
tions for in vivo applications. However, there is also clear evi-
dence that certain particle geometry scenarios exist in which 
particles can be delivered to the cytosol upon spontaneous 
cellular uptake. [ 51,52 ] In the case of delivery to the cytosol, the 
particles can be either fi rst endocytosed and then released 
from the intracellular vesicles (“endosomal escape”), [ 53–55 ] or 
they can directly traverse the cell membrane (i.e., by transient 
poration) and thus bypass endocytotic uptake. [ 56 ] The details 
of such mechanisms are still under scientifi c discussion. For 
fast uptake into cells and delivery through the cell membrane 
to the cytosol, a common functionalization of the particle sur-
face involves specifi c peptide sequences, e.g., cell-penetrating 
peptides (CPPs), [ 57–59 ] which usually are derived from viruses. 
The data shown in  Figure 1 demonstrate an example, in 
which polyethylene glycol (PEG)-modifi ed particles bearing 
CPPs at the termini of the PEG molecules were internalized 
in vitro by HeLa cells to a higher extent than similar parti-
cles without CPP functionalization. Quantifi cation of particle 
internalization can be done via different techniques, such as 
transmission electron microscopy (TEM), [ 60–62 ] fl uorescence 
microscopy, [ 63–65 ] fl ow cytometry, [ 47,50 ] and inductively coupled 
plasma mass spectrometry (ICP-MS). [ 66,67 ] As fl ow cytometry 
and ICP-MS do not possess direct lateral resolution at a sub-
cellular level, these techniques do not allow one to distinguish 
between internalized particles which are free in the cytosol 
from those which are localized inside intracellular vesicles. 
Even worse, these methods do not allow intracellular particles 
to be distinguished from particles just sticking to the outer 
cell membrane. However, this limitation has been overcome 
using protocols for removing particles attached to the surface 
based on iodide etching [ 68 ] or, in the case of fl ow cytometry, 
by using the local pH around the particles as a discriminator 
between internalized (acidic pH) and extracellular (neutral 
pH) particles. [ 69 ] In contrast, fl uorescence microscopy, when 
applied together with appropriate immunostaining methods, 
and in particular TEM, due to its high spatial resolution, can 
demonstrate particle internalization, and can in principle also 
indicate whether internalized particles are inside intracellular 
vesicles or not. [ 47,49,52 ] However, in many cases, uptake studies 
are based on fl uorescence microscopy images without staining 
of intravesicular membranes (cf.  Figure  1 ), with the conse-
quence that, from such images, no conclusion about the intra-
cellular localization of the particles can be drawn. In fact, it is 
important to be highly critical about the possible delivery of 
particles to the cytosol. Just the presence of CPPs on the par-
ticle surface does not automatically mean their delivery to the 
cytosol. This is illustrated in the example shown in Figure  1 , 
which is based on two CPPs that both are rich in NH 2 groups. 
In these data, one can see a clear indication of enhanced cel-
lular uptake (cf. the ICP-MS data), but neither a reliable quan-
tifi cation nor the intracellular location of the particles can be 
derived. Even if the same CPPs have been demonstrated in 
the literature for one particle system resulting in delivery to 
the cytosol, without experimental verifi cation it must not be 
assumed that the same CPPs will also work for other systems 
in the same manner. Depending on the respective particle 
geometry (surface chemistry, density of CPPs, size of parti-
cles, distance of CPPs to the particle core, etc.), the effects of 
attached CPPs, as well as the physico-chemical properties of 
the particles themselves may be quite different. In the case 
of the example presented in Figure  1 , one has to take into 
account that PEG molecules are partly coiled and, in this way, 
the CPPs at the terminal ends do not always point towards the 
solution, but may be buried in the PEG shell instead. Also, 
the density of the CPPs may play a role. Thus, without experi-
mental proof concerning the characterization of the used 
particle system as well as the chosen cell system, one should 
not assume the presence of particles in the cytosol. 
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 There is no easy solution to the “endosomal escape 
dilemma”. It is most important to be aware of this poten-
tial problem. Most uptake studies, without a proper colo-
calization study, are not able to distinguish between particles 
free in the cytosol and particles embedded in intracellular 
vesicles. As mentioned above, the standard route of particle 
internalization by cells is endocytosis. [ 62 ] Thus, unless proven 
differently, [ 51,53 ] particles should be assumed to be in acidic 
intracellular vesicles, and thus the read-out of such ion-sensi-
tive particles would determine the ion concentrations inside 
the endosomes/lysosomes, [ 8,74 ] and not the ion concentrations 
in the cellular cytosol. In this way, particle-based ion-sensitive 
particles are ideal for sensing inside endosomes/lysosomes, 
and one smart strategy would be to look for potential appli-
cations in this direction, e.g., sensing related to lysosomal 
storage diseases, instead of targeting the cytosol. Otherwise, 
in cases where applications defi nitely require sensing in other 
intracellular compartments, sensing methodologies need to 
be accompanied by profound localization studies providing 
information about the particle localization. 
 3.  Many Ion-Sensitive Fluorophores Have 
Massive Crosstalk with pH 
 As pointed out previously, unless special surface coatings 
and very small particles are used, internalized particles are 
typically located in acidic intracellular vesicles, i.e., in an 
environment with low pH. Unfortunately, many ion-sensitive 
fl uorophores have signifi cant crosstalk with pH, as shown in 
the examples given in  Figure  2 . Thus, without knowledge of 
the local pH value of the particle environment, the concen-
tration of the respective ions cannot be determined. Besides 
pH, many ion-sensitive fl uorophores also have crosstalk with 
other ions. For example, potassium-sensitive fl uorophores 
have crosstalk with sodium, and vice versa. [ 41 ] 
 Crosstalk with pH is a severe problem for intracellular (in 
vitro) ion sensing. On their standard internalization pathway 
from the typical slightly alkaline extracellular medium, parti-
cles are located in subsequently more and more acidic intra-
cellular vesicles. In this way, the internalization of particles 
involves massive changes in pH. [ 8,24 ] Thus, in the case of a 
particulate ion-sensitive fl uorophore which not only responds 
to its target ion but also to pH, it is not straightforward to 
interpret changes in fl uorescence intensity, as they may 
refl ect changes in target ion concentration or in pH. This is 
demonstrated in  Figure  3 , where particles, here micrometer-
sized multilayer capsules with integrated calcium-sensitive 
fl uorophores (Calcium Green-1 linked to dextran), were 
added to cells and their fl uorescence was recorded for extra-
cellular as well as for internalized particles. For the calcium-
sensitive fl uorophore, it is not clear whether the change in 
fl uorescence emission upon cellular internalization, leading 
to localization in the lysosome, [ 49 ] is due to changes in Ca 2+ 
or in pH. Thus, with this particle-based calcium sensor, it is 
not possible in a straightforward way to determine lysosomal 
calcium concentrations. 
 Again, there is no easy solution concerning avoiding cross-
talk of ion-sensitive fl uorophores with pH. Being aware of the 
 Figure 1.  HeLa cells were incubated with polymer-coated Au nanoparticles (core diameter d c ≈ 4.6 nm) with the red fl uorophore Cresyl violet (CV) 
integrated in their polymer shell. [ 70 ] The surface of these nanoparticles was modifi ed with PEG of molecular weight M w = 3000 Da. 
[ 71 ] For some 
particles, the terminal end of each PEG molecule was conjugated with cell-penetrating peptides (CPPs) rich in NH 2 groups. Two different CPPs 
were used as random examples. a) Sketch of the three different particles, with PEG, PEG-CPP1, and PEG-CPP2 surfaces. b) Overlay of the bright-
fi eld and red fl uorescence images of HeLa cells after 6 h of incubation with the particles. The scale bars correspond to 20 µm. c) The amount 
of internalized particles  N (as quantifi ed by the atomic gold content inside cells) was determined with ICP-MS after t = 0.5, 1.5, and 2.5 h of 
incubation. The decrease in  N for PEG-CPP2 was most likely due to the death of some cells. In both cases, the presence of CPPs enhanced uptake 
of particles by cells. The presented data here do not allow for any conclusion about the intracellular location of the internalized particles. Note that 
the fl uorescence images shown in (b) are overexposed, and thus no accurate and precise quantitative data about differences in uptake between 
the different particles can be derived. This “homogeneous” distribution of fl uorescence along the cell must in particular not be mistaken as proof 
for delivery to the cytosol. The granular structure of the intracellular vesicles in which the particles are embedded can be seen in cases where 
appropriate particle concentrations and imaging parameters are used. [ 46,72,73 ] 
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problem is clearly only the fi rst step. Naturally one may think 
of developing ion-sensitive fl uorophores which do not respond 
to pH. Alternatively, in case one needs to rely on existing 
particle-based fl uorophores that are affected by crosstalk with 
pH, one can think of a multiplexed read-out of several fl uo-
rophores, as will be discussed below. Here, the advantage of 
the “particle” character comes into play: As two particle-based 
fl uorophores with the same surface chemistry/dimensions 
will have the same uptake pathway and intracellular location, 
several particle-based fl uorophores selective to different ions 
could be applied and read-out at the same time. In case two 
Ca 2+ -sensitive fl uorophores show different crosstalk to pH, a 
2D calibration curve could be obtained. By reading out the 
values of different Ca 2+ -sensitive fl uorophores in parallel, 
the Ca 2+ concentration could be determined even without 
knowledge of the local pH. In a similar way, a Ca 2+ -sensitive 
fl uorophore could be combined with a pH-sensitive fl uoro-
phore. Again, a 2D calibration curve correlating the read-out 
of both fl uorophores would allow determination of both the 
pH and the Ca 2+ concentration. In this way, however, two dif-
ferent fl uorophores need to be read-out simultaneously which, 
due to spectral overlap of fl uorescence emission, can be chal-
lenging, as will be explained in detail in the following section. 
 4.  Multiplexed Detection of Several 
Fluorophores Based on Different Fluorescence 
Lifetimes 
 For many applications it would be desirable to determine 
the intracellular concentration of several ions in parallel. 
This is the case if there is, for example, crosstalk between 
different fl uorophores, and calibration curves correlating 
the read-out of different fl uorophores are required (see 
above). Such a case is shown in  Figure 4 , where the read-
out of a Ca 2+ -sensitive fl uorophore depends on both the 
Ca 2+ concentration and also the pH. In this way, it would be 
desirable to combine the Ca 2+ -sensitive fl uorophore (which 
has crosstalk with pH) with a pH-sensitive fl uorophore. 
However, the emission spectra of many ion-sensitive fl uoro-
phores unfortunately overlap, and thus the number of fl uo-
rophores that can be spectrally resolved and independently 
detected in parallel is limited. [ 40,80,81 ] The fl uorescence spec-
trum of the Ca 2+ -sensitive fl uorophore shown in Figure  4 is 
relatively broad, and thus it would be complicated to fi nd a 
pH-sensitive fl uorophore emitting in a very different spec-
tral range. 
 One solution to circumvent this problem is to use multi-
plexed detection techniques which are not based on spectral 
resolution. Besides distinguishing different fl uorophores from 
separate emission peaks (i.e., spectral resolution), other ways 
of discrimination are possible. If the fl uorophore-carrying par-
ticles are big enough to be optically resolved (i.e., sized above 
the optical resolution limit due to refraction), individual par-
ticles can be laterally resolved and identifi ed by respective 
barcodes (i.e., lateral resolution). [ 40,41,82–84 ] While this is not 
possible for smaller particles, they still can be resolved by dif-
ferent fl uorescence lifetimes (i.e. temporal resolution). [ 40 ] If 
two different fl uorophores possess different lifetimes, their 
emission can be distinguished with time-resolved fl uores-
cence spectroscopy. This also offers the advantage that no 
absolute intensity information is required, which depends 
on the number of particles inside each cell. This principle 
 Figure 2.  Different sensitive fl uorophores were added to solutions in which the concentration  c of one ionic specie as well as pH were varied, and 
their fl uorescence intensity  I was measured. a)  N -[2-[2-[2-[bis(carboxymethyl)amino]-5-[[2′,7′-dichloro-3′,6′-dihydroxy-3-oxospiro[isobenzofuran-
1(3H),9′-[9H]xanthene)-5-yl]carbonyl]amino]phenoxy]ethoxy]phenyl]- N -(carboxymethyl) (Calcium-Green-1) specifi c for calcium. [ 75 ] b) 1H-Indole-
6-carboxylic acid, 2-[3-[2-[(acetyloxy)methoxy]-2-oxoethoxy]-4-[bis[2-[(acetyloxy)methoxy]-2-oxoethyl]amino]phenyl], (acetyloxy)methyl 
ester (Mag-Indo-1) specifi c for magnesium. [ 76 ] c)  N -(Ethoxycarbonylmethyl)-6-methoxyquinolinium bromide (MQAE) specifi c for chloride. [ 77 ] 
d) 10,10′-Bis[3-carboxypropyl]-9,9′-acridiniumdinitrate (BAC) specifi c for chloride. [ 78 ] In all cases the emission intensity I of the fl uorophore does 
not only respond to changes in the concentration of the target ions, but also to changes in pH.
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 Figure 4.  a) The fl uorescence emission of OGB-2 depends on the Ca 2+ concentration as well as on pH (recorded at 350 nm excitation wavelength). 
b) OGB-2 had been linked closely to the surface of (Zn x Cd 1-x )S/ZnS QDs and time resolved fl uorescence (at the OGB-2 emission wavelength) was 
recorded. Decay times depend on Ca 2+ and pH. c) From the different decay times, a resulting response curve R(c(Ca 2+ )) can be derived, which is 
shown here for OGB-2 coupled to (Zn x Cd 1-x )S/ZnS and to CdSe/ZnS QDs at pH 7.2. From these curves, dissociation constants K d can be obtained 
(for details, refer to the Supporting Information). 
 Figure 3.  Micrometer-sized particles as synthesized by layer-by-layer assembly were loaded with the Ca 2+ -sensitive fl uorophore Calcium Green-1 
linked to dextran. [ 26,79 ] a) One has to differentiate between different local concentrations: extracellular calcium and pH, c e (Ca 
2+ ) and pH e , intracellular 
calcium and pH in the cytosol, c i (Ca 
2+ ) and pH i , and calcium and pH inside lysosomes, c l (Ca 
2+ ) and pH l . Upon internalization the particles undergo 
several acidifi cation steps in their local environment, from the extracellular space to their fi nal localization inside lysosomes. [ 49 ] b) Fluorescence 
emission spectra I(λ) of Calcium Green-1 loaded particles depend on calcium, but also on pH. Changes in pH infer crosstalk with the Ca 2+ -sensitive 
read-out. c) Ca 2+ -sensitive particles were added to cells and microscopy images were recorded. Fluorescence images, together with an overlay 
with bright-fi eld images, are shown. The scale bars correspond to 20 µm. After 4 h of incubation, some particles were internalized (the ones 
in the big red circle), whereas other particles were located outside cells (the one in the small red circle). However, due to crosstalk, changes in 
emission intensity between extracellular particles and particles inside the lysosome cannot be unequivocally correlated with changes in calcium 
concentration. Reduction in fl uorescence can be caused by lowering of the calcium concentration, but also by lowering in pH. Therefore, if the local 
pH is unknown, the calcium concentration cannot be determined. 
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has already been applied for ion-sensitive fl uorophores. [ 85–87 ] 
While many organic fl uorophores have similar lifetimes of a 
few nanoseconds, fl uorescent nanoparticles such as QDs can 
have much longer photoluminescence lifetimes which, by 
using doping, can reach even milliseconds. [ 88 ] If fl uorophores 
are coupled closely to the surface of QDs, and the emission 
spectrum of the QDs overlaps with the excitation spectrum of 
the fl uorophores, FRET occurs. [ 89–92 ] Upon FRET from the 
QD to the fl uorophores, the effective fl uorescence lifetime of 
the fl uorophores is increased towards the fl uorescence life-
time of the QDs. [ 93,94 ] In this way, the detection of ions could 
be carried out upon linkage of ion-sensitive fl uorophores to 
the surface of QDs. The optical changes induced by ion com-
plexation produce changes in the FRET process and, conse-
quently, in the fl uorophore lifetime that can be determined in 
time-resolved fl uorescence measurements. [ 95 ] The principle of 
time-resolved fl uorescence measurements and ion-concentra-
tion determination via fl uorescence lifetimes is illustrated in 
Figure  4 , with the example of the Ca 2+ -sensitive fl uorophore 
Oregon Green Bapta-2 (OGB-2), [ 96,97 ] which was coupled 
to the surface of (Zn x Cd 1-x )S/ZnS and CdSe/ZnS (Lumidot 
480 bought from Sigma Aldrich) QDs. [ 98,99 ] The fl uorescence 
spectra of OGB-2 depend on the calcium concentration but, 
as mentioned above, like many organic fl uorophores, also 
on pH. The Ca 2+ - and pH-dependence can also be seen in 
time resolved fl uorescence, also when OGB-2 is coupled to 
the surface of QDs and excited via FRET. The time resolved 
fl uorescence curves can be fi tted with a simple kinetic model, 
which provides the relevant lifetimes. [ 93 ] While the lifetimes 
themselves depend on the calcium concentration, they can be 
combined to a resulting response curve R, which is derived 
from all fi t parameters. Assuming a linear increase of the 
FRET rate as calcium binds to OGB-2, the dissociation con-
stants of Ca 2+ binding to OGB-2 can be determined from this 
Ca 2+ -dependent response curve (cf. Figure  4 ). In this way, 
instead of quantifying Ca 2+ via intensity changes at a certain 
emission wavelength, it can be carried out via changes in fl u-
orescence lifetime. This offers the possibility for temporally 
resolved multiplexed measurements of multiple ion concen-
trations in parallel. [ 40 ] 
 5.  Discussion 
 The examples shown in this review indicate that particle-
based intracellular ion-sensing is by far not trivial and 
involves several pitfalls. From the point of view of the sensor 
itself, one should be aware of the fact that the presence of 
the particles can change the fl uorescence response, as par-
ticles impose a different nano-environment, which changes 
ion concentrations as compared to the bulk. [ 27,31,32 ] Another 
important drawback in the development of particle-based 
ion sensors originates from the few commercially available 
ion-sensitive fl uorophores with enough specifi city. To get a 
wide range of selective ion-sensitive fl uorophores towards 
different target cations and anions of interest is a big chal-
lenge that needs to be addressed in order to advance fl uores-
cence-based intracellular ion sensing. There are also several 
important points to take into account when ion-sensitive 
particles are used for sensing ion concentration in cells: 
First, the location of the particle sensors needs to be experi-
mentally determined and, unless experimentally proven 
otherwise, they should be assumed to be inside highly acidic 
intracellular vesicles and not free in the cytosol or other 
cellular organelles. Thus, in the most straightforward way, 
applications which involve irregularities in ion concentra-
tions inside endosomes/lysosomes could be investigated, 
such as lysosomal storage diseases. Localization of the sensor 
particles in endosomes/lysosomes involves massive changes 
in the pH surrounding the particles upon their internaliza-
tion by cells. Transitions occur from the slightly alkaline/
neutral extracellular medium to the acidic environment of 
endosomes/lysosomes. Due to crosstalk of many ion-sensi-
tive fl uorophores with pH, this affects the ion-sensitive fl uo-
rescence read-out. Thus, for most intracellular ion-sensing 
experiments, knowledge of the local pH around the particle 
sensors would be needed, which could be achieved by addi-
tionally using pH-sensitive sensor particles. The effect of pH 
might also impose limits on sensors which involve enzymes 
as recognition elements, such as urease, [ 100 ] glucose oxidase, 
or lactate oxidase to convert the analyte (urea, glucose, 
or lactate) into H + , [ 101 ] which then is measured as a pH-
dependent fl uorescence signal. Therefore, in biological media 
such as the interior of cells, these sensors might give signal 
changes which would be problematic to interpret. Multi-
plexed sensing of several ions (or other relevant molecules) 
in parallel would offer a solution, not only to crosstalk with 
pH but also in the case of interference with other molecules. 
Thus, a reasonable strategy would involve determining the 
fl uorescence read-out of different ion-sensitive fl uorophores 
(or pH) in parallel. However, spectral overlap of different 
fl uorophores sensitive to different ions/molecules imposes a 
severe limit, and hampers detection of several fl uorophores 
in parallel. One solution is to resolve different fl uorophores 
not spectrally, but in different modes. Discrimination can, 
for example, be achieved via determination of fl uorescence 
lifetimes. 
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 In this Progress Report some recent trends and future perspectives towards 
the use of nanomaterials for smart food packaging and quality control of food 
are given. The examples and discussion are meant to illustrate the potential 
use of nanotechnology for food sustainability rather than to review the state 
of the art of nanomaterials in this area, which although expected to have a 
groundbreaking impact on food sustainability is still on an early stage. 
 1.  Food Sustainability 
 The true challenge for our generation is that of sustainability. 
The world population keeps increasing at a rapid pace. We are 
currently close to 7.5 billion and will be close to 10 billion in 
2050, which is only 35 years from now. [ 1 ] This large world pop-
ulation will need energy, materials, and importantly food for 
itself and for generations to come. At present there are no solu-
tions on how to feed 10 billion people. This is quite obviously 
an important problem that has to be rapidly addressed. While 
in this short position paper we cannot address all aspects of 
food sustainability, we will rather focus on one important part 
of it. Despite feeding ∼6 of the 7.5 billion people in the world, 
we waste ∼30% of the total world food production. This means 
that yearly 1.3 billion tons of food are wasted. If we could avoid 
this waste, the world would make a giant leap towards feeding 
 everybody and allowing for true food sustainability. Among the 
many steps needed to address this problem, we need to have a 
better control of food quality, and we need to have intelligent 
 Xingyu  Jiang ,*  Daniel  Valdeperez ,  Moritz  Nazarenus ,  Zhuo  Wang ,  Francesco  Stellacci , 
 Wolfgang  J.  Parak ,  and  Pablo del  Pino* 
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Smart Food Packaging and Quality Control 
food packaging that slows the degradation 
process, but also determines when the food 
is truly rotten based on real data. Besides 
these global issues, also in so-called devel-
oped countries quality control during 
food processing, packaging and storage 
is paramount, as potentially the health of 
consumers may be endangered. This has 
lead already to legislation guidelines. [ 2 ] 
Politics and industry have developed sys-
tems to prevent food with undesirable conditions (microbio-
logical, chemical or physical) from reaching the fi nal consumer. 
The most practical approach hereby is a label on most products 
in which a theoretical “expiration date” is detailed. While this 
drastically reduces the risk that food in unacceptable conditions 
may mistakenly be sold, this approach is, however, some kind 
of “over-protective”, i.e. often impeccable food will be disposed, 
just because the expiration date has passed. Unfortunately, it 
is impossible to precisely calculate expiration dates, as these 
depend on a number of external parameters, which cannot 
always be controlled individually. More individual markers, 
i.e. indicators of spoilage, instead of general “expiration dates” 
might be an interesting and useful alternative to optimize the 
product shelf life. Naturally, they would need to be harmless, 
without any risk of food contamination, cheap, and consumer-
friendly. For the interested reader regarding smart packaging 
for monitoring of food quality, we refer to the review article 
by Kuswandi et al. in which the state of the art in this fi eld 
was reviewed with a strong focus on commercially available 
time-temperature indicators (TTIs) and radio frequency identi-
fi cation (RFID) tags. [ 3 ] As already acknowledged by Kuswandi 
et al., the potential of nanotechnology to enhance current smart 
packaging systems or to motivate new approaches is impressive. 
 2.  Why Nanomaterials? 
 Nanotechnology has provided in the recent years an amazing 
set of new materials and devices, which nowadays are making 
their ways towards applications. [ 4 ] Beginning from health and 
energy related applications, these materials also have  potential 
to impact everyday life consumer products, as we will describe 
herein in the case of food packaging/quality control. New 
 nanomaterials certainly could provide new impact in this 
 direction. [ 3,5 ] Many products in the supermarket are packaged 
in standard plastic foils. They prevent direct contact of the food 
with the environment, and shield in particular bacteria. We 
envisage “smart” plastic foils, which provide feedback about 
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potential undesired decomposition / contamination of the food, 
and thus suggest that this product does not retain its optimal 
conditions and therefore should not be consumed anymore. 
Indeed sensors for monitoring of temperature, humidity, 
reducing and oxidizing gases, and volatile organic compounds 
have been successfully integrated on plastic foil. [ 6 ] There has 
been an ever-growing number of reports on the integration of 
sensing nanostructures on fl exible substrates, [ 7 ] which might 
have a groundbreaking impact on monitoring systems, for 
instance, in clothing and implants, and clearly in food industry, 
the topic of this report. In addition, nano-based sensors might 
be very useful for rapid in situ analysis of food at critical 
locations (e.g. customs, storage facilities, in situ control of 
food’s transportation, etc.). Last but not least, nanomate-
rials might not be only useful for detecting spoilage but also 
for prevention. Appropriate coatings with antibacterial prop-
erties could be used, as for instance, fi lms derivatized Ag 
nanoparticles (NPs). [ 8 ] Obviously, biocompatibility, long-term 
stability, and toxicity remain major issues, which will have to be 
further characterized and optimized, particularly in the case of 
direct contact between nanomaterials and food. [ 9 ] 
 In the last years the range of functions which can be 
 performed by NPs has been greatly expanded including 
 antimicrobial activity, sensing of biomolecules and ions, 
tunable optoelectronic properties, light shielding, etc. The 
 versatility in terms of NP-based functionalities, in many cases 
completely novel and different from the bulk, have been 
achieved due to several important developments in colloidal 
chemistry with regards to controlling the size, shape, struc-
ture and  composition, as well as suitable surface coatings. [ 9,10 ] 
Those functional NPs can be easily incorporated in polymer 
matrixes, [ 11 ] and thus could be readily integrated in plastic foils. 
Shoseyov et al. have made plastic foils from  nanocrystalline 
cellulose, which in combination with integrated ZnO NPs are 
currently introduced as air tight food packaging, which also 
eliminates IR and UV exposure. [ 12 ] Appropriate surface coatings 
can provide these NPs the ability to sense their environment 
and report the results optically, for example by fl uorescence, [ 13 ] 
or simply by changes in transmitted or refl ected color, [ 14 ] or 
by electrical readout. [ 15 ] Thus, NPs could be used as reporters 
of a variety of basic parameters, which are indicators for 
ongoing decomposition, in particular for perishable food. More 
 importantly, nanotechnology allows for monitoring of these 
parameters in real-time. 
 3.  Sensing Spoilage 
 Sensing based on changes of the physicochemical proper-
ties of NPs, which are driven by target analytes, stand as one 
of the most widely explored applications of NPs in the con-
text of life sciences, including sensing of ions and small mol-
ecules, and bio-sensing, that is, detection of biomolecules 
such as proteins and nucleic acids. [ 16 ] In those sensing nano-
platforms based on direct contact with the analyte, the surface 
of inorganic NPs is typically modifi ed with organic molecules 
such carbohydrates, [ 17 ] nucleic acids, [ 18 ] aptamers, [ 15b ] anti-
bodies, [ 19 ] combinations of hydrophilic and hydrophobic linear 
chains, [ 20 ] etc., which have strong affi nity for a target analyte. 
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The analyte’s “catching” event can then lead to a change on the 
physicochemical properties of the NPs such as fl uorescence, 
surface plasmon resonance, conductivity, magnetic relaxivity, 
etc. Indeed, choosing the right composition, size and shape of 
the inorganic core, and the surface functionalization of the NPs 
allows for tailoring the response of nano-based sensing systems 
to specifi c stimuli and thereby, a variety of sensing nanoplat-
forms have been demonstrated. [ 10 ] The possibilities of such sys-
tems are manifold, ranging from ultrahigh sensitive complex 
approaches [ 21 ] to affordable easy-to-use alternatives, depending 
on the principle of detection and equipment required. Clearly, 
in the case of sensing spoilage, several indicators such as 
 time-temperature, pH, a variety of volatile compounds, etc. can 
be monitored using such nanosystems. Yet, approaches which 
are simple, easy-to-use, affordable, reliable (even at the cost of 
sensitivity) and which provide real-time signals are required if 
are to be used by the food industry, [ 22 ] be it as an analytical tool 
for food control or as an element of the packaging. 
 One of the most straightforward and widely used nano-
sensing approach relies on the color change that solutions 
of metallic NPs undergo (directly or indirectly) in the pres-
ence of a particular analyte, i.e. colorimetric sensors based 
on plasmonic NPs. The colorimetric nanosensors are par-
ticularly appealing for sensing food spoilage because they 
are  cost-effi cient, fast and easy to use. In this direction one 
 particularly illustrative example was reported by Zhang et al. who 
proposed a TTI based on the color changes of Au nanorods 
Part. Part. Syst. Charact. 2014, 
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upon  incorporation of a Ag shell. [ 23 ] The thickness of the Ag 
shell, which depends on the temperature, could be synchro-
nized with the growth of bacteria. The longer a perishable 
product is exposed to elevated temperatures (regardless of 
the detailed history), the higher is the probability that it will 
start to spoil. This spoilage can be microbiological (among 
others such as oxidation and enzymatic degradation), due 
to the growth of mesophilic bacteria such as  Escherichia coli, 
Listeria monocytogenes, or  Staphylococcus aureus . All these 
bacteria cause food poisoning, since they are able to multiply 
in the intestine and have an optimum growth  temperature 
around 37 °C in common, in which they start to grow more 
rapidly. Based on this fact Zhang et al. could  correlate the 
change of color of core/shell Au/Ag nanorods with the growth 
of  Escherichia coli ( E. coli ) bacteria. The longer these bacteria 
are exposed to elevated temperatures (regardless of the detailed 
history), the higher their growth rate becomes. Then the 
longer this system is exposed to elevated temperatures (again, 
regardless of the detailed history), the more the shell growth 
 progresses. The growth of the silver shell is directly correlated 
with a change of color (i.e. blue-shift in the surface plasmon 
band). Thus, the longer these NPs are exposed to elevated 
temperatures, the more their color in solution shifts from red 
to green. In this way, these NPs form a chronochromic TTI, 
which can be directly observed by eye. The more this indicator 
has been shifted from red to green, the longer the embedded 
product has been exposed to elevated temperatures and the 
higher the numbers of bacteria will be. [ 23 ] A little color spot 
on the packaging foil, without any direct contact with the 
embedded food, thus could be an indirect indicator for the 
degree of bacterial contamination. 
 Besides overgrowth of Au NPs with Ag, also  agglomeration 
of Au NPs can be easily observed by naked eye, cf.  Figure  1 . 
This effect is due to the plasmon coupling of the adjacent 
NPs and this effect has been used for decades for molecular 
assays. [ 24 ] In this direction plasmonic Au NPs have been applied 
to quantify contamination with mercury. [ 25 ] Presence of Hg 2+ 
causes a specifi c agglomeration of modifi ed Au NPs, as indi-
cated by the color change of the Au NP solution from red to 
blue, cf.  Figure  2 . With the same concept it was also possible to 
control the amount of proteins in milk products, to guarantee 
their quality. As pointed out, color changes of these particles 
offer a straightforward read-out, which can be observed with 
the naked eye. Milk and other dairy products are vital protein 
sources. A quick method to quantify the amount of proteins in 
milk is thus very useful for consumers, as well as producers 
and distributors. Zhu et al. have reported a convenient system 
based on functionalized gold NPs combined with click chem-
istry. [ 26 ] The assay is based on the fact that the peptide chains 
of proteins can reduce Cu(II) to Cu(I), depending on the abso-
lute quantity of the peptide bond, and Cu(I) then catalyzes the 
click reaction between azide-/alkyne-functionalized gold NPs, 
cf.  Figure  3 . Presence of proteins thus results in the aggrega-
tion of the Au NPs, leading to the typical color change from 
red to purple. [ 27 ] With this method, the amount of proteins can 
be quantifi ed within the range from 30 to 2500 µg/mL In the 
same direction, Song et al. reported on a colorimetric test based 
on Ag NPs for the detection of melamine, an illegal toxic addi-
tive in milk. [ 28 ] The authors proposed Ag NPs functionalized 
with chromotropic acid, which in the presence of melamine 
induce NPs aggregation and thus, a color change from yellow 
to orange. 
Part. Part. Syst. Charact. 2014, 
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 Figure 1.  Dispersed gold NPs have distinct color, as shown here for solutions of colloidal gold with NPs core NP diameters of 2, 5, 50, 100, and 
200 nm (from Tedpella, Inc). Their plasmon absorption peak (for Au NPs > 2 nm) lies in the green, and thus solution in refl ection appear red. Upon 
agglomeration the plasmons of adjacent NPs couple, which shift the plasmon absorption to the red, i.e. the solution appears more bluish. Parts of 
this image reproduced with permission from Faraday. 
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 In the same way agglomeration of Au NPs and the  subsequent 
red-shift of their absorption can be used for  detection of nucleic 
acids, following the classical approach by Mirkin et al. [ 29 ] As 
example, for the detection of pathogenic  Vibrio cholerae  (foodborne 
pathogens responsible for cholera, a common diarrheal illness) 
in food samples, Guo et al. developed a sensitive method to 
detect nucleic acids with the use of the target oligonucleotide-
modifi ed Au NPs, which undergo target-induced Au NP dimer 
formation upon presence of the target nucleotide. [ 18 ] This 
sensor turned out to be much more sensitive than a commonly 
used sensor fabricated using conventional strategies. This 
signifi cant improvement in sensitivity can be largely attributed 
to the Y-shaped DNA duplex upon hybridization, the formation 
of which enables two linked Au NPs to be pulled together to 
a very close distance, yielding a maximum color change. The 
ability of the sensor to rapidly detect unamplifi ed genomic DNA 
isolated from foodborne pathogens in a complex sample matrix 
might have important applications, in particular in the sense 
that this method might circumvent the need to  culture bac-
teria before any assay. The straightforward read-out shown 
in these assays makes them very convenient  indicators of 
food  contamination. It has to be noted, however, that in these 
 analytical assays (in contrast to the TTI based on Au/Ag 
nanorods) direct chemical contact of the sensor  components 
(Au NPs, Ag NPs, enzymes, substrates, etc.) in solution 
still is necessary, and therefore requires  additional steps for 
 incorporation into food packaging. 
 While the so-far mentioned examples are based on direct 
 colorimetric read-out, also fl uorescence is a signal that 
 conveniently can be detected. [ 30 ] There is a variety of potential 
applications for such read-out. Upon their presence specifi c 
analytes can change the color and/or intensity of fl uorescence of 
NPs upon UV exposure, which provides and easily  detectable 
optical signal. This principle has been used for example for the 
direct detection of toxins, which are excreted from  bacteria. [ 31 ] 
Sapsford et al. modifi ed the surface of fl uorescent NPs 
 (so-called quantum dots) with specifi c peptide sequences that 
bear an additional organic fl uorophore at their free end. This 
fl uorophore is in resonance with the quantum dot, in a process 
called fl uorescence resonance energy transfer (FRET). Certain 
Part. Part. Syst. Charact. 2014, 
DOI: 10.1002/ppsc.201400192
 Figure 2.  Highly sensitive, colorimetric detection of mercury(II). Presence of Hg 2+ causes the specifi c agglomeration of Au NPs, which can be seen 
in the transmission electron microscopy images, as also in the change of color of the solution from red to blue. Reproduced with permission. [ 25 ] 
Copyright 2010, ACS.
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toxins, in this case botulinum neurotoxins, specifi cally cut the 
peptides, the fragment with the organic fl uorophore diffuses 
apart, and FRET is stopped, which can be observed as change 
in the fl uorescence color. [ 31 ] While not as easy to observe as 
refl ected or transmitted color, also such kind of fl uorescence 
changes could be directly observed by a customer in a super-
market by holding the packaging foil against illumination, 
although again, direct contact of the sensor with the food would 
be required. Recently, such detection has been made possible 
with the camera of a smartphone. [ 30 ] Please note, while changes 
in intensity would be hard to quantify, the here mentioned 
sensors are based on spectral changes, i.e. on changes in the 
color of fl uorescence. A variety of different surface modifi ca-
tions hereby allows for detection of several contaminants in 
parallel. [ 32 ] 
 In addition, combinations of both read-outs are possible 
as highlighted in the following example. Pesticides are widely 
used in the production of fruits and vegetables. They exert 
 toxicity on human health through their residues in  agricultural 
products and contamination of water. Organophosphorus 
compounds and carbamates are the pesticides most widely 
used in  agriculture. Liu et al. developed a sensitive assay with 
dual read-out (colorimetric and fl uorimetric) for these two 
classes of  pesticides, which uses rhodamine B-covered gold 
NPs and makes use of the inhibition of acetylcholinesterase 
(AChE) by organophosphorus and carbamate pesticides. [ 33 ] The 
 fl uorescence of rhodamine B, which is pre-immobilized on the 
surface of the gold NPs, is quenched. Upon presence of AChE 
and acetylthiocholine (ATC) the solution turns from red (dis-
persed gold NPs) to blue (agglomerated gold NPs) and further-
more the green fl uorescence of rhodamine B can be observed, cf. 
 Figure  4 . The reason is that AChE converts ATC to  thiocholine, 
which has a higher binding affi nity to the gold NPs than 
rhodamine B, thus releasing rhodamine B into solution, where 
the quenched fl uorescence is recovered. Moreover, the gold 
NPs, now partly covered with rhodamine B and partly with 
 thiocholine, attract each other due to the opposite charges of 
rhodamine B and thiocholine, leading to agglomeration and 
thus blue color of the solution. In presence of organophosphorus 
or carbamate pesticides AChE is inhibited, leading to less 
 fl uorescence and agglomeration of the gold NPs in the  solution. 
Concentrations of the pesticides are determined using calibra-
tion curves of fl uorescence and absorbance. With this method, 
the lowest detectable concentrations for several types of 
pesticides including carbaryl, diazinon, malathion, and phorate 
were measured to be 0.1, 0.1, 0.3, and 1 µg/L, respectively. Most 
importantly, this assay also allows for  pesticide detection in 
complex samples such as agricultural products (tomatoes and 
cucumbers) and river water. 
 The advantage of using NP-based sensors as described above 
is the possibility for convenient direct optical read-out, either 
by naked eye or by very simple optical devices such as the inte-
grated camera of a smartphone. There are, however, also sev-
eral other detection schemes. Some contaminant molecules 
could also be detected directly, once they adsorb to the surface 
of gold or silver (i.e. plasmonic) NPs with an effect called sur-
face enhanced Raman scattering (SERS). [ 34 ] For the interested 
reader, we refer to the review of J. Zheng and L. He about SERS 
for the chemical analysis of food, which covers the state of the 
art of SERS detection of small analytes in food, including food 
additives, pesticides, antibiotics and illegal drugs, melamine, 
illegal food dyes and small-molecule toxins. [ 35 ] While read-out 
of SERS signals could not be done directly by eye, portable 
detectors in this direction will be available in the future. Due to 
Part. Part. Syst. Charact. 2014, 
DOI: 10.1002/ppsc.201400192
 Figure 3.  Click-chemistry based assay for proteins. Presence of proteins reduces copper (II) to copper (I). Cu + triggers agglomeration of Au NPs 
which can be observed as red-shift in the absorption spectra, i.e. in a color change of the solution from red to blue. Reproduced with permission. [ 26 ] 
Copyright 2012, ACS.
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the sharp Raman bands with this technique, potentially many 
different molecules can be detected in parallel, without the 
need to introduce any label. [ 36 ] 
 Besides optical read-out, also electrical read-out via small 
cost-effective devices created with printed electronics on pack-
aging foils can be foreseen. [ 6 ] Classical routine methods for 
molecular analysis, such as fi eld-effect transistors (FETs) and 
electrochemiluminescence are somewhat limited in their 
application towards the direct customer-based analysis of food-
related samples. NPs, however, can drastically improve the 
effi ciency of such methods of detection. This offers a transi-
tion from large-scale devices to much smaller detectors. This 
is demonstrated for example by using carbon nanotubes for the 
detection of bacteria. [ 37 ] Adsorption of bacteria can change the 
conformation and thus, electronic structure of nanomaterials, 
which in change can be electronically detected. [ 37 ] The NPs can 
also allow for a local accumulation due to specifi c binding of 
the analytes. Cho et al. have shown in this direction a simple 
electric readout for very low levels of toxic ions in food. [ 20 ] In 
order to better demonstrate the state-of-the-art of such devices 
two examples for quality control of mussels are given. Seafood, 
such as mussels, faces some serious contamination problems, 
such as heavy metals, toxins, etc. Mercury is one of the most 
common toxic heavy metals found in seafood, and its detection 
is important. An et al. described the fabrication and characteri-
zation of a liquid-ion gated FET-type fl exible graphene aptamer-
based sensor with high sensitivity and selectivity for Hg. [ 15b ] 
The graphene aptamer-based sensor had excellent sensing 
performance down to very low concentrations of 10 pM, which 
has been claimed to be 2–3 orders of magnitude more sensi-
tive than previously reported mercury sensors using standard 
electrochemical systems. The fl exible graphene aptamer-based 
sensor showed a very rapid response, providing a signal in less 
than 1 s, when the Hg ion concentration was altered in mussel 
samples. [ 15b ] Another example of improved detection effi ciency 
is the detection of palytoxin (PITX, a very potent toxin) in sea-
food using electrochemiluminescence. Zamolo et al. developed 
an ultrasensitive electrochemiluminescence-based sensor for 
the detection of PITX, taking advantage of the specifi city pro-
vided by anti-PlTX antibodies, the good conductive properties 
of carbon nanotubes, and the excellent sensitivity achieved by 
a luminescence-based transducer. [ 38 ] The sensor was able to 
produce a concentration-dependent light signal, allowing PlTX 
quantifi cation in mussels, with a limit of quantifi cation (LOQ = 
2.2 µg/kg of mussel meat). This is more than 2 orders of mag-
nitude more sensitive than that of the commonly used detection 
techniques, such as Liquid Chromatography Mass Spectrom-
etry (LC-MS) or other Mass Spectrometry techniques (MS). [ 38 ] 
These examples demonstrate that due to the excellent trans-
ducer properties of nanomaterials smaller devices are possible. 
 So far we have discussed detection of “direct” contaminants, 
such as bacteria, toxins, heavy metal ions. However, food 
spoilage upon storage can be also detected by several indirect 
indicators. One important cause of food spoilage is the oxygen 
content in the package. Increase in oxygen can lead to different 
effects, such as the decrease of the ascorbic acid content, enzy-
matic browning, the possibility of growth for aerobic bacteria, 
and the oxidation of unsaturated fatty acids, aromas and color-
ants. [ 39 ] Although the food industry uses different techniques 
such as modifi ed atmospheres to avoid the initial headspace 
content of oxygen in certain products, there is always an 
increase of oxygen content over time due to the permeability of 
the package material. In order to monitor the oxygen content in 
food packages, the Mills group developed a colorimetric redox 
dye-based indicator that gradually changes the color with small 
amounts of oxygen using TiO 2 NPs mixed with methylene blue 
in water. [ 40 ] This sensor must be activated by UV light exposi-
tion on the TiO 2 NPs to generate electron–hole pairs that oxi-
dize the sacrifi cial electron donor (in this case triethanolamine), 
which leads to an accumulation of the photogenerated electrons 
Part. Part. Syst. Charact. 2014, 
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 Figure 4.  Highly sensitive, dual-readout assay for organophosphorus and carbamate pesticides. Reproduced with permission. [ 33 ] Copyright 2012, ACS.
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on the TiO 2 NPs. These electrons fi nally reduce the redox dye 
and thus change its color. Incorporation of such oxygen sensors 
in food packaging would allow for on-site indication of spoiled 
food. Most importantly, this sensor would not require direct 
contact with the food and could be integrated in an oxygen-per-
meable compartment within the package material. 
 As important as the oxygen content is the moisture inside the 
package, which can give an idea of the freshness of a product. 
Luechinger et al. designed a sensor using 20–50 nm carbon-
coated copper NPs dispersed on a several micrometer thick 
hybrid fi lm. [ 41 ] This sensor was based on a surface plasmon res-
onance shift due to the water uptake of the fi lm, affecting the 
membrane thickness at high relative humidity. Once this fi lm 
was exposed to atmospheres with different water vapor con-
tent, it got sensitively colored with spectral shifts around 50 nm 
per % of relative humidity in a range of 70–80% relative 
humidity. At low humidity, the effect could be assigned to sur-
face plasmon resonance shifts, whereas thin-fi lm interference 
within a condensed water or solvent layer forming on top of the 
fi lm accounted for the intense coloration at higher humidity. 
The present results suggest use of such porous hybrid metal/
polymer fi lms as an economically attractive alternative to 
electronic-circuit-based humidity sensing. Again, this optical 
humidity detection principle would not require direct con-
tact with the food and could be integrated within a separated 
 compartment with water-permeable enclosure. Also pH can 
be an important indicator for the quality state of food. [ 42 ] It can 
easily be detected optically with NPs, for example by changes in 
fl uorescence color, which can be observed under UV light. [ 13 ] 
However, in this case contact with the food is required. 
 Besides oxygen, moisture and pH, several volatile com-
pounds can be indicative of food spoilage, or even food fresh-
ness. [ 43 ] For instance, some volatile compounds are directly 
related to the health and nutritional value of some vegetables 
(e.g. tomato [ 44 ] whereas others (e.g. trimethylamine, dimeth-
ylamine, ammonia, esters, alcohols, ethylene, etc.) can be 
indicators of spoilage, for instance, in fi sh, [ 45 ] meat, [ 46 ] eggs [ 47 ] 
and fruits. [ 48 ] As previously stated, nanotechnology and new 
printing technologies allows for integration of multiple gas 
sensors on plastic and fl exible substrates, thereby providing 
the foundations for cost-effi cient sensors, which could be used 
for real-time monitoring of several volatile indicators of food 
spoilage as well as temperature and humidity in parallel. [ 6 ] 
In this direction, Pandey et al. reported on a fl exible resistive 
nano-based sensor for ultrasensitive detection of ammonia, [ 49 ] 
one of the common volatiles resulting from microbial degra-
dation of food. [ 45 ] The sensor relies on current changes upon 
adsorption of ammonia on fi lms of nanocomposites formed 
by Ag NPs and guar gum, a type of polysaccharide. Indeed, 
an optical sensor for ammonia based on this nanocomposite 
has been also demonstrated, though in this case in solution. [ 50 ] 
In contrast to other common gas sensors which require high 
temperature operation, the ammonia nanocomposite based 
sensor proposed operates at room temperature and further-
more, it presents fast response/recovery. Such a fl exible fi lm 
ammonia sensor could be readily integrated on food pack-
aging. Given the state of the art of printing & organic elec-
tronics, we envisage “smart” labels on food packaging, which 
by multiple nano-based sensors (temperature, humidity, and 
volatiles) can warn consumers, producers and distributors of 
potential food spoilage. 
 4.  Preventing Spoilage 
 Nanomaterials may help not only to detect contamination, but 
also to reduce it, which will be explained for the cases of bac-
teria, heavy metal ions, and oxygen as examples. While silver 
NPs with their antibacterial properties [ 51 ] might not be wanted 
for food packaging due to potential cytotoxic effects by release 
of Ag + ions (though they might be negligible), also other anti-
bacterial NPs are known, which are made from more biocom-
patible materials. Zhao et al. showed that also gold NPs can 
be potent antibiotics, particularly for multi-drug resistant bac-
teria. [ 52 ] While they have not demonstrated their use in the food 
industry yet, it can be envisioned that using gold-based mate-
rials for killing germs in food might be safer than silver, as 
small amounts of gold are already approved and consumed as 
food in the form of gold foil. The group of Aaron Gedanken has 
pioneered the use of zinc oxide and titanium oxide NPs as anti-
bacterial agents, [ 53 ] which have been used in many consumer 
products over years. While so far mainly used for textiles, [ 54 ] this 
group has demonstrated that these NPs can be incorporated 
without problems in synthetic polymer fi lms. In order to mini-
mize any potential contamination of food, the packaging foil 
also could be built in double-layer geometry, thus preventing 
any direct contact of the sensor/antibacterial coating with the 
food. In the same direction, nanomaterials could also be used 
to (partly) remove toxic substances. For this, specifi c recogni-
tion leading to binding of the toxic molecules and thus to their 
removal is required. Due to their high surface-to-volume ratio, 
nanomaterials here offer clear advantages over bulk material. 
An example in this direction was given by Ojea-Jimenez et al., 
who used NPs to remove toxic ions from water. [ 55 ] Also oxygen 
can be removed by oxygen scavengers, which is already used for 
food preservation. [ 56 ] One of the most traditionally used oxygen 
scavengers is iron powder, which is separately packaged in small 
sachets in order to avoid direct contact with the food. Oxygen 
reduction is based on the oxidation of the iron. [ 57 ] For the same 
purpose, iron NPs have been used as oxygen scavengers, in this 
case attached to one of the inner permeable polymer layers of 
the multilayered package, again in a way which prevents direct 
contact with the product. [ 58 ] These Fe NPs were attached in kao-
linite forming micrometric structures, leading to the formation 
of active nanocomposites that act as passive barriers avoiding 
gas diffusion through the membrane and as reductants due 
to the reactivity of the Fe NPs. In this case the big surface-to-
volume ratio of the NPs is the key point. [ 58 ] 
 Last in this section, we want to acknowledge the pres-
ence in food industry of several products based on nanoclays 
(i.e. naturally occurring nanoparticles of layered aluminium 
 silicates), [ 59 ] which are already commercially available, such 
as Imperm, Aegis, and Durethan. [ 60 ] In these products, 
nanoclays are incorporated into plastics, which are used to 
produce  bottles, providing improved barrier properties for 
retaining CO 2 and keeping out O 2 (keeping beverages fresher 
and extending shelf life) and improved stiffness (nanoclays 
reinforcement). 
Part. Part. Syst. Charact. 2014, 
DOI: 10.1002/ppsc.201400192
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim8 wileyonlinelibrary.com
www.particle-journal.com www.MaterialsViews.com
P
R
O
G
R
ES
S
 R
EP
O
R
T
 5.  Perspective 
 While the above mentioned examples clearly need to be seen 
as examples to illustrate a fi eld still in its infancy, we believe 
that smart nanomaterials offer the potential for many disrup-
tive technologies to be widely used in the future for food pack-
aging applications. Compared to existing methods, which are 
usually dependent on bulky instruments, and are thus not 
suitable for on-site detection, the illustrated approaches allow 
convenient protocols and straightforward read-outs. Read-outs 
of NPs, in particular optical read-out, which relates molecular 
events to colorimetric and fl uorimetric signals, [ 61 ] can be pos-
sible with the naked eye or simple tools such as standard digital 
cameras. This, together with the fact that nanomaterials can be 
integrated into standard matrixes, in particular in the detection 
schemes where no direct chemical contact with the food sample 
is required, [ 23 ] will allow for small and reasonably inexpensive 
integrated sensor devices. While nowadays customers upon 
inspecting a product in the supermarket look on the expiration 
date, in the future this might be a small and easily to under-
stand sensor integrated into the packaging foil, which by means 
of a color code indicates onset of decomposition or contamina-
tion. Clearly, smart nano-based packaging systems have a long 
way ahead in order to be incorporated by the food industry. 
Issues such as nanoparticle toxicity (e.g. release of toxic metal 
ions), nanoparticle ecotoxicity, recycling (e.g. plastic foils which 
contain NPs) and regulation of the use of NPs in food, are still 
to be addressed. As the population grows and food becomes 
increasingly more precious and sustainability becomes more 
accepted, maybe in the future intelligent web-connected pack-
agings will be used to detect the onset of degradation and pre-
vent waste of edible food. 
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Composite Colloidal Nanosystems for Targeted Delivery
and Sensing1
Pilar Rivera Gil, Moritz Nazarenus, andWolfgang J. Parak
3.1
Introduction
Therapeutic bio(macro)molecules like antibodies, antigens, nucleic acids, or
(poly)peptides have gained in the past years a great biotechnological devel-
opment relevant to their clinical use. The production of these drugs is often
still very tedious and costly so that normally, small amounts of materials are
obtained. More importantly, most of these new pharmaceuticals, although
other old formulations too, are very sensitive for degradation on administration,
which often results in the drug not effectively achieving its target. Reduced
plasma doses and difficulties in adjusting the dose to be administered as well
as possible immunogenic effects are also derived by a premature degradation of
the therapeutics. In order to save the material during technological processes
as well as to preserve the bioavailability of the drug by protecting it from degra-
dation and clearance and to assist the drug to reach its target, novel and smart
formulations are required [1]. The two most common forms of pharmaceuticals
are tablets and capsules (or encapsulated forms being the bioactive molecule
surrounded by a shell), the latter being considered the most efficient method
of taking a medication. Common “encapsulating” formulations like soft- and
hard-shell capsules, solid lipid particles, liposomes, polymeric conjugates, and
so on, are “mono- or bi-functional” meaning being able to offer only one or
two functionalities: often protection and/or increased intracellular doses (as in
the last case). However, for advanced formulations, “multifunctional” carriers
that aim at protection, targeting, delivery, responsiveness, and site-specific
manipulation are of paramount importance. Nanotechnology can contribute to
the development of novel formulations by fabricating functional hybrid materials
composed of nanoscaled building blocks. These multifunctional platforms [2, 3]
combine a variety of properties allowing for the simultaneous or sequential
performance of multiple functions in single cells, including enzymatic catalysis,
1) This work is based on the “Habilitationsschrift” of PRG at the Philipps Universität Marburg.
Bioinspired and Biomimetic Systems for Drug and Gene Delivery, First Edition. Edited by Zhongwei Gu.
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controlled release, directed cargo (e.g., drug) delivery, and sensing. Relevant
requirements of a multifunctional system include (i) physiological stability,
(ii) protection of cargo, (iii) targeting via nonspecific and specific strategies,
(iv) stimuli sensitivity and responsiveness to the local environment (pH, tem-
perature) or to an external applied trigger (e.g., light, ultrasound, magnetic
field), (v) enhanced intracellular delivery of different types of cargo, and (vi)
different labeling for characterization (imaging) or if required, for multiplexing
of analytes.
Combining biological principles with physicochemical procedures, novel,
smart, and multifunctional materials can be developed to fulfill the aforemen-
tioned requirements.
3.1.1
Working Toolkit
The tools or functionalities needed include the presence of a carrier vessel and
responsive elements for remote control, labeling, and sensing.
Nanomaterials (colloids) in a submicron size range from a few to a few hun-
dreds of nanometers (nm) and possess unique physicochemical and thus medical
properties that differ from their macroscopic counterparts. Organic platforms
including polymeric nanoparticles (NPs), dendrimers, liposomes, and other lipid
assemblies, and engineered viral NPs mostly for drug/gene delivery [4] are cur-
rently the most common nanopharmaceutical forms used, where the nanomate-
rial plays the pivotal therapeutic role or adds additional functionality to the active
compound [5]. Nevertheless, the development of inorganic nanosystems is open-
ing the pharmaceutical nanotechnology novel horizons for diagnosis, imaging,
and therapy, mainly because of their size in the nanometer range, their high sur-
face area to volume ratios – which allow for specific functions that are not possible
in the macroscopic scale – and, distinctly, their superior colloidal stability and
well-defined physicochemical properties [6, 7].
Inorganic colloidal NPs are commonly composed of an inorganic core and
a biocompatible surface coating that provides chemical stability under physio-
logical conditions, dispersibility in aqueous solution, and reduced toxicity. The
inorganic cores are crystalline clusters of a few hundred up to a few thousands
of atoms, which can be prepared from many different materials to exhibit dif-
ferent properties proper from their colloidal state. For example, semiconductor
materials containing cadmium possess special optical properties, NPs composed
of cobalt or iron oxide show paramagnetic characteristics, and metal NPs
made of gold exhibit unique photothermal performances. The most common
synthesis route is at high temperatures in the presence of organic surfactants,
which are crucial for the controlled growth, shape, and stability of the NPs.
The polar head groups of the surfactant molecules are bound to the surface
of each NP, while leaving the hydrophobic tails to the outer environment. The
presence of this stable, organic, charged coating prevents the agglomeration
of neighboring NPs, thus resulting in a solution of well-dispersed particles [8].
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The resulting particles are hydrophobic and need to be transferred to water
solutions. By wrapping an amphiphilic polymer around the particles, the NPs
become hydrophilic and maintain their colloidal stability via electrostatic
repulsions forces [9]. Furthermore, this surrounding organic shell of stabilizing
molecules also acts as an anchor for further functionalization on attachment of
biomolecules [10].
Different applications within the health care include the use of inorganic NPs (i)
as active pharmaceutical ingredient, where themain role is played by the nanoma-
terial, that is, for the purpose of therapy, diagnostics, imaging and (ii) as vectors (a
solid carrier that introduces the active ingredient into a recipient or host organ-
ism) or with an enabling function. In the latest application, the NPs add a new
functionality to the preexisting product, for example, NPs for target delivery or as
biomaterials [5].
The fabrication of organic hollow microcapsules via layer-by-layer (LbL)
assembly [11] offers an interesting platform for the assembly of multifunctional
carrier systems. Polyelectrolyte multilayer (PEM) capsules are fabricated through
stepwise adsorption of PEs (polyelectrolytes) using electrostatics (mostly used),
H-bonding or covalent chemistry as driving forces, followed by the chemical
dissolution of the core template [12, 13]. The resulting hollow capsules usually
have a wall thickness of between a few tens and several hundreds of nanometers
and a diameter ranging from tens of nanometers to several micrometers (μm),
depending on the size of the original core. The technique is highly versatile as
different materials can be used to construct the shell or can be used as tem-
plates. The nature of the components used for the fabrication of these capsules
determines their mechanical/physicochemical properties. For example, by using
templates of different diameter (from 60 to 10mm), the size of the resulting
capsules can be tuned [14–16], whereas by using different types of component
layers, such as synthetic PEs [17], charged and noncharged biopolymers [18–20],
the chemical properties of the multilayer shell can be tailored.
The toolkit presented here comprises materials with different physicochemi-
cal properties, for example, surface chemistry (organic, inorganic, and hybrid),
charge, size as well as with different functionalities.
3.1.2
Engineering a Multifunctional Carrier
There is no single material that fulfills all the requirements to be the “perfect”
carriermentioned before.Multifunctionality requires the coordinated assembly of
building blocks with different functionalities into one single system to a resulting
composite object. By using a carrier, the performances of all single materials are
comprisedwithin it and cargomolecules (therapeutics or bioactivemolecules) can
be additionally integrated for theragnostic approaches.
The use of PEM capsules as theragnostic vehicles presents several advantages: (i)
PEM capsules can easily be administered and are easily internalized by different
types of cells [21–23]; (ii) they are mechanically highly stable [24]; and (iii) they
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possess two distinct compartments (shell and cavity) that can be functionalized
with different building blocks. The cavity of the capsules represents the main vol-
ume and encapsulates the therapeutic or active molecules, offering at the same
time protection to the cargo. Because of the big volume of the cavity, great quan-
tities of cargo can be loaded within one single capsule. In this way, the number of
administered capsules necessary to reach effective concentrations can be reduced;
(iv) they are relatively easily engineered for a sustained release of their cargo at
their target site, though only after the appliance of a specific physicochemical stim-
ulus or after the power-on of an external trigger [25, 26].
As mentioned before, the distinct advantage of this carrier is the ability to be
engineered with different building blocks to combine all the functionalities in one
unique system (Figure 3.1).
NPs with different physicochemical properties can be easily incorporated
within the shell of the capsules through the use of electrostatic interactions to
impart optical, magnetic, and photothermal properties to microcapsules. By
adding colloidal luminescent semiconductor NPs such as CdSe/ZnS quantum
dots (QDs) [27, 28], the capsules can be easily detected by measuring their
fluorescence signal with noninvasive optical techniques. The use of fluorescent
NPs as fluorophores for labeling applications presents two main advantages
compared with commercial organic fluorophores. Firstly, they are characterized
by nearly continuous excitation spectra with narrow emission bands, located at
different wavelengths depending on the NP size [29, 30]. This allows for simulta-
neous excitation of probes of different colors by light of a single wavelength [31].
Secondly, their reduced photobleaching makes them suitable for measurements
over long periods of time [32, 33]. On the other hand, the Cd-based QDs, which
are still most frequently used, can cause cytotoxic effects by releasing Cd ions
Color Fig.: 3.1
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Gold NPs
Magnetic NPs
Fluorescent molecules
Targeting moieties
PEG
Cargo
Figure 3.1 Schema of a multifunctional
carrier vessel. The surface chemistry of the
carrier is characterized by a stealth coating
and cell-recognition molecules. The shell is
decorated with different NPs to add func-
tionalities like responsiveness, labeling, or
targeting. The cavity contains the cargo to
be delivered.
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[34, 35]. However, with an appropriate coating that avoids ions leaking from the
surface of the NP, toxic effects can be acutely neglected in vitro. By embedding
superparamagnetic iron oxide based NPs (SPIONs) into the capsule walls, the
movement of capsules toward a desired direction can be controlled by applying
an external magnetic field gradient [36–38]. In addition, heating of the NPs on
application of radiofrequency fields increases the permeability of the capsule
walls [39]. Noble metal NPs such as gold (Au) and silver (Ag) are known to
strongly absorb light. On irradiation, the major part of the absorbed light energy
by each NP is transformed into heat. The collective effect of several NPs within
the capsule shells serves to amplify the heating effect and the resulting increase
in temperature in the surrounding areas [40–42]. In this way, by embedding
metal NPs into the walls of the capsules, the integrity/permeability of the wall of
individual capsules can be selectively perturbed [43–46]. Furthermore, Au NPs
are electron dense and therefore very suitable for characterization techniques
like electron microscopy.
Another possibility for the functionalization of PEM capsule is through
conjugation of biological molecules (e.g., PEG, antibodies, streptavidin) to theirQ1
walls. Biomolecules can be added to the outermost layer of the capsule walls by
electrostatic adsorption or covalent binding, depending on their charge features.
The addition of low-fouling polymers that possess protein-repellent qualities
is required besides targeting features toward the design of novel vehicles for
targeted delivery in vivo. For instance, microcapsules coated with a layer of
PEG-grafted PEs have been shown to escape clearance by the mononuclear
phagocyte system [47–49]. Such biofunctionalized capsules might fully mimic
the features of bioactive molecules, thus improving the biocompatibility and
physiological stability of the capsules as well as adding molecular recognition
properties [50–52].
The cavity of the PEM capsules can also be loaded with different cargoQ2
molecules including the aforementioned functionalitites. More meaningful for
pharmaceutical/medical applications is the encapsulation of biotherapeutics
(e.g., nucleic acid, drugs, vaccines, or peptides). Especially, hydrophobic drugs
[53] or extremely costly biomolecules can be efficiently entrapped within the
container. Because of the big size of the cavity, higher amounts of material can
be loaded and the dose of capsules to be administered to perform its action
can be minimized. Because of the high versatility of the technique that allows
to encapsulate different types of cargo molecules, the LbL approach appears
nowadays to be useful in a wide range of applications including cancer, anti-
sense or hormone-substitution therapies [20, 54–58], vaccination [22, 59], and
diagnosis [60].
The shell modification with different types of NPs combined with an efficient
loading of the cavity of these capsules allows for addressing important functions
such as labeling, targeting, and the controlled opening of the capsules together
with cargo delivery and protection. Those are essential features for using these
vessels as theragnostic vehicles.
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3.2
Objective
Theobjective of this work is to present a novel multifunctional carrier systemwith
different abilities:
• Tracking following the presence of different labels, for example, fluorescent
QDs, electron dense Au NPs, organic dyes.
• Manipulation of the carrier with NPs responsive to light (Au NPs) or to a mag-
netic field (SPIONs) for a controlled opening and/or targeting, respectively.
• Encapsulation and delivery of active compounds, for example, therapeutic
biomacromolecules (nucleic acids, peptides, antigens, drugs, and sensors).
• Sensing, for example, optical readout of local analytes to get a feedback of the
environment of the carrier.
To achieve this objective, materials are developed according to different
approaches, and chemical modifications are performed to make these materials
suitable for living organisms.This work is focused on materials for pharmacy and
medicine. Therefore a good in vitro characterization of the interactions of these
materials with living cells needs to be performed.
3.3
Cellular Behavior of the Carrier
3.3.1
Intracellular Fate
Cells can incorporate objects ranging from the molecular up to the micrometer
scale by numerous processes. Extensive studies with NPs show that NPs with dif-
ferent physicochemical properties have different mechanisms of internalization
and different intracellular distribution patterns. For example, surface chemistry
plays a key role as the surface of the NPs can be modified with specific molecules
either to increase or to reduce uptake. Ligands like transferrin increase the rate
of internalization via receptor mediated endocytosis; however, if the particles are
conjugated with PEG molecules, the uptake is decreased [61]. This is especially
important for in vivo application. By reducing uptake from the mononuclear
phagocyte system, particles can, for example, after an i.v. injection, circulate in
the blood for longer periods of time and can reach the target organ at the desired
concentration. Charge also plays an important role in the internalization pattern
of particles. A positive overall charge ensures faster internalization rates than a
negative charge because of electrostatic interaction with the negatively charged
glycocalyx of the cells. However, the observed increase in the internalization rate
of positively charged NPs is strongly dependent on membrane accumulation and
thus directly related to a specific NP concentration [62, 63]. I thus hypothesized
an NP-concentration threshold responsible for the fast internalization rates of
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positively charged NPs. Size appears to be a limiting factor. Both positive and
negative charged NPs are internalized via clathrin- or caveloae-mediated endo-
cytosis depending on their surface chemistry and charge [64, 65]. However, NPs
with a size between 500 and 1000 nm are rather caveolae internalized compared
to smaller particles (<200 nm) that are endocytosed via clathrin-coated vesicles
[66]. Other mechanisms like macropinocytosis and phagocytosis have been
described for the engulfment of solutes and bigger particles (>1 μm), respectively,
whereas signal-mediated transport via pores occurs when the size is less than
0.1 μm [67].
PEM capsules of different sizes (from nanometers to micrometers) are taken
up by living cells. Despite their “big” size (normally around 2 μm) PEM capsules
are easily incorporated not only by phagocytic cells (macrophages) but also by
a great variety of different cells (e.g., embryonic fibroblasts, neuro- and glioblas-
toma cells, and epithelial cancer cells) including primary cells (e.g., cortical neu-
rons, monocyte-derived dendritic cells).The incorporation of the capsules occurs
spontaneously and is noncell specific. Therefore, special attention should be kept
on improving the molecular recognition properties of the capsules. In general,
the internalization of capsules by cells appears to be a highly energy-consuming,
actin-mediated process that depends on microcapsule intrinsic factors like size
and composition rather than on cell type.
Although the exact mechanism of cellular uptake is still largely unknown, some
important parameters that regulate this process have recently been elucidated.
For instance, the overall charge of capsules has been demonstrated to play a role
for capsule uptake. As for smaller colloidal NPs, charged capsules are ingested
faster than uncharged ones, and positively charged capsules are found to be
engulfed more than negatively charged ones [68]. At any rate, adsorption of cell
medium proteins to the capsule surface tends to smear out differences in surface
chemistry for long incubation times. Atomic force microscopy measurements
of adhesive forces between capsules and cell membranes show that the uptake
of PEM capsules strongly correlates with the adhesion of capsules to the outer
cell membrane [68]. These results have also been confirmed by Confocal Laser
Scanning Microscopy (CLSM) and by Transmission Electron Microscopy (TEM)
(unpublished data). Using CLSM membrane ruffling and redistribution of the
actin cytoskeleton to form large cytoplasmatic protrusions to engulf the PEM
capsules was observed (Figure 3.2a). Incubation of the cells with Cytochalasin
D clearly disturbed the internalization of the capsules. Although attachment to
the plasma membrane and an attempt of internalization was visible with the
CLSM and with the TEM (Figure 3.2c,d), the actin cytoskeleton was not able to
reorganize properly and invagination of the vesicles into the cytosolic side of the
cells was not completed. Mostly all uptake processes, except caveolae-mediated,
macropinocytosis, and phagocytosis appear to be enhanced by, although are
not strictly dependent on, a functional actin cytoskeleton. Labeling of cellular
structures with different markers clearly revealed an initial colocalization of
the capsules with lipid rafts, which are membrane microdomains enriched in
cholesterol, specific proteins, and glycosphingolipids, the last being stained
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Figure 3.2 Characterization of the inter-
nalization of PEM capsules via CLSM (upper
images) and TEM (lower images). For this
purposes, capsules were synthesized hol-
low to carry fluorescent molecules (FITC
(a) and red QDs (b)) together with Au NPs
within their shells to allow their visualization
with CLSM and TEM, respectively. (a) Actin
reorganization (red) of the cytoskeleton to
engulf a PEM capsule (green) in a sort of
phagocytic cup and (b) final localization of
capsules (red) in (phago)lysosomal structures
(green). (c–d) TEM pictographs of cells incu-
bated with capsules for 4 h in the absence
(c) or presence (d) of cytochalasin d.
by Cholera toxin B1 [69] and a final colocalization with structures containing
LAMP1, that is, (phago)lysosomes (Figure 3.2b).
On the one hand, the uptake of the capsules after 4 h was completely abolished
by methyl-β-cyclodextrin that removes cholesterol from cultured cells thus
inhibiting uptake-associated processes like macropinocytosis and lipid rafts.
However, as cholesterol is a common component of the plasma membrane
and the engulfment of capsules involves large parts of the plasma membrane,
phagocytosis cannot really be excluded. Caveolin-dependent and -independent
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lipid rafts can be excluded as internalization route because the markers used did
not stain caveosomes. Furthermore, caveosomes have a different pH (neutral)
and a different content compared to endosomes (acid) and do not end up fusing
the lysosomes [70, 71]. Whereas the vesicles involved in the internalization of
the capsules are clearly acidic [72] and possess lysosomal markers (unpublished
results). In addition, caveosomes are transported within the cell along micro-
tubules, and inhibition of microtubule formation with Nocodazole had no effect
on the internalization of capsules. On the other hand, cellular incubation with
Bafilomycin A disturbed the uptake of the capsules in a concentration-dependent
manner. Bafilomycin is a specific inhibitor of the vacuolar type H+-ATPase that
prevents reacidification of the lysosome [60] and is required for the maturation
of the phagosomes. Although the exact mechanism of internalization of the
capsules cannot be elucidated yet, these unpublished results demonstrate a
primary localization in plasma membrane invaginations (enriched in cholesterol
and glycosphingolipids) and a final localization in (phago)lysosomes located
in the perinuclear region. This would point out to phagocytosis as a predom-
inant route of internalization. Nevertheless, different mechanisms could be
sequentially involved. For example, first of all, adsorptive mechanisms, because
of the electrostatic interactions, are responsible for the primary cell-capsule
contact. Once the capsules are attached to the cellular membrane, there is a local
accumulation of glycosphingolipids and cholesterol, which might form a sort
of microdomains as the lipid rafts do. Strong actin reorganization occurs then
to form long protrusions (not lipid rafts) to engulf the “big” capsules similar to
by phagocytic processes. Finally, the capsules are transported to the perinuclear
region of the cell and remain in acidic (phago)lysosomes.
3.3.2
Biocompatibility
Regarding the cytotoxicity of the capsules, although not yet well studied, the
main sources for toxicity come obviously from the PEs composing the wall as
well as from the functionalities embedded in the cavity and/or in the wall. Initial
studies have suggested that capsules alone do not exhibit acute cytotoxic damage
on cell cultures, but rather the NPs with which the capsules are functionalized
are potentially cytotoxic, as, for example, when Cd-based semiconductor NPs
embedded in the capsule walls corrode and release toxic cadmium ions [73].
On the other hand, both magnetic and Au NPs are relatively harmless to the
cells [74, 75].
Themagnitude of the cytotoxic effect of the capsules is primarily concentration-
and time-dependent [23, 73]. In addition, the intrinsic chemical properties of the
positively charged PE (polycation) turned out to make polycations effective trig-
gers of mitochondrial-mediated cell death (apoptosis/necrosis) [76, 77]. Because
of their positive charge, polycations cause cellular membrane damage with sub-
sequent activation of signaling pathways that end up with mitochondrial depolar-
ization and generation of reactive oxygen species resulting in cell death. In this
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regard, together with the molecular weights, the cationic charge density of the
polycations are key parameters for the interaction with cell membrane and cell
damage [78, 79]. Furthermore, polycations containing polyamine functionalities
may result in an increased interaction with anionic intracellular components that
also lead to oxygen-independent cell death [80]. In this regard, a reduction of the
cytotoxicity could be obtained by using alternative materials (to polyamines) that
mimic natural cell components [81]. Interestingly, when the polycation is com-
plexed with the polyanion as in the case of supramolecular structures like the
PEM capsules, a strong reduction or even disappearance of toxicity was observed
(Figure 3.3).
Cytotoxicity assays in vitro have been employed to confirm the innocuousness
of PE-based systems [82]. In general, the internalization of several capsules in
vitro neither interferes with the regular cell cycle nor with the viability of the
cells. Life imaging of cultured cells in the presence of PEM capsules showed
how cells move toward the capsules, engulf them, and continue their movement.
Furthermore, cells pass their internalized capsules to daughter cells on cellular
division and continue their proliferation to mature cells [26]. Nevertheless, more
advanced studies involving animal tissue demonstrate that plain unfunctional-
ized PEM capsules can transiently cause local inflammations after subcutaneous
injection [23]. Despite the impact this would have on medical applications, the
cytotoxicity effects of capsules in vivo have not yet been fully investigated.
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Figure 3.3 Citotoxicity derived by the
PEs. In this case the toxicity of the two PEs
(DEXS, dextran sulfate and pARG, poly argi-
nine) commonly used for the synthesis of
biodegradable PEM capsules was compared.
Each PE either alone or conjugated (as in the
capsules) was tested for viability. High flu-
orescent values correspond to viable cells
whereas low values are characteristics of
death cells.
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3.4
Applications
As mentioned before, the use of PEM capsules as carriers have found different
applications in clinics including therapy and diagnosis. However, the main goal
is to present PEM capsules as a multifunctional carrier system, which is able to
perform both actions. Therefore, the main applications studied were PEM cap-
sules for targeted delivery of biotherapeutics and for sensing of analytes, the last
being additionally used to get a feedback from the environment of the carrier. To
proof the effectiveness and the versatility of these carriers, the geometry of the
carrier was varied depending on the problem addressed, that is, different cargos
(e.g., siRNA, drugs, proteins, and sensors) aswell as differentwall constituentwere
used to synthesize and functionalize the capsules for different purposes.
3.4.1
Delivery with Multifunctional PEM Capsules
Delivery systems have to fulfill some basic physicochemical requirements. They
have to be biocompatible and able to navigate within living organisms using
remote guidance. They have to be able to entrap efficiently different molecules
with different sizes, which can be hydrophobic or hydrophilic, and have to protect
the entrapped molecule from undesired degradation thus providing improved
cargo stability, sustained and controlled release rates, and increased bioavail-
ability. For targeted release, the cargo must not leak out from the carrier system
before it reaches its target. Once there, the cargo should not leave the carrier
uncontrollably but rather on controlled release, that is, by the manipulation
of the carrier. To the best of my knowledge a system that combines all these
functionalities into one single structure has not been developed yet despite great
efforts, probably because colloidal engineering is being extremely challenged to
fulfill all these conditions.
3.4.1.1 Magnetic Targeting andMagnetofection
Targeting is a must-have. Targeted delivery technologies are especially crucial for
most drugs either because their designated site of action is difficult to reach or
because cytotoxic side effects have to be minimized.There is currently no applied
pharmaceutical treatment available that can be applied locally in a controlled way,
thereby shielding healthy cells from drug interaction.
Magnetic drug targeting has been suggested as a method to locally accumu-
late drugs. It has recently been shown in vivo that it is possible to direct drugs
bound to magnetic NPs to tumor tissue using magnetic field gradients [83, 84].
The same concept can be applied for PEM capsules whose walls are functionalized
with magnetic NPs [38]. Naturally, the classical concept of targeted drug delivery
via receptor–ligand interaction can also be applied to the capsules. For this pur-
pose, molecules with molecular recognition properties, for example, antibodies,
growth factors, and so on, can be immobilized on the capsule surface, resulting in
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an increase in the uptake rate of capsules by target cells compared with surround-
ing cells [85].
Delivery systems carrying nucleic acids that shells are functionalized with mag-
netic NPs, that is, SPIONs, allows for magnetic force-assisted transfection (mag-
netofection) as well as magnetic targeting in both static and fluidic conditions
mimicking the blood stream [86, 87].
Antisense therapies are very promising tools against diseases like cancer;
however, the administration of genetic materials is subject to important restric-
tions like rapid clearance or fast degradation by nucleases [88]. Many carrier
systems, that is, viral and nonviral have been developed [89–93].The transfection
efficiency using viral vectors is significantly higher than using nonviral vectors
but their application in human raises many safety concerns [94]. Many efforts
are being directed in creating nonviral carriers with comparable transfection
efficiency but less immunological responses [95]. In this sense, PEM capsules
appear as ideal carriers to improve the efficiency of nonviral vectors.The capsules
are biocompatible and are easily incorporated by the cells. Furthermore, the
wall can be functionalized with targeting moieties, for example, with SPIONs to
approach high local accumulation of the carriers by applying a magnetic field,
thus increasing the number of capsules in the cell area. PEM capsules can deliver
great quantities of material because of the big size of their cavities, which at the
same time offer protection to the cargo. All this should allow for an increased
transfection efficiency compared to polymeric/lipid complexes.
Although the use of PEM capsules as nonviral vectors for genetic material has
not been well studied yet, I would like to point out that my research outlook next
focuses on this direction as it appears very promising to me.
Some previous works support this assumption. Zebli et al. already described the
functionalization of PEM capsules with SPIONs to target the capsules to desired
cell culture areas. By applying a magnetic field, capsules moved toward a perma-
nent magnet that was located in a specific cell area. The magnetic force gradient
surely caused local accumulation of the magnetic capsules at the outer membrane
of the target cells increasing in this way the internalization of the capsules by
those cells [96]. Planck et al. [97] have intensively researched lipospheres tagged
with siRNA to try to improve the transfection efficiency of nonviral vectors by
adding a second driving force that ismagnetic targeting as described before.These
magnetic acoustically active lipospheres appeared to be quite safe and achieved a
down regulation of reporter gene expression even at very low concentration of
siRNA [98].
Both systems used a flow channel system for modeling the bloodstream in the
circulatory system thus proving the feasibility of magnetic assisted transfection in
vivo.
Although focussing magnetic field gradients do not work on a single cell level,
at least two parallel ways of targeting can be achieved by PEM capsules: (i) local
accumulation of capsules near the target tissue by attraction of magnetic NPs in
the capsule walls with magnetic field gradients and (ii) enhanced uptake by tar-
get cells because of cell-specific molecules attached to the surface of the capsule
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walls. In this way, the combination of two strategies within one carrier system is
expected to lead to improved targeting and thus less unwanted delivery of drugs
to the surrounding tissue.
3.4.1.2 Strategies for Controlled Opening
Targeted cargo delivery can be combined with remotely controlled cargo release.
Remote activation is based on the manipulation of the carrier if necessary, with
help from an external physical stimulus (i.e., trigger) that acts on the carrier to
enable the release of the cargo from the cavity to the cellular environment. There
are several strategies to achieve this performance. Some carriers are designed
to disintegrate on changes in the conditions of the environment, for example,
pH, temperature, solvent. A quick release is observed when the carrier breaks
on contact with a surface or specifically when it encounters a protein/enzyme.
In this sense, PEM capsules composed of biodegradable PEs such as polypep-
tides and polysaccharides have a great potential for the delivery of therapeutics
[19]. These systems retain their structural integrity before cellular uptake but get
rapidly degraded on enzymatic cleavage after internalization. To prove the ability
of these systems to trigger release and activation of cargo, polyarginine/dextran
sulfate biodegradable capsules filled with amodel for a prodrug – a self-quenched
(nonactive) fluorescence-labeled protein – were synthesized (Figure 3.4). In this
way, the cavity of the capsules was additionally used for a spatially confined reac-
tion, that is, activation of the prodrug after its enzymatic hydrolysis. Furthermore,
the release of the active drug occurred exclusively intracellularly [26].
Nevertheless any of the strategies mentioned before can be controlled.
Manipulation of the carrier to temporarily and spatially control its opening is
of paramount importance and inorganic NP-modified PEM capsules are ideally
carriers to fulfill this work. Depending on the nature of the NPs present in the wall
of the capsules, different stimulus such as light [43], oscillating magnetic fields,
ultrasound [99], or radio frequency [100] can be applied to achieve a controlled
rupturing/permeation of the walls of the capsules so that the cargo is released
from the cavity to the cellular environment whenever and wherever is required.
For example, light-responsive capsules can be synthesized by functionalizing the
shell of the capsules with metal NPs, for example, Au [101, 102]. Agglomerates
of Au NPs have been used to efficiently open the wall of the capsules through
plasmon-assisted photothermal processes [103]. Au NPs are able to strongly
absorb light if the corresponding frequency matches with their surface plasmon
resonance frequency [104]. Au-NPs-based formulations make use of different
forms of laser excitation (near infrared, NIR, or visible light) to cause a light-to-
heat energy conversion [105, 106]. In case the Au NPs are agglomerated (as in
the case of the capsule shell), their plasmon peak is moved to higher wavelengths
and can be efficiently illuminated with near-infrared light thus making use of the
optical transparent window of biological tissues. Nevertheless, when using this
trigger, the limitation of light to penetrate deep in the tissue is to be kept in mind.
Optical excitation and light absorption of Au NPs produce a heat dissipation
and subsequent local increase in the temperature [107] as well as the local
Trim Size: 170mm x 244mm Zhongwei c03.tex V1 - 07/17/2014 5:59pm Page 74
74 3 Composite Colloidal Nanosystems for Targeted Delivery and Sensing
Color Fig.: 3.4
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Figure 3.4 Release and cargo activation
mediated by biodegradable PEM capsules.
Capsules were synthesized with biodegrad-
able polymers. On cellular internalization,
the capsule wall was degraded and the
cargo (a fluorogenic substrates for enzymes)
was available for activation. In this case
the selected cargo acted as a model for a
prodrug that needs to be cleavage (“activat-
ed”) into its functional form. When the cargo
was structurally intact, the fluorescence was
quenched. However, when the capsule wall
was degraded and enzymes could reach the
cargo, the fluorescence was dequenched and
a visible green signal was detected. (Image
taken from Ref. [26].)
destruction of the capsules shell mediated by disintegration/fragmentation of the
Au NP clusters [108]. Those are competing mechanisms that rule the capsule
opening and the cargo release on switching on/off the external trigger (i.e.,
light). Furthermore, sequential light illumination of individual capsules allows for
subsequent release of cargo to the cytosol of the cells interfering neither with the
integrity of the cargo [46] nor with the viability of the cells [109].
Other external triggers used to open NP-modified PEM capsules through
mechanical disintegration of their walls include sonication, ultrasound, and
radio frequency [101, 110]. However they can penetrate the tissue well, they are
complicated to focus.
Several key advances for controlled release using PEM capsules were then
demonstrated: manipulation of the carrier for a controlled opening, delivery of
cargo to the cytosol of the cell, and maintenance of the functionality of the cargo.
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3.4.2
Intracellular Ion Sensing
Besides the potential use of PEM capsules as carriers for targeted and controlled
release of cargo, capsules can also be designed for diagnostic applications. In this
sense, the capsules carry sensormolecules that allow the transduction of chemical
concentration information into optical signals. Fluorescent indicators are a class of
fluorophores whose spectral properties are sensitive to a substance (the analyte) of
interest. Numerous indicators are commercially available for a variety of analytes,
including Ca2+, Mg2+, Cl−, H+, Na+, and O2 [111]. This represents an interesting
research line as the control of intracellular ion homeostasis is essential for all cel-
lular organisms. At physiological condition ions like K+ or H+ are found at high
concentrations inside the cells whereas ions likeNa+, Ca2+, or Cl− are rather found
extracellularly [112]. Many pathological situations like liver insufficiency, diabetic
ketoacidosis, hypercatabolism, fibrosing disorders, sickle cell anemia, infection
[112], cystic fibrosis [113–115], or intoxication with metals [116] are associated
with a defective regulation of the ion concentrations.
So far, most of the techniques employed to measure ion concentrations make
use of electrodes [117] or fiber-based optodes [118, 119].These systems work well
for solutions but in general not for cellular organism, as they are too big to enter the
cells over extended periods of time.There are other techniques like microanalysis
that can measure intracellular analyte concentrations. However, they are destruc-
tive for the biological sample [120]. For subcellular (intracellular) analyte detec-
tion, smaller noninvasive sensors are required, especially if long-term measure-
ments in live cells are envisaged. One possibility toward this direction is the use
of particles as carrier matrix/container for analyte-sensitive molecules. Examples
of such nano/micrometer-sized containers include solid particle matrices [121,
122], liposomes [123], hollowfibermembranes [124], vesicles [125], inorganicNPs
[126, 127], and PEM capsules [72, 128].
Carriers must be designed in a way that ions or molecules are able to freely
diffuse to the location of the sensor. The biggest advantage of using micrometer-
sized carriers is the great capacity for loading, which can be enhanced by filling the
whole volume with analyte-sensitive molecules. Compared to other micrometer-
sized carriers, PEM capsules offer the distinct and novel advantage of multiplex-
ing. This is based on the fact that capsules can be functionalized with fluorescent
molecules at two distinct positions, in their walls and in their cavities. Following
this concept, fluorophores sensitive to different analytes (e.g., H+, Na+, K+, and
Cl−) are loaded into the cavities of different capsules [129] and the walls of each
capsules are fluorescently labeled with barcodes [130]. The color of the capsule
wall would allow for the identification of each capsule, thus providing the infor-
mation for which analyte this particular capsule is sensitive to.
The lysomotropy showed by the capsules can be used to measure changes in
the concentration of lysosomal ions, for example, H+ in situ over long periods of
time [60]. Because of the continuous readout provided by the capsules, dynamic
measurements of changes in the lysosomal pH can be performed ( Figure 3.5). In
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Color Fig.: 3.5
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this way, differences in themechanism of action of agents disturbing the lysosomal
acidification could be elucidated [60].
In conclusion, the presented sensor based microcapsules offer a great possibil-
ity to engineer multidetection systems in which several ions in parallel could be
sensed.The presented sensing abilities can be combined with targeted delivery to
create multifunctional systems that strongly interact with their (cellular) environ-
ment thus giving us crucial information.
3.5
Conclusions
Multifunctional PEM capsules fabricated by the LbL assembly technique pos-
sess remarkable properties. In particular, this very general assembly mechanism
allows for the integration of virtually all different types of nanoscale objects into
and on top of their walls. These building blocks introduces functionality (such
as fluorophores, magnetic particles, and local heat sources) and specificity (such
as molecular recognition ligands). The cavity of the capsules can be filled with
cargo, which is to be released at designated targets or with activemolecules, as, for
example, for multiplexed sensing. Compared with other carrier systems, capsules
can be functionalized at two distinct compartments, walls and cavities, introduc-
ing in this way flexibility for the interference-free assembly of multiple function-
alities.
Nowadays several in vitro [20, 24, 131–133] and in vivo studies [20, 134] have
established the use of these capsules as carriers in living systems. Notably, cap-
sules with different physicochemical properties have been produced for different
applications ranging from simultaneous imaging and delivery of biologically active
molecules [27, 135, 136] to intracellular sensing and bioreactors [72, 137–140].
In the context of this work, I presented clear proofs of how to design multifunc-
tional carriers. I could demonstrate that tuning the physicochemical properties
of the materials used to build up the carrier, functionalities like biocompatibil-
ity, targeted delivery, controlled release of cargo, and sensing can be efficiently
performed.
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Abstract
The availability of different materials with well-defined and tunable physico-
chemical properties, for example, surface chemistry, size, or charge significantly
increases the probability to design multifunctional systems with real possibilities
of success in clinical translation. In this work, different materials with different
functionalities for targeting, delivery, sensing, and site-specific manipulation
are integrated in a common carrier. The carriers are organic, three-dimensional
hollow microstructures that can be modified at two distinct positions, the cavity,
and the shell. The different materials (i.e., building blocks) that are incorporated
range from inorganic nanoparticles to molecules or more complex structures.
Depending on the building block selected different functionalities can be inte-
grated within the carrier. For example, the incorporation of gold, iron oxide, or
semiconductor nanoparticles within the shell of the capsules gives the carrier
responsiveness to light and magnetic fields. On the one hand, the capsules can
be efficiently tracked by embedding semiconductor nanoparticles. On the other
hand, stimuli–responsive capsules can also be obtained. Modification with gold
nanoparticles controls the opening of individual capsules on light absorption
whereas the presence of iron oxide nanoparticles targets the capsules to the cells
on activation with a magnet. By attaching molecules with molecular recognition
properties, the capsules can be targeted to specific cells. Furthermore, the cavity
can be efficiently loaded with bioactive molecules with different lyotropy, for
example, hydrophobic/hydrophilic drugs, vaccines, hormones, enzymes, or
sensors. Entrapment of these molecules impart cargo protection increasing its
bioavailability and reducing side effects.
Indeed, different materials with different properties for different purposes are
integrated within the carrier. More interestingly, the physicochemical properties
of the carrier can also be tuned. Different constituents for the layer as well as
for the cores can be used in order to get, for example, mechanical highly stable
versus degradable capsules or smaller versus bigger capsules, and so on. I would
also like to point out that these sophisticated materials with novel properties are
always tried to get adjusted to the requirements/demands of clinicians. These
multifunctional systems are biocompatible, are easily incorporated by numerous
types of cells, and are able to interact with the cellular environment. In this sense,
the targeting and the spatially and temporally resolved, controlled release of
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several types of cargoes is demonstrated. Neither the viability of the cells nor the
integrity of the cargo is impaired. Furthermore, because of the multiplexing abili-
ties of barcoded capsules modified with sensor molecules, different information,
for example, concentration of different ions can be obtained in parallel.
In summary, a multifunctional delivery system that offers cargo protection as well
as efficient and sufficient loading capacity is created. This biocompatible carrier
possesses the distinct ability of multiplexing, that is, the ability of performing dif-
ferent inputs/outputs (targeting, controlled release, and sensing), during a single
application.
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SensorspH-Sensitive Capsules as Intracellular Optical Reporters 
for Monitoring Lysosomal pH Changes Upon Stimulation
Pilar Rivera_Gil, Moritz Nazarenus, Sumaira Ashraf, and Wolfgang J. Parak*The concept of a long-term sensor for ion changes in the lysosome is presented. The 
sensor is made by layer-by-layer assembly of oppositely charged polyelectrolytes 
around ion-sensitive fluorophores, in this case for protons. The sensor is spontaneously 
incorporated by cells and resides over days in the lysosome. Intracellular changes 
of the concentration of protons upon cellular stimulation with pH-active agents are 
monitored by read-out of the sensor fluorescence at real time. With help of this sensor 
concept it is demonstrated that the different agents used (Monensin, Chloroquine, 
Bafilomycin A1, Amiloride) possessed different kinetics and mechanisms of action in 
affecting the intracellular pH values.1. Introduction
Public media have long since envisioned miniaturized “ sub-
marines”, such as devices to be injected into human bodies 
where they could diagnose and treat diseases (e.g., the novel 
Fantastic Voyage by Issac Asimov). Though such devices are 
science fiction, in particular the idea of down scaling func-
tional objects to the nano- and microscale, smart materials 
could nevertheless go in a direction to fulfill part of these 
visions.[1] Concerning diagnosis an observed object would be 
needed which could reside non-invasively inside cells, and 
which would continuously report data about its local environ-
ment to the outside. In this work we want to demonstrate one 
prototype device towards this goal, which fulfills the basic 
requirements, though arguably with limitations. We chose 
pH as parameter to detect. Protons are heavily involved in 
biological processes on all levels and irregularities in their 
concentration are also associated with diseases.[2] As carrier © 2012 Wiley-VCH Verlag Gmb
DOI: 10.1002/smll.201101780
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small 2012, 8, No. 6, 943–948vessel polyelectrolyte capsules fabricated with layer-by-layer 
assembly[3] were used. These capsules have a semipermeable 
wall, which confines big molecules to their cavity, whereas 
small molecules like protons can diffuse through the wall.[4] 
It was recently demonstrated that pH-sensitive fluorophores 
can be loaded to the cavity of such capsules and that changes 
in pH can be observed by reading out the fluorescence origi-
nating from the capsule cavity.[5,6] These pH sensitive cap-
sules are spontaneously incorporated by living cells,[7] are 
finally localized in the lysosome,[6,8] and do not exhibit acute 
cytotoxicity.[9] The transition from the slightly alkaline cell 
medium to the acidic lysosome can be followed by reading 
out changes in fluorescence of the capsules.[5,10] For intrac-
ellular sensing clearly translocation to the cytosol would be 
desirable. However, this has not been achieved so far, though 
some ideas have been reported.[11] On the other hand, this 
obstacle can be turned into an advantage. As the capsules 
are trapped in the lysosome their location is exactly defined. 
The capsules reside over long time (weeks) in the lysosome, 
whereby they are passed to the daughter cells upon cellular 
division.[12] There is no acute cytotoxicity.[9,13] In this way the 
capsules are reporters which can stay at one defined location 
over long periods of time and which report the local analyte 
concentration (in this case of local pH) via fluorescence to 
the outside. We need to state that the present work is dealing 
with in vitro experiments involving cell cultures, and thus 
the present system certainly can’t be directly transferred to 
an in vivo “submarine” - like device, though it nevertheless 
presents a first step in this direction.943H & Co. KGaA, Weinheim wileyonlinelibrary.com
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A variety of other fluorescence-based particle reporters 
for intracellular sensing have already been described in lit-
erature.[14] However, most of these reporters allow rather 
for static instead of dynamic measurements, i.e. the change 
in fluorescence intensity of the reporter after addition of the 
agent is recorded only once. The capsule system presented 
here on the other hand facilitates continuous read-out of the 
local analyte (in this case H+) concentration. This is mainly 
attributed to the microscopic size of the capsules (in our case 
around 2.5 μm, though capsules smaller than 1 μm can easily 
be made), which allows for optical addressing of individual 
capsules. Most analyte sensitive fluorophores change their 
fluorescence intensity (at fixed wavelength) upon presence 
of the specific analyte.[15] In this way, absolute fluorescence 
intensities (at the respective wavelength) originating from 
the reporters inside the cells have to be recorded. Obviously 
the more reporters are present in one cell, the higher the flu-
orescence intensity originating from this cell will be. As there 
is no way to fix the number of reporters inside each cell to a 
desired value (as uptake by cells happens statistically) abso-
lute fluorescence intensities will vary significantly between 
different cells. This is further enhanced due to dilution of the 
reporters, as upon cell division they are (statistically) divided 
between the daughter cells. Thus, due to variation in reporter 
density in time and per cell continuous detection of analyte 
concentrations via absolute fluorescence intensity read-out 
is complicated. On the other hand, if the reporters are big 
enough to be individually resolved by optical microscopy 
this problem is circumvented. Under these circumstances 
the number of reporters in each cell is precisely known at 
each point of time (simply by counting the number of the 
analyte-sensitive particles) and as fluorescence can be traced 
back to each individual particle absolute intensity measure-
ments are possible. Photobleaching involves another com-
plication for absolute intensity detection. However, effects 
of photobleaching can be partially overcome by ratiometric 
measurements, in which the fluorescence intensity of an 
analyte-sensitive fluorophore (at one wavelength) is com-
pared to the intensity of a reference fluorophore (at another 
wavelength). Due to the big cavity of polyelectrolyte capsules 
mixtures of different fluorophores can easily be embedded, 
thus allowing for relative, ratiometric, instead of absolute flu-
orescence detection.[16] Ratiometric measurements allow for 
compensation of inhomogeneities in capsule loading with the 
fluorophores and size distribution of capsules[16].
2. Results and Discussion
In our study we used a commercial pH-sensitive fluoro-
phore from the seminaphthorhodafluors (SNARF) class of 
indicators. In order to increase its molecular weight (thus 
allowing to retain the SNARF inside the cavity of the cap-
sules) we conjugated SNARF to amino-dextran (MW = 
500 kDa).[16] CaCO3 particles filled with SNARF-dextran 
were produced via coprecipitation by CaCl2, Na2CO3, and 
SNARF-dextran.[16] These particles were used as template 
cores for subsequent deposition of poly(styrenesulfonate) 
(PSS, MW = 70 kDa) and poly(allylamine hydrochloride) 44 www.small-journal.com © 2012 Wiley-VCH V(PAH, MW = 70 kDa), leading to the final architecture of 
(PSS, PAH)5 (for more information the reader is referred 
to the supporting information, §1.1). The template cores 
were finally dissolved with ethylenediaminetetraacetic 
acid (EDTA), leading to capsules with SNARF-dextran 
in their cavity.[16] Due to the embedded SNARF the color 
of fluorescence originating from the cavity of the capsules 
depended on the surrounding pH, leading to more yellow 
fluorescence (λ = 580 nm) at acidic pH and to more red flu-
orescence (λ = 640 nm) at alkaline pH, cf. Figure 1b (see SI 
§1.2 for a detailed information about the sensitivity of the 
sensors). When these capsules were added to cultured cells 
their ability to sense local pH could be directly seen. After 
spontaneous incorporation capsules residing in the lyso-
some were more fluorescent in the yellow, whereas capsules 
remaining in the slightly alkaline cell medium were fluores-
cent more in the red, cf. Figure 1a,c.[5] As outlined above the 
internalized capsules can be regarded as intracellular long 
term reporters for lysosomal pH.
In order to demonstrate the reporting principle we were 
looking for agents which are related to lysosomal acidifica-
tion. (i) Chloroquine is a weak base that accumulates in 
and neutralizes the lysosome.[17] In its non-protonated form 
Chloroquine passes through cellular membranes. However, 
upon lowering of environmental pH Chloroquine becomes 
protonated and remains entrapped in the acidic vesicles 
(i.e. the lysosome). In this way the pH of the lysosome in 
the presence of this lysosomotropic substance increases. 
(ii) Bafilomycin A1 is a well known inhibitor of the activity of 
the vacuolar (V) proton pump ATPase (V-type ATPase)[18] 
which is present in cellular membranes (plasma membrane 
as well as intracellular membranes).[19] The vacuolar ATPases 
hydrolyse ATP, generating a proton gradient which is used 
for acidification of compartments within cells. Upon addi-
tion of Bafilomycin A1 this effect is blocked and an increase 
in the pH is observed. (iii) Amiloride is an inhibitor of the 
sodium-proton exchange (NPE). The NPE is present in the 
membrane of cells and catalyses the electroneutral exchange 
of sodium ions for protons. The different isoforms of NPE are 
involved in the regulation of the pH within the cytosol and 
within organelles of the endocytic pathway.[20] NPEs exclude 
protons from and take up sodium ions into the cells. When 
Amiloride is added to the cells, the Na+/H+ flux is reverted 
thus causing alkalinisation. (iv) Monensin is an exogenous 
Na+/H+ exchanging ionophore[21] with antiporter properties. 
Monensin disrupts intracellular Na+ and H+ gradients leading 
to alkalinisation of the media. Extracellular Na+ ions are 
exchanged by intracellular H+ ions, thus decreasing the con-
centration of H+ available.
Data resulting from one typical challenge of cells to one 
of the above mentioned agents are shown in Figure 1d. First, 
cells were incubated with pH-sensitive capsules for 24 hours 
(≈30 capsules added to the medium per cell) (see SI §2 for 
the cell culture procedures). After this period most cells had 
at least one capsule incorporated, while other capsules still 
remained in the extracellular medium. The cell culture dishes 
containing the cells were mounted in an incubator on top of a 
fluorescence microscope and phase contrast and fluorescence 
images (yellow and red channel) were recorded in intervals erlag GmbH & Co. KGaA, Weinheim small 2012, 8, No. 6, 943–948
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Figure 1. a) Cells have been incubated with pH-sensitive polyelectrolyte capsules. Some of the capsules are spontaneously incorporated by the 
cells and are transported to the lysosome. b) The ratio of red to yellow fluorescence (Ir/Iy) of the capsules depends on the surrounding pH. Capsules 
in the slightly alkaline extracellular medium are more fluorescent in the red, whereas capsules inside the acidic lysosome are more fluorescent in 
the yellow. If an agent which increases the pH in the lysosome is added changes in the capsule fluorescence from yellow to red can be detected. 
c) Overlay of microscopy images (phase contrast, yellow fluorescence, red fluorescence) before and after addition of an agent (in this case the 
agent was Chloroquine) which increases the pH inside the lysosome. The change of the fluorescence of internalized capsules from yellow to red 
reports the pH change in the lysosome, whereas control capsules in the extracellular medium retain their red fluorescence. d) The ratio of red to 
yellow fluorescence is plotted over time for capsules inside lysosomes versus control capsules located in the extracellular medium. The points of 
time when the agent was added and rinsed out are indicated. Note that the Ir/Iy ratio diminishes over time due to photobleaching over time. For 
this reason the Ir/Iy ratio of capsules inside the lysosome needs to be compared with control capsules in the extracellular medium that serve as 
reference.ranging from a few minutes to 70 hours, cf. Figure 1d. From 
each cell in each image the absolute (background-corrected) 
yellow (Iy) and red (Ir) fluorescence intensities originating 
from the respective incorporated capsules were determined 
(see SI §3 for a detailed information about image processing 
and data evaluation). The mean values of different cells 
and images of the Ir/Iy ratio were then plotted versus time, 
cf. Figure 1d. During experiments the agent whose effect 
on the lysosomal pH was to be probed was added at fixed 
time and rinsed out after a defined incubation time, cf. Figure 
1d. A series of dose-dependent viability experiments was 
performed in order to choose appropriate concentrations 
of the added agents, at which no cytotoxic effects happened 
(see SI §6).© 2012 Wiley-VCH Verlag Gmsmall 2012, 8, No. 6, 943–948In Figure 2e the red-to-yellow ratio of internalized cap-
sules is plotted versus incubation time. The Ir/Iy values close 
at the beginning indicate the acidic environment of the inter-
nalize capsules in the lysosome (cf. Figure 1d). However, the 
Ir/Iy values slightly decay over time, although no stimulus 
was applied. We ascribe this effect to photobleaching (see SI 
§5), which changes the Ir/Iy ratio and thus the Ir/Iy versus pH 
calibration curve over time.[5] As a control capsules outside 
cells which were remaining in the extracellular medium were 
concomitantly analyzed. Also for extracellular capsules ini-
tial high Ir/Iy values correctly indicated a slightly alkaline pH 
of the cell medium, and also Ir/Iy values decayed over time 
(cf. Figure 2e). This behavior was clearly not associated with 
changes in pH, as the pH of the cell medium was checked to 945www.small-journal.combH & Co. KGaA, Weinheim
P. Rivera_Gil et al.full papers
Figure 2. Cells have been incubated with pH-sensitive capsules as shown in Figure 1. Different agents were added and rinsed out: a) Bafilomycin 
A1 (600 nM), b) Monensin (20 μM), c) Chloroquine (100 μM), d) Amiloride (1 mM). In an additional control experiment e) no agent was added. 
The ratios of red to yellow fluorescence (Ir/Iy) originating from capsules inside the lysosome (drawn in green) and from control capsules in the 
extracellular medium (drawn in red) are plotted versus time. The data show the average ratios Ir/Iy as detected on typically >40 internalized 
capsules and >25 control capsules and the corresponding standard deviations as error bars.
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based pH meter (SI §5.1). In this way one has to keep in 
mind that photobleaching changes the Ir/Iy versus pH calibra-
tion curve over time. However, control experiments as shown 
in Figure 2e allow in principle for the recording of time-
dependent calibration curves, which in principle would need 
to be recorded also at different pH values, as photo-bleaching 946 www.small-journal.com © 2012 Wiley-VCH Vmight depend on the pH. However, more pragmatic, changes 
in intracellular pH can be compared to external control cap-
sules, cf. Figure 2. In this way imaging was always performed 
as well on internalized capsules as on control capsules out-
side cells. The Ir/Iy values of internalized capsules thus always 
were referred to the Ir/Iy values of extracellular capsules, 
which form the baseline for the slightly alkaline pH of the erlag GmbH & Co. KGaA, Weinheim small 2012, 8, No. 6, 943–948
pH-Sensitive Capsules as Intracellular Optical Reporters for Monitoring Lysosomal pH Changes Upon Stimulationcell medium. The possibility to use extracellular control cap-
sules is one conceptual advantage of our system, which helps 
reducing effects due to photobleaching and substituting abso-
lute by relative measurements.
Typical results of lysosomal pH responses to different 
stimulating agents are shown in Figure 2. Additionally all 
the results of the different experiments performed for all pH 
active agents are presented in the SI §4. Upon addition of 
Bafilomycin A1 the lysosomal pH raised to the extracellular 
pH. The elevated pH level remained even after rinsing out 
of Bafilomycin A1 (Figure 2a). The presence of Monensin 
also increased the lysosomal pH to the extracellular one. 
However, the lysosomal pH went back to its acidic value 
after Monensin had been rinsed out (Figure 2b). The effect 
of Monensin on the intracellular pH has been extensively 
studied; however, to our knowledge no data exist regarding 
the effect on the intra-lysosomal pH. Monensin increases 
the intracellular Na+ ion concentrations by decreasing the 
H+ concentrations. In our study Monensin also exhibited a 
clear lysosomal alkalinisation. Increase in the intracellular 
Na+ concentration normally induces an activation of the Na+/
Ca++ exchanger to restore the normally low intracellular Na+ 
values. Since the effect of Monensin is Na+ dependent and 
the intracellular Na+ concentration is prone to be maintained 
low, as soon as Monensin is rinsed the normal pH values can 
be restored. The response to Chloroquine was phenomeno-
logically similar to that of Bafilomycin A1 (Figure 2c). In the 
case of stimulation with Amiloride no change in lysosomal 
pH was observed (Figure 2d). In changing the lysosomal pH, 
the different agents showed a different mechanism of action. 
Whereas Chloroquine as well as Monensin induced a rapid 
increase in the pH the removal of the ionophore led to a 
rapid recovery of the regular lysosomal pH. On the other 
hand, removal of the weak base from the cell medium had 
no effect on the acidification of the lysosome. The intra-lys-
osomal pH values were still comparable to the extracellular 
control capsules after 50 h. This effect was also visible in case 
of Bafilomycin A1. Inhibition of the V-ATPase with Bafilo-
mycin A1, induced an irreversible change of the lysosomal 
pH (at least during our time lapse, i.e., 50–70 h). These results 
indicate that both the H+ availability as well as the V-ATPase 
are crucial mechanisms of long term regulation of the intra-
lysosomal pH. No neutralization in the pH of the lysosome 
was observed by the presence of Amiloride, an inhibitor of 
NPE. Therefore, if the antiporter is regulating the pH within 
the organelles involved in the endocytic processes then the 
Na+/H+ pump involved must be Amiloride-insensitive. It is 
well known that there are different NPE isoforms with dif-
ferent sensitivity to Amiloride.[22] However, their intracellular 
or tissue distribution is not totally clarified yet. Furthermore, 
it could also be possible that the binding-site for Amiloride 
was not available due to our experimental conditions. This 
means, Amiloride was added once the capsule sensors have 
already been internalized whereas the NPE responsible for 
acidification of the intracellular vesicles is believed to be 
present in the extracellular site of the NPE.[23]
The data presented in Figure 2 demonstrate that in fact 
our capsule system can be used for real-time monitoring of 
the lysosomal pH over days. During this period the method © 2012 Wiley-VCH Verlag Gmbsmall 2012, 8, No. 6, 943–948 [1] J. Peteiro-Cartelle, M. Rodríguez-Pedreira, F. Zhang, P. Rivera_Gil, 
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is virtually non-invasive. The capsules act as intracellular 
reporters at defined location, the lysosome, and time-
dependent changes in lysosomal pH upon stimulation can be 
observed. A key feature of our system is the relatively large 
size of the capsules. This may impose limitations for sensing 
in other compartment and inside the cytosol, but for sensing 
in the lysosome reporters with the size of a few μm do not 
challenge cells. Size could be decreased to a few 100 nm, 
though it needs to be bigger that the optical resolution limit, 
as our technique is based on identifying individual capsules. 
By putting a barcode on the surface of the capsules reporters 
for different ions and small molecules could be created and 
ultimately allow for multiplexed imaging.[5,24] Due to the uni-
versal construction, in principle cavities could also be loaded 
with analyte-sensitive molecules which are not detected 
with fluorescence but for example with SERS.[25] Though 
continuous multiplexed intracellular reporting of analyte 
concentrations even in vitro still is far from route we think 
that the system here describes a significant step towards this 
direction.
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Gene transfer technologies are an important biological research tool
to investigate gene expression and function. Concerning in vitro applica-
tion, this technology allows, for example, the identification of genes
involved in cellular processes. By modification of genes, the behavior
of cells can be controlled by modifying the particular composition of
proteins they express. Also in vivo application is envisaged. In the future,
gene therapy might develop into a molecular medicine that provides
new treatment possibilities for several pathophysiological states. In
many cancers and inherited diseases, genes are altered or damaged, so
that the encoded proteins are no longer functional. Defect genes mightsical and Inorganic Chemistry,
y Center of Catalonia (CTQC),
Philipps-Universität Marburg,then be substituted by healthy ones (gene therapy). It also occurs that
genes are regulated incorrectly, such that proteins involved in the
disease process are over-expressed. Thus, expression of the genes
could be blocked (antisense therapy). The aim of such inhibitory anti-
sense therapy is to use synthetic oligonucleotides (ONTs), i.e. short frag-
ments of nucleic acids, such as double-stranded oligodeoxynucleotides
(dsODNs) and small hairpin RNA (shRNA) or small interfering RNA
(siRNA) to block the expression of proteins involved in the disease.
This can occur at different levels of the gene expression process,
i.e. during transcription or translation. The development of antisense
technologies as therapeutic agents has led to numerous clinical trials.
However, a limitation of the silencing approach is toxicity upon
transfection of cells and its suspected effect on the expression of other
genes or proteins (off-target effects). Therefore, safe transfection
procedures with controlled release kinetics are highly desirable.
Formany in vivo applications, a carrier is strongly required to deliver
and protect the genetic material. In general, the ideal delivery method
for therapeutic genetic materials needs to fulfill three major criteria. It
should (i) impart protection in intercellular matrices (i.e. biological
fluids and the intracellular space) against nucleases, (ii) perform
133C. Ganas et al. / Journal of Controlled Release 196 (2014) 132–138transport across biological barriers, e.g. the plasma membrane, in order
to reach its action site, and (iii) exclude toxic or off-target effects. Viral
platforms are probably the most efficient method of getting foreign
genetic material into large numbers of cells with high possibility of
long-term inhibition. They are, however, associated to high host immu-
nogenicity and mutagenesis [1]. This has raised serious safety concerns.
Thus, although the great potential of gene or antisense therapy for some
diseases is already demonstrated, viral vectors are still not authorized
for gene or antisense therapy in Europe. Therefore, there is a strong
necessity to develop alternative non-viral carriers with comparable
transfection efficiencies and low host immunogenicity. Frequently
used non-viral carriers include lipoplexes and polyplexes. Furthermore,
there are commercial transfection agents based on different cationic
lipids, which allow transfecting cells with plasmid DNA, siRNA, miRNA,
etc. [2]. Typically used cationic polymers involve polyethylenimine
(PEI), chitosan (CS), poly(L-lysine) (PLL), and poly(allylamine) (PAA)
[3,4]. Carriers usually enter cells via endocytic pathways, and genetic
material (DNA/RNA) is then translocated from endocytic vesicles to
the cytosol. The exact mechanism of translocation to the cytosol is still
under debate, though buffering of vesicular pH due to the cationic
polymers (proton sponge effect) which cause influx and accumulation
of Cl− ions, and thus swelling and lysis of the vesicles, is likely to play
a role [5,6]. While needed for translocation to the cytosol, cationic poly-
mers are in general toxic, in particular those of high molecular weight
[7,8]. Thus, the amount of cationic polymers in the polyplexes has to
be chosen carefully in order to maximize transfection efficiency while
minimizing cytotoxicity.
Apart from lipoplexes and polyplexes, colloids, such as nanoparticles
[9,10], lipospheres [11,12], and polymeric capsules [13,14] are currently
being discussed as non-viral carriers for the delivery of genetic material.
Polymeric capsules can be synthesized under mild conditions by a
multilayer assembly of oppositely charged polyelectrolytes. These cap-
sules possess tunable physicochemical properties that strongly depend
on thematerial used for their synthesis. They can also be functionalized
at two distinct positions, their wall and their cavity, with additional
building blocks, such as inorganic nanoparticles, antibodies, drugs,
analyte-sensitive fluorophores, etc. to create a multifunctional delivery
system [15–17], and they are steadily internalized by mammalian cells
via phagocytosis and lipid-raft-mediated macropinocytosis [18,19].
Polymeric capsules have already been used for several sensing and
drug delivery applications [20–22] including DNA delivery [23,24].
However, there are only few reports on siRNA delivery [25,26]. The
biggest advantage of these capsules compared to other non-viral
carriers is their superior colloidal stability over time, loading capacity,
and good biocompatibility [27]. Nevertheless, as for other carriers, off-
target effects dependent on the capsules themselves cannot be excluded
[25]. In addition, one general obstacle is that after uptake by cells
capsules are located in the lysosome [19], and thus the delivered cargo
is not readily available for cytosolic targets. Translocation of capsule-
delivered cargo from the lysosomal compartments to the cytosol can
either be achieved by biodegradable capsules [28] or by local heating
which transiently opens the capsules and the surrounding lysosomal
membranes [22,24,29]. In case of biodegradable capsules, translocation
efficiency is not very high and in the case of local heating, relatively
complicated set-ups are required, which in fact also reduce the percent-
age of successful translocation events.
In this study we thus attempted to combine the advantages of
polyplexes and polyelectrolyte capsules for siRNA delivery. For this
purpose, polyplexes formed by siRNA and PEIwere encapsulatedwithin
multilayers of biodegradable polymers. By encapsulating PEI with the
siRNA (in the form of polyplexes) several advantageous properties can
be obtained: (i) reduction of the toxicity of PEI during transfection,
as it is encapsulated until the walls of the capsules are degraded;
(ii) facilitation of the lysosomal escape of the siRNA due to the proton
sponge effect of PEI; (iii) inhibition of siRNA leakage from the capsule
cavity as siRNA itself is a small molecule and could escape throughthe permeable walls, in contrast to the bigger PEI/siRNA complexes;
(iv) increased stability of the polyplexes. By encapsulating the siRNA
within the cavity of capsules it is protected frommetabolizing enzymes,
thus increasing its bioavailability and reducing the quantity needed
to be administered. By using biodegradable polyelectrolytes for
the capsules, a release of the siRNA is obtained inside the cells upon
digestion of the capsule walls [28]. Taken together, the main idea is
that the capsules add a controlled shield to the siRNA and the rather
cytotoxic PEI. Outside the cells the PEI is encapsulated and thus
assumed to be less toxic. Inside the cells, the PEI becomes effective in
mediating endosomal escape once the capsule shell has been digested,
thus favoring translocation of the siRNA to the cytosol. This concept
is investigated in the present study. Within this work we show a
systematic investigation involving quantification of siRNA loading of
biodegradable capsules, the efficiency of in vitro intracellular delivery
and release, and the cellular effect of siRNA. Transfection efficiency of
the encapsulated polyplexes is compared to that of standard polyplexes.
2. Materials and methods
2.1. Fluorescent labeling and concentration determination of
polyethylenimine (PEI)
The red fluorophore DY-651 (Dyomics, λexcitation = 656 nm,
λemission=678 nm) or the green fluorophorefluorescein isothiocyanate
(FITC, Sigma-Aldrich, λexcitation = 492 nm, λemission = 518 nm) were
linked as fluorescent labels to PEI (branched, 25 kDa, Sigma-Aldrich).
All details can be found in the supporting information (SI). The PEI:dye
ratio of the purified labeled PEI was determined via UV–Vis absorption
spectroscopy. For Dy-651 we found a molar labeling ratio of PEI:Dy-
651 = 1:10 and for FITC a ratio of PEI:FITC = 1:25. This ratio was
found to be an optimal compromise between complexation of DNA/
siRNA by PEI, fluorescence signal for tracking, and for the quantification
of PEI. PEI quantification was achieved by using the ability of (primary)
amino functionalities to form tetra-amino copper(II) complexes upon
mixture with an aqueous CuSO4 solution [30,31] (cf. SI).
2.2. Synthesis of PEI/siRNA and PEI/DNA polyplexes
siRNA (sequence: 5′- GAA CUU CAG GGU CAG CUU GCC G -3′)
fluorescently labeled with Alexa Fluor-546 (AF-546, custom special
order from Qiagen, λexcitation = 554 nm, λemission = 570 nm) against
the expression of GFP in GFP-expressing HeLa cells was complexed
with PEI to form polyplexes. 40 μg/mL siRNA and 25 kDa PEI at a fixed
nitrogen-to-phosphor-ratio (N/P-ratio) of 10 were mixed in an isotonic
NaCl solution. After gently mixing, the solution was stored for 10–
15 min at room temperature, before using the freshly prepared
polyplexes in cell experiments [32]. As amodel system for initial uptake
studies, single-stranded DNA labeled with Cy5with a random sequence
of comparable length to siRNA was used to form PEI/DNA polyplexes.
For all details we refer to the SI.
2.3. Synthesis of biodegradable capsules filled with polyplexes
Biodegradable capsules were fabricated by Layer-by-Layer (LbL)
adsorption of the biodegradable polyelectrolytes dextran sulfate
(DexS) and poly-L-arginine (pArg) onto spherical templates (Fig. 1) as
published before [33]. Hereby, the CaCO3 templates with PEI were
precipitated from solutions of calcium chloride (CaCl2) and sodium
carbonate (Na2CO3) in the presence of PEI under vigorous stirring,
leading to spherical CaCO3 particles with an average diameter of
3.5 μm measured by an optical microscopy. Afterwards, siRNA (or
ssDNA (30 bp)) was adsorbed on the PEI-filled CaCO3 cores. Then, the
CaCO3 particles were coated by multiple LbL assembly of DexS and
pArg in 0.5 M NaCl solutions with extensive washing in between the
formation of the different layers. In this way, five polyelectrolyte
Fig. 1. Schematic representation of the synthesis of biodegradable capsules filledwith PEI-
DY-651 and siRNA-AF-546. The insets correspond to confocal laser scanning microscope
images of the CaCO3 loaded templates and the prepared biodegradable capsules compris-
ing five double layers (DexS/pArg)5with encapsulatedDY-651-labeled PEI andAF-546-la-
beled siRNA. The images correspond to the fluorescent signals of PEI (violet) and siRNA
(red), the transmission channel, and the overlay of all channels. The scale bars represents
5 μm. The schematic representation is not drawn to scale.
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Finally, the CaCO3 template cores were removed by complexation of
Ca2+ with ethylenediaminetetraacetic acid (EDTA) solution (0.2 M,
pH 7), leaving the PEI and the siRNA inside the hollow polyelectrolyte
walls. Afterwards, the PEI- and siRNA- (or DNA-) filled capsules were
washed three times with Milli-Q water by repetitive centrifugation
and sedimentation at 1100 rpm for 8 min. The resulting encapsulated
polyplexes were stored as suspension in Milli-Q water at 4 °C. We
assume an overall size of 3.5 μm as the polyelectrolyte layers do not
significantly increase the size of the capsules [33]. The number of
capsules per volume was determined by counting the capsules in a
defined volume with a hemocytometer chamber under a microscope.
Typically obtained amounts of capsules fromone synthesiswere around
108 capsules. For more details we refer to the SI. As control non-
degradable capsules made of poly(sodium 4-styrenesulfonate) (PSS)
and poly(allylamine hydrochloride) (PAH) were synthesized.
2.4. Determination of the amount of encapsulated PEI/siRNA and PEI/DNA
per polymer capsule
UV–Vis absorption spectroscopy could not be used to quantify the
amount of encapsulated PEI/siRNA and PEI/DNA due to the intrinsic
scattering and absorption of the polymer capsules, which turned out
to bemuch larger than the absorption originating from thefluorescently
labeled PEI and fluorescently labeled siRNA. Therefore, the fluorescence
emission of the labels of PEI and siRNA in the capsules was measured
instead. Quantification was done based on previously recorded
calibration curves, relating the fluorescence of DY-651 or FITC to
the amount of PEI, and the fluorescence of AF-546 to the amount of
siRNA (and the fluorescence of Cy5 to the amount of DNA). In order
to make the obtained calibration universal, i.e. independent of the
excitation intensity, the settings of the fluorescence spectrometer, etc.,
all spectra were normalized to the Raman scattering peak of water, to
so-called “raman units” [34]. The amount of capsules in solution was
determined as described above by counting. More details are given in
the SI.
2.5. Cell culture
GFP-expressing HeLa cells (HeLa-GFP, human cervical epithelial
adenocarcinoma cells stably expressing the green fluorescent protein
(GFP) [12]) were cultured at 37 °C in 5% CO2 atmosphere. Cells were
supplied with Eagle's Minimum Essential Medium (EMEM), supple-
mentedwith 10% fetal bovine serum (FBS) and 1%penicillin/streptomy-
cin as additives. For transfection experimentswith siRNAa total amountof 2 · 104 HeLa-GFP cells per cm2 was seeded in 8-well μ-slide culture
dishes purchased from Ibidi. Each well had an area of 1 cm2 and was
filled with 300 μL of medium. After seeding, the cells were stored in
the incubator until adhesion (around 24 h for the used HeLa cells). For
transfection with encapsulated polyplexes, the cells were incubated
with 20 capsules per seeded cell. For transfection with plain PEI/siRNA
polyplexes, the culture medium was first exchanged (after cell adhe-
sion) for medium without FBS, followed by a subsequent exchange
with complete growth medium again after 22 h. This step was done
according to standard transfection protocols. In a control experiment
(cf.SI) it is demonstrated that the presence or absence of serum had no
effect on the release and effect of PEI/siRNA in the case of encapsulated
PEI/siRNA polyplexes. Thus, transfection with encapsulated polyplexes
and plain polyplexes could be directly compared according to the
amount of PEI/siRNA added to the cells. The used concentrations are
enlisted in Table 1. For uptake studies of PEI/DNA polyplexes (plain and
encapsulated), non-transfected MDA-MB-231 cells were used. We refer
to the SI for all details. Cyototoxicity assays were performed with HeLa-
GFP cells using a standard resazurin assay (details can be found in the SI).
2.6. Quantification of the intracellular siRNA delivery and GFP silencing
After incubation with polyplexes or encapsulated polyplexes, the
cells were imaged either with a confocal laser scanning microscope
(CLSM; LSM 510 Meta, Zeiss) or with a fluorescence widefield micro-
scope (Axiovert 200 M, Zeiss). Images were taken at different points
in time from 0 to 50–70 h and the integrated fluorescence intensity
was measured, i.e. the area of the cells times the mean fluorescence
intensity. In delivery studies, the amount of released PEI/DNA from
polyplexes and encapsulated polyplexes was compared in terms of
DNA fluorescence (Cy5 label of DNA). In GFP-silencing studies, the re-
duction in GFP fluorescence intensity upon delivery of PEI/siRNA by
polyplexes or encapsulated polyplexes was compared in terms of GFP
fluorescence. Details can be found in the SI.
3. Results and discussion
3.1. Determination of polyplex concentrations
PEI/siRNA and PEI/DNA polyplexes were efficiently synthesized
according to previously published protocols [35]. The polyplexes were
used as prepared or were encapsulated within polyelectrolyte
multilayer capsules by use of the LbL technique. Some loss of PEI
and siRNA (or DNA) had to be accounted for during the LbL assembly
procedure and in particular upon dissolution of the template core.
Furthermore, depending on the polymer used for the formation of the
capsule walls, the porosity changes [36] and thus, additional loss of
PEI and siRNA (or DNA) is likely to occur. Leaching of cargo is a general
problem of LbL encapsulation, as has been reported also for other cargo
[37]. While for many applications the amount of encapsulated cargo is
not crucial, here the amount of encapsulated PEI and siRNA (or DNA)
needs to be known exactly, as otherwise delivery of plain versus
encapsulated PEI/DNA polyplexes, and therefore gene silencing by
plain versus encapsulated PEI/siRNA polyplexes, cannot be compared.
In other words, because in transfection experiments the amount of
deliveredmaterial is crucial for estimation of the transfection efficiency,
the concentrations of encapsulated material must be determined
precisely [30]. Often, the amount of encapsulated cargo is determined
by subtracting the amount of cargo found in the supernatant after the
encapsulation from the amount of cargo, which had been added initially
[37]. However, this method can be quite inaccurate, in particular
because pooled supernatants from all purification steps need to be
considered. An alternative method frequently used in literature is con-
centration determination via UV–Vis absorption spectroscopy. As PEI
does not have a distinct intrinsic absorption peak, a characteristic peak
can be generated by the formation of PEI–copper-complexes mediated
Table 1
Amounts and concentrations of siRNA and PEI. Mw is the molecular weight, and mcaps
and mdish the mass of siRNA or PEI per capsule and per culture dish (well), respectively.
Hereby, 20 capsules were added per cell and 2 · 104 cells had been seeded per dish:
mdish = mcaps × 40 × 2 × 104. Note that rounded values are given. Vdish is the volume
of the cell culture medium in each culture dish. Thus, the concentration of siRNA and PEI
in solution is cdish ¼ mdishMW Vdish .
Mw (g/mol) mcaps [pg]
(per capsule)
mdish [ng]
(per culture dish)
Vdish [μL] cdish [nM]
siRNA 8187 0.016 6.4 300 2.60
PEI 25,000 6.250 25 300 3.33
Fig. 2.MDA-MB-231 cells were incubated with free DNA, DNA/PEI polyplexes, biodegrad-
able (DexS/pArg)5 capsules with embedded PEI/DNA, and non-degradable (PSS/PAH)5
capsuleswith embedded PEI/DNA at equal concentrations of geneticmaterial. After differ-
ent incubation times t, as indicated in the top panel, cells were imaged. The transmission
channel shows the cells, and the green and violet (false color) channels show the emission
of the FITC labels and Cy5 labels of PEI and DNA, respectively. Insets with dashed outlines
show the release profile of DNA or PEI mediated by the capsules. Images from serum-free
experiments are shown. The scale bar corresponds to 20 μm.
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limitations; upon encapsulation of polyplexes, scattering and absorp-
tion of the capsule walls dominate, and thus make the identification of
the PEI–copper-complex absorption peaks complicated. Furthermore,
due to the use of pArg, the walls of the capsules contain amino groups
as well, and thus also provide a signal at the PEI–copper-complex
absorption peak. PEI/siRNA polyplexes are often quantified in terms of
(N/P)-ratios, where the nitrogen and phosphor concentration corre-
sponds to the amount of PEI (which contains amino groups) and the
amount of siRNA (which contains phosphor in the phosphate group of
its backbone), respectively. However, as also the walls of the capsules
contain nitrogen due to the amino groups of pArg, this method is not
well suited for determining the amount of encapsulated polyplexes.
To this end, we used fluorescently labeled PEI (FITC or DY-651) and
fluorescently labeled siRNA (AF-546) or DNA (Cy5). The amount of
fluorophore per PEIwasdetermined viaUV–Vis absorption spectroscopy
with PEI-copper-complexes (cf. the SI). siRNA and DNAwere purchased
with fluorescent label and we assume 100% labeling efficiency, i.e. one
fluorophore per siRNA and DNAmolecule, respectively. As the autofluo-
rescence of the capsule walls in the spectral range from green to red is
much lower than that of the fluorescent labels FITC, AF-546, DY-651,
and Cy5 fluorescence of the capsule walls can be neglected. Therefore,
fluorescence measurements allow direct concentration determination
both for PEI and siRNA (or DNA). As concentration determination is
paramount but error-prone, as described above, all experimental
details, such as the used calibration curves are provided in the SI. At
any rate, absolute concentrations always have to be considered with
care, which often is not done critically enough. Our data yielded an
average mass of 1.6 · 10−8 μg siRNA and 625 · 10−8 μg of PEI per
capsule (cf. Table 1).
3.2. Quantification of PEI/DNA delivery to cells in free and encapsulated
form
Fluorescent labels of the cargo (PEI, DNA or siRNA) allowed us not
only to quantify the amount of PEI and DNA (or siRNA) in each pharma-
ceutical form but also to quantify its release within the cells. First, the
kinetics of cellular uptake and release were evaluated. A comparative
study of freeDNA, PEI/DNApolyplexes, PEI/DNApolyplexes encapsulated
in biodegradable (DexS/pArg)5 capsules, and PEI/DNA polyplexes
encapsulated in non-degradable (PSS/PAH)5 capsules was done. It is
worth noting that the uptake of these capsules by a huge variety of
eukaryotic cells has been extensively demonstrated [19,20,26]. DNA
was used instead of siRNA for these experiments as only delivery and
not transfection was investigated here and DNA is cheaper and easier
to handle than siRNA. For this reason, no transfected cells were required
for these experiments and thus a standard cell line used in our laboratory,
MDA-MB-231, was used. The experiments were done both with
serum-free (following standard transfection protocols) and serum-
supplemented medium. Images were taken after different incubation
times (Fig. 2). The amount of PEI and DNA released to the cytosol was
then determined. Cargo remaining trapped in the capsules was not
considered for this evaluation (details can be found in the SI). The inte-
grated fluorescence intensities I(t) after different times of incubation,which are assumed to be proportional to the amount of PEI or DNA
released to the cytosol, are presented in Fig. 3.
As can be seen from Figs. 2 and 3, no DNA could be detected inside
the cytosol in case of administration of free DNA or PEI/DNA polyplexes
at the used concentrations. Capsules, in contrast, were clearly incorpo-
rated by cells. Both for the biodegradable and the non-degradable
capsules some release of PEI to the cytosol could be observed. The re-
lease of DNA from the capsules to the cytosol was only significant for
the biodegradable capsules, cf. Figs. 2 and 3, which is in line with previ-
ous observations for the delivery of other types of cargo [28]. In this
cited work the use of biodegradable capsules to release cargo to the cy-
tosol, while maintaining cell viability and cargo integrity, and the kinet-
ics of release were shown. The incubation was first performed in
absence of serum following standard transfection protocols. This,
however, is a limitation as the cells suffer from stress when incubated
under serum-free conditions. In order to see if our carrier could help
overcoming this limitation, we also performed the experiments under
normal physiological conditions, i.e. in the presence of serum (10%
FBS). As seen in Fig. 3, the release from biodegradable capsules is even
higher with serum compared to serum-free conditions. Thus, our data
indicate that by using biodegradable capsules as carriers for the
polyplexes an effective DNA release can be achieved even in the
presence of serum and the carrier protects the genetic material against
possible degradation. In particular, more DNA was released to the
cytosol from encapsulated PEI/DNA polyplexes (biodegradable poly-
electrolytes) compared to free PEI/DNA polyplexes. Furthermore, the
release occurs relatively fast, within less than one day of incubation.
3.3. Quantification of gene silencing upon delivery of PEI/siRNA in free and
encapsulated form
While encapsulation of polyplexes in biodegradable polyelectrolyte
shells improved the delivery efficiency of oligonucleotides to the cytosol
(cf. Fig. 3), these data do not give any information about the biological
activity of the delivered oligonucleotides. We thus used, in a next step,
siRNA instead of DNA and stably GFP-transfected HeLa cells. Biological
activity of the chosen siRNA sequence was demonstrated by GFP
Fig. 3. From the microscopy data, as presented in Fig. 2, for each cell in each recorded
image the integrated fluorescence intensity IDNA was determined. The integrated fluores-
cence intensity corresponds to the area of the cell (determined from the transmission
channel) times the mean fluorescence intensity from the Cy5 (DNA) channel in that
area. Note, that fluorescence originating from the capsules was not considered, but only
fluorescence located in the cytosol. The mean fluorescence intensities, as observed for
the different means of delivery, are displayed for incubation in a) serum-free and in
b) serum-containing media together with the corresponding standard deviations. For
each data point at least 30 cells were analyzed.
Fig. 4.GFP expressing HeLa cells were incubatedwith free (left column) and encapsulated
((DexS/pArg)5, right column) PEI/siRNA polyplexes. Live images of the same cells were
taken over time t. Besides the transmission channel showing the cells, also GFP (green),
AF-546 labeled siRNA (red), and DY-651 labeled PEI (violet) are displayed in false colors.
The straight arrow indicates a homogenous cytosolic distribution of PEI, whereas the
dashed arrow shows a punctuate distribution. Cells markedwith asterisks (*) have clearly
lost their GFPfluorescence. The insets (#) correspond to images of thepolyplexes. For clar-
ity these insets were enhanced in contrast in order to show the presence of the siRNA in-
side the cells. The scale bars correspond to 10 μm.
Fig. 5.GFP-expressingHeLa cellswere incubatedwith free (black squares) or encapsulated
(within biodegradable capsules; blue triangles) PEI/siRNA polyplexes. The total amount of
siRNA and PEI was 6.4 · 10−3 μg and 25 · 10−3 μg for capsules and 10 · 10−3 μg and
12.5 · 10−3 μg for polyplexes, respectively. Images were taken at different points in time
t (cf. Fig. 4) and the mean integrated fluorescence density of GFP, i.e. the area of each
cell times its mean fluorescence intensity, is displayed. Error bars represent standard
deviations of the mean.
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recorded (false colors: green: GFP, red: AF-546 label of siRNA, violet:
DY-651 label of PEI), cf. Fig. 4. Incubation of cells was done with
6.4 · 10−3 μg of siRNA and 25 · 10−3 μg of PEI for capsules and
10 · 10−3 μg of siRNA and 12.5 · 10−3 μg of PEI for polyplexes. In
Fig. 4 no reduction of GFP fluorescence can be observed upon addition
of PEI/siRNA polyplexes, though an effect was observed at higher
polyplex concentrations (data can be found in the SI). In contrast, a
reduction of GFP fluorescence could be observed upon incubation with
encapsulated PEI/siRNA (biodegradable polymers) (see cells labeled
with an asterisk in Fig. 4).
Quantitative evaluation turned out to be complicated due to the fact
that cells are “individuals”. Though stably transfected, the GFP fluores-
cence intensity was in general significantly different for each cell within
one cell culture (more examples in the SI). However, the fluorescence
intensity did not fluctuate within the same cell over time, though
naturally after cell division the fluorescence was slightly altered in a
cell-dependent manner. In order to obtain a quantitative analysis, the
effect of siRNA on the GFP expression was quantified on the level of
individual cells and not as average over the cell culture. This way of
analysis decreased the statistics, as fewer cells could be evaluated, but
it increased the reliability of the results, as they were no longer suscep-
tible to intrinsic fluctuations. Quantitative analysis in the form of inte-
grated fluorescence intensities IGFP of expressed GFP demonstrated
that polyplexes encapsulatedwithin biodegradable polymers effectivelyknocked down the GFP expression in a time-dependent manner,
cf. Fig. 5. The inhibition of GFP expression hereby showed a kind of
sigmoidal time dependence (cf. Fig. 5) in contrast to other carriers that
show amore linear effect [12] or polyplexes containing a higher amount
of siRNA (cf. SI). These results indicate that inhibition by siRNA encapsu-
lated within polyelectrolyte capsules is dependent on the carrier, as it
clearly influences the mechanism of release of the siRNA cargo and its
availability to the cell.
Within the first day, IGFP remained unaffected, but after one day of
incubation the GFP expression was significantly blocked and IGFP
decreased rapidly, reaching a level of minimum GFP expression. These
results indicate that the released siRNA from encapsulated polyplexes
could perform its action, i.e. interaction with the mRNA and inhibition
of translation, already after 30 h,which is remarkably fast in comparison
to the effect caused by plain polyplexes or other commonmethods that
require around 48 h to make the siRNA available to perform its action
[12,38] (cf. SI). This is in line with the work of others [25]. The total
amount of siRNAdelivered to the cells with biodegradable capsules nec-
essary to cause down regulation of protein expression is clearly below
the total required amount of siRNA delivered to the cells when using
137C. Ganas et al. / Journal of Controlled Release 196 (2014) 132–138commercial transfection agents. In our study we needed 2.6 nM siRNA
(cf. Table 1), whereas the amount required for successful transfection
with one of these agents lies around 100 nM [39].
3.4. Quantification of induced toxicity of free versus encapsulated PEI
Due to the concentration-dependent toxicity reported for PEI in
polyplexes [40], the amount of PEI has to be controlled carefully to
avoid harmful effects. The idea therefore was to protect the cells from
the toxic effects of PEI by encapsulation. To test this hypothesis, a
resazurin-based viability assay was used. In Fig. 6 concentration-
dependent cytotoxic effects of free and encapsulated PEI are compared.
For free PEI the LD50 value was (0.80 ± 0.02) μg. When PEI was
encapsulated in biodegradable capsules, the viability of the cells was
far less affected than by non-encapsulated PEI. 20 capsules per cell,
which was the amount added for experiments (cf. Fig. 4) corresponds
to a value of 0.188 · 10−3 μg PEI, which is in the non-toxic range. Note
that this number is different from the one in Table 1 as for cytotoxicity
studies 15,000 instead of 20,000 cells were seeded in each well. Thus,
by encapsulating the PEI/siRNA polyplexes within the cavity of poly-
electrolyte capsules, the viability of the cells was preserved while
allowing an efficient delivery and cellular action. This was probably
due to the fact that upon encapsulation much less PEI and siRNA had
to be used to achieve transfection.
4. Conclusions
We demonstrate that PEI/siRNA polyplexes can be encapsulated
within biodegradable polymer capsules and that due to encapsulation
release inside cells and in vitro transfection efficiencies of siRNA are
higher compared to non-encapsulated polyplexes. The stability of the
PEI/siRNA polyplexes against undesired degradation and the viability
of the cells are preserved by adding a physical barrier in form of the
capsules in between the cells and the cargo. Since this polymeric barrier
is degraded only in the lysosomes of the cells, an effective cargo release
is ensured. Delivery works both for serum-containing and serum-free
cell culture conditions. Cytosolic release of cargomediated by these cap-
sules without an external trigger could be proven. The biodegradable
capsule shell and the PEI made the siRNA to be released to the cystosol.
Indeed, the efficacy of siRNA was increased (gene silencing was
observed already after 20 h) while PEI-derived toxicity was reduced.
Thus, we demonstrated that biodegradable capsules with integrated
PEI constitute an alternative to viral carriers for efficient delivery and
in vitro transfection of genetic material.Fig. 6. Reduction of cell viability caused by encapsulated and non-encapsulated PEI. The
normalized cell viability in terms of resazurin fluorescence intensity I versus the amount
of added PEI mPEI is displayed. The average of six (PEI capsules) and three (PEI solution)
independent measurements is displayed. Higher amounts of encapsulated PEI could not
bemeasured due to the impossibility to obtain amore saturated capsule solution. Further-
more, there is a threshold atwhich the capsules themselves can induce toxicity if added in
too high quantities to the cells [27]. Error bars represent standard deviations of the mean.Acknowledgments
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Abstract: 
Lysosomal storage disorders are diseases where proteins in the lysosomes of certain cells are 
not sufficiently expressed due to a gene defect. The defect leads to accumulation of toxic 
metabolites in the cells. Here, we take advantage of the natural endocytotic uptake route of 
polymer capsules, which are finally localized inside the lysosomes. For diagnostics, we 
monitored the lysosomal pH with polymer capsules in oligodendritic cells upon accumulation 
of the metabolite psychosine. We found different results for cells expressing the enzyme and 
knockout cells deficient of the enzyme. For therapy, we utilized biodegradable capsules to 
deliver the missing enzyme to the lysosomes of the cells and found that the adverse effects of 
psychosine could be prevented in enzyme-deficient cells. In a cell model for Fabry disease, 
we used biodegradable capsules to deliver the deficient enzyme to the cells and determined 
the intracellular efficacy based on the degradation of a fluorescently labeled substrate of the 
enzyme.  
Introduction: 
Particulate delivery vehicles such as colloidal nano- and microparticles offer the possibility to 
combine different functionalities within one vehicle 
[1-4]
. Concerning theragnostics, this 
allows for example combining delivery with sensing in one single carrier. Sensing is meant as 
in situ analysis of the local effect of the delivered molecules, and thus immediate feedback of 
the caused action upon delivery would be obtained. However, one general problem with 
particle-based delivery vehicles is their biodistribution. In case of intravenous injection, like 
most pharmaceutical agents, a large fraction of the particles end up in the liver 
[5]
 and show 
the general problems of specific targeting. Nevertheless, a significant difference exists 
concerning intracellular distribution. While some classical pharmaceutical agents can diffuse 
through the plasma membrane of cells, particles are in general internalized via endocytosis, 
and subsequently are located in endosomal / lysosomal compartments rather than the cytosol 
[6]
. In case delivery to the cytosol is required, methods for translocation of particles from 
endosomal / lysosomal compartments to the cytosol exist 
[7, 8]
. Unfortunately, in most cases 
such translocation suffers either from relatively low yields, or involves cytotoxic effects. In 
contrast, one may think of applications, in which delivery of particles to the endosome or the 
lysosome would be beneficial. 
Lysosomal storage disorders are caused by malfunctions of lysosomal proteins, typically 
enzymes, which result in lysosomal accumulation of undegraded metabolites 
[9, 10]
. This class 
of diseases involves, for example, sphingolipidoses 
[9]
, in which missing enzymes cause 
D
ra
t
increased levels of sphingolipids, such as psychosine or globotriaosylceramide, as those are 
not sufficiently catabolized 
[11]
. Sphingolipids are expressed in the membrane of cells for the 
purpose of stabilization, protection, and recognition sites for specific chemicals, as well as for 
signaling purposes. In order to regulate their concentration, catabolizing enzymes exist. They 
typically remove sugar molecules from the lipid part upon hydrolyzation. 
Galactocerebrosidase (galactosylceramidase, GALC), for example, is an enzyme which 
cleaves galactose from psychosine (galactosylphingosine), leading to sphingosine (2-amino-4-
octadecene-1,3-diol), cf. Figure 1a. Insufficient levels of GALC are associated with Krabbe 
disease. As another example, α-galactosidase A (GLA) cleaves galactose from 
globotriaosylceramide (ceramide trihexoside, CD77, Gb3) leading to lactosylceramide, cf. 
Figure 1b. Lack of GLA has been associated with Fabry disease. The enzymes (e.g. GALC, 
GLA) hereby are located in the cellular lysosome, as otherwise they could digest the 
important sphingolipids in an uncontrolled way. As pointed out, if these enzymes are not 
sufficiently present in the lysosome, or in case they are defective, which is often associated 
with genetic mutation, the concentration of certain sphingolipids rises to harmful levels, 
ultimately leading to sphingolipidoses, e.g. Krabbe or Fabry disease. One possibility to treat 
such diseases is enzyme replacement therapy 
[12]
, which involves the delivery of the defective 
enzymes to the lysosome 
[13]
. GLA, for example, can be brought to the lysosome directly via 
endocytotic uptake 
[14, 15]
, or by gene therapy via a viral vector encoding for GLA 
[16]
. 
 
 
 
Figure 1: a) Galactocerebrosidase converts psychosine to sphingosine. b) α-galactosidase A converts 
globotriaosylceramide to lactosylceramide. 
 
Particle-based delivery of enzymes may in particular be interesting in the case of lysosomal 
storage diseases as they naturally target the lysosome and allow for combination with other 
functionalities, such as in the context of sensing. In this work, polyelectrolyte capsules are 
discussed in this context. Such capsules posses the geometry of ping-pong balls, with a large 
cavity in the size of microns, and very thin polymer walls (a few nanometer), which are 
synthesized by layer-by-layer assembly 
[17]
. The cavity can be used as reservoir for delivery of 
different types of molecules 
[18]
, such as proteins 
[19]
. In in vitro models, capsules are readily 
endocytosed by many cell lines 
[20, 21]
, and are ultimately located in the cellular lysosome 
[22]
. 
In case of protein delivery by biodegradable capsules 
[23, 24]
, the proteins will be directly 
present in the lysosome after endocytotic uptake and degradation of the capsules in the 
lysosome. It is important to be aware that the lysosome is filled with proteases, which can 
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digest certain proteins enzymatically 
[24]
. In addition to using capsules as delivery vehicle of 
proteins to the lysosomes, they also can be used as platforms for optical sensing. Ion-sensitive 
fluorophores integrated into non-degradable capsules allow for monitoring lysosomal 
concentrations of specific ions 
[25]
. Detection of local pH values is an important example in 
this direction 
[26, 27]
. Impairment of cellular viability upon exposure to toxic substances, for 
example, can lead to loss of the acidic conditions in the lysosome, which can be monitored by 
continuous optical read-out of lysosomal pH 
[28]
. Most importantly, capsules allow for 
integration of different functionalities within one carrier. Functionalities can be either added 
to the cavity of their shells 
[29]
, or even to multiple compartments in core-shell 
[25, 30]
 and other 
geometries 
[31]
. 
Materials and Methods: 
Fabrication of pH-sensitive capsules: Template particles of 2-3 µm in diameter as determined 
by light microscopy were obtained by coprecipitation of SNARF-dextran (Lifetech, D-3304) 
with CaCO3 from solutions of CaCl2 (0.33 M) and Na2CO3 (0.33 M) in NaCl (0.5 M). 615 µL 
of CaCl2 were mixed with 770 µL SNARF-dextran (1mg/mL in DMSO) for 30 seconds prior 
to adding of 615 µL of Na2CO3 and subsequent vigorous mixing for 30 seconds at room 
temperature (RT). The particles were left for 2 minutes at RT, then centrifuged at 150 g to 
sediment them, and washed twice with Milli-Q water. Two bilayers of polystyrene sulfonate 
(PSS, pH 6.5 in 0.5 M NaCl) and polyallylamine hydrochloride (PAH, pH 6.5 in 0.5 M NaCl) 
were adsorbed to the particles, starting with PSS. In between each step, the particles were 
washed twice with Milli-Q water. Afterwards, the core was removed with 
ethylendiaminetetraacetic acid (EDTA, 0.2 M, pH 5), and the resulting SNARF-filled 
capsules were washed three times and stored in Milli-Q water at 4 °C until use in 
experiments. The concentration of the capsules was determined using a hemocytometer. 
Fabrication of enzyme-filled capsules: Template particles of 3-5 µm in diameter as 
determined by light microscopy were obtained from coprecipitation of enzyme (GALC, R&D 
Systems, 7310-GH-005, or GLA (Replagal
®
 from Shire)) with CaCO3 as above. Here, 
however, the volumes of enzyme, CaCl2, and Na2CO3 solutions were equal (1 mL in case of 
GLA, c = 1mg/mL, 50 µL in case of GALC, c = 0.05 mg/mL), and the enzyme was mixed 
first with Na2CO3 and precipitated by adding CaCl2. The particles were left for 2 minutes at 
RT, then centrifuged at 150 g to sediment them, and washed twice with Milli-Q water. Two 
bilayers of dextran sulfate (DexS, 2 mg/mL, pH 6.5 in 0.5 M NaCl) and poly-L-arginine 
(pArg, 1 or 2 mg/mL, pH 6.5 in 0.5 M NaCl) were deposited onto the particles starting with 
DexS. The core was dissolved as above and the capsules were stored at 4 °C until use. 
Cell culture: MO3.13 (both WT and KO) cells were cultured in DMEM supplemented with 
10 % FBS, 1 % L-glutamine, and 1 % penicillin-streptomycin and kept at 37 °C and 5 % CO2 
atmosphere. MO3.13 KO cells were stably transfected cells with knocked out GALC. Mouse 
aorta endothelial cells (MAEC) were obtained from sacrificed mice according to Shu et al. 
[32]
 
and cultured in RPMI medium (HyClone) supplemented with 1 % L-glutamine (Lonza, 17-
605E), 1 % antibiotic-antimicotic (Lifetech, 15240-096), 1 % non-essential amino acids 
(Lonza, 13-114E), 0.5 mg/mL endothelial cell growth supplement (Becton Dickinson, 
356006), 0.1 mg/mL heparin (Sigma-Aldrich, H3149), and 0.001 mg/mL hydrocortisone 
(Sigma-Aldrich, H0888). The FBS content depended on the passage: for passage 1 and 2, 
20 % heat-inactivated FBS (hiFBS) was added, for passage 3 and 4, 15 % hiFBS, and for 
passage 5 or higher, 10 % hiFBS. 
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pH-sensing experiments: 1.5 x 10
4
 per cm
2
 MO3.13 cells (WT or KO) were seeded in cell 
culture dishes and incubated for 24 h. The medium was exchanged for “starvation medium”, 
i.e. DMEM supplemented with 0.2 % FBS, 1 % L-glutamine, and 1 % penicillin-
streptomycin, and the cells were incubated for 24 h to provoke differentiation. 
Simultaneously, 5 pH-sensitive capsules per seeded cell were added to the cells. For imaging, 
the cells were mounted on a CLSM (Zeiss Meta 510) and the medium was changed for 
“starvation medium” supplemented with psychosine (Santa Cruz Technology, sc-202781) at a 
concentration of 2 or 10 µM. The cells were imaged for up to 24 h every 10 or 15 minutes. 
MTT viability test: 5000 MO3.13 (WT and KO) cells were seeded in 96-well plates in 
DMEM supplemented with 10 % FBS, 1 % L-glutamine, and 1% penicillin-streptomycin for 
24 h. Then, the medium was exchanged for “starvation medium” and GALC-filled capsules 
were added at a concentration of 5 or 10 capsules per seeded cell. In KO cells, also empty 
capsules were tested at a concentration of 5 capsules per seeded cell. 24 h later, the medium 
was exchanged for “starvation medium” containing psychosine at different concentrations and 
the cells were incubated for another 24 h. For the MTT assay (Roche, 11465007001), the cells 
were washed with PBS and medium containing 10 % MTT-1 solution was added for 4 h. 
Subsequently, solubilization solution (MTT-2) was added and the cells were incubated for 
12 h. The absorption maximum at 590 nm was measured by UV-vis. The absorption for cells 
not treated with psychosine was set to represent 100 % viability and all values of one 
experiment were normalized by this absorption value. 
GLA delivery: 10
5
 MAEC were seeded in 24-well plates in 0.5 mL growth medium 
appropriate for the cell passage and incubated for 24 h. The medium was exchanged for NBD-
Gb3-supplemented medium and either GLA or GLA-filled capsules at various concentrations. 
The preparation of the NBD-Gb3 medium can be found in the SI. The cells were incubated for 
another 48 h. Then, the cells were rinsed with PBS, trypsinized, centrifuged, and kept in ice-
cold PBS until use in flow cytometry. Approximately 10
4
 cells were examined per sample. 
Details can be found in the SI. 
Results and Discussion: 
Response of lysosomal pH upon stimulation of GALC-deficient cells with psychosine: First, 
the effect of psychosine on WT and KO cells was examined. In order to observe the effect, 
cells were incubated with pH sensitive non-degradable capsules, which reside inside the 
lysosome as local fluorescent pH reporters 
[28]
, cf. Figure 2. 
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Figure 2:  a) pH-sensitive capsules comprise pH-sensitive fluorophores in their cavities, surrounded by polyelectrolyte 
walls permeable to H+ [27]. b) Local pH around the capsules is indicated by ratiometric emission, in which intensity in 
the red (Ir) is smaller than intensity in the yellow (Iy) at acidic conditions 
[27]. The intensity ratio Ir/Iy of both emission 
peaks is a measure for the local pH. Emission in the yellow is depicted in green false-color. c) After internalization by 
cells, capsules are located in the lysosome (depicted in gray) [28]. In case of WT cells, the enzyme GALC (depicted in 
blue) is present in the cellular lysosome, but not in case of KO cells. Psychosine (drawn in red) is added to cells. Only 
if GALC is present, psychosine can be converted to sphingosine (drawn in green). The color of the capsules indicated 
the local pH inside the cellular lysosome. Schemes are not drawn to scale. 
In Figure 3, the development of the lysosomal pH upon exposure of WT and KO cells to 
psychosine at 2 M and 10 M concentration is shown. First, it needs to be pointed out that 
determination of absolute pH values is error-prone 
[27]
, for example due to variations in the 
Ir/Iy-pH calibration curve in-between individual capsules. For this reason, emphasis in 
evaluation is given to analysis of relative changes in pH. Second, in order to reduce 
fluctuations in read-out, a low-pass filter in the form of averaged values was applied, which 
limits temporal resolution of the data to tens of minutes. In KO cells, lysosomal pH remains 
constant upon cellular stimulation with psychosine. On the contrary, in WT cells at high 
concentration of psychosine, i.e. 10 M, but not 2 M, the lysosomal pH rises from the 
normal acidic conditions to the neutral pH of the cytosol. This is an indication for cellular 
impairments. A possible explanation may be that proton pumps localized in the cellular 
membrane, which typically warrant acidic lysosomal pH, had been deactivated. In this way, 
pH-sensitive capsules can be used as lysosomal reporters for probing effects of cellular 
stimulation. 
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Figure 3: Intracellular pH as determined from the Ir/Iy signal from pH-sensitve capsules which are localized in the 
lysosome of WT or KO cells, as sketched in Figure 2. Changes in lysosomal pH upon stimulations of cells with 
psychosine at t = 0 are reported, together with the controls (c(psychosine) = 0). 
 
Capsule-based delivery of GALC to GALC-deficient cells: In a second set of experiments, 
biodegradable capsules loaded with GALC were added to KO cells, cf. Figure 4. Effect of 
delivery was probed by exposure of the cells to psychosine and a subsequent test of cellular 
viability. 
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Figure 4: a) GALC was encapsulated within the cavity of biodegradable capsules. b) KO cells were stimulated with 
psychosine, and cellular response was probed with MTT viability assay. c) Cells were incubated with GALC-filled 
capsules, which were degraded in the cellular lysosome [24] and released GALC. Cells were then stimulated with 
psychosine and cellular response was probed via MTT viability assay. Schemes are not drawn to scale. 
Instead of probing the effect of cellular stimulation with psychosine via lysosomal pH 
changes, also standard viability tests such as the MTT assay can be used. In Figure 5, data of 
cellular viability upon incubation of cells with psychosine are presented. In case of WT cells, 
stimulation of cells with psychosine did not reduce cellular viability (Figure 5a). In case cells 
were pre-incubated with encapsulated GALC, there was some reduction of cellular viability at 
high psychosine doses. In contrast, in the case of KO cells, stimulation with psychosine 
drastically reduced cellular viability (Figure 5b). In case GALC was delivered to the cellular 
lysosomes in encapsulated form, reduction of cellular viability upon psychosine exposure 
could be omitted. This demonstrates that encapsulated GALC can be delivered to the 
lysosome, where it fulfills its function to hydrolize psychosine. The effect is clearly attributed 
to the encapsulated GALC, as delivery of empty capsules did not have an effect on cellular 
viability compared to non-treated cells (Figure 5c). While empty capsules did not cause 
cytotoxic effects, they also had no reducing effect on cytotoxicity upon exposure to 
psychosine.  
 
 
 
Figure 5: The normalized viability V of WT and KO cells are plotted versus the concentration c of added psychosine. 
The experimental procedure is shown in Figure 4. Cells were preloaded with either GALC-filled (a, b) or empty (c) 
biodegradable capsules. 
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Capsule-based delivery of GLA to GLA-deficient cells: In a third set of experiments, KO cells 
were exposed to GLA, either as free protein or in encapsulated form inside the cavity of 
biodegradable capsules, cf. Figure 6. Cells were exposed to globotriaosylceramide (Gb3) with 
attached fluorophore (N-[7-(4-nitrobenzo-2-oxa-1,3-diazole)]-aminocaproyl; NBD), cf. 
Figure 6. Digestion of Gb3 by GLA to lactosylceramide, involving cleavage of NBD from the 
sphingolipid, was probed by flow cytometry. 
 
 
 
Figure 6: a) GLA was encapsulated. b) Cells with knocked-out GLA were incubated either with native (not shown) or 
with encapsulated GLA. In both forms of administration, GLA is endocytosed and delivered to the cellular lysosome. 
Cells were then stimulated with NBD-labeled Gb3 (drawn in red), which in case of presence of GLA in the lysosome 
was degraded to lactosylceramide (drawn in green) under release of a non-fluorescent derivative of NBD. Loss in 
fluorescence was probed by flow cytometry. Schemes are not drawn to scale. 
In order to verify that lysosomal enzymes can be delivered to enzyme-deficient cells by 
capsules as shown in Figure 6, we demonstrated this effect with another enzymatic system. In 
Figure 7, the effect of delivery of free and encapsulated GLA to KO cells deficient in 
lysosomal GLA is shown. Free and encapsulated form was compared according to the amount 
of GLA added to the cells. Cellular effect upon exposure of cells to fluorescently labeled Gb3 
was monitored by flow cytometry in terms of fluorescence loss inside cells. Upon hydrolysis 
of fluorescently labeled Gb3, the fluorophore is converted to a non-fluorescent derivative, 
leading to a reduction of intracellular fluorescence. The data shown in Figure 7 clearly 
indicate that delivery of GLA leads to hydrolysis of Gb3. However, larger effect is observed 
for free rather than for encapsulated GLA. As also free GLA is readily endocytosed 
[15]
 one 
may ask which advantage encapsulation may involve. First, biodistribution of free proteins 
and encapsulated proteins can be different, and by integration of targeting moieties, for 
example magnetic nanoparticles, specific targeting could be achieved 
[33]
. Second, and more 
important, release kinetic can be changed by encapsulation; in particular slower release over 
extended periods of time is possible 
[24]
. 
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Figure 7: Fluorescently labeled Gb3 was added to cells deficient of GLA, together with GLA either as free protein or 
in encapsulated form in different concentrations. Upon enzymatic hydrolysis, the fluorescently labeled Gb3 was 
converted into non-fluorescent products (cf. Figure 6) and the reduction in intracellular fluorescence intensity I was 
recorded. The fluorescence loss is plotted versus the amount of added GLA in either form. 
Conclusion: 
We demonstrated that polymer capsules are capable of both delivery of deficient enzymes and 
analysis of pH in cells. We oriented on cells representing lysosomal storage diseases, namely 
Krabbe and Fabry disease. As the capsules automatically are trafficked to the lysosome, the 
encapsulated enzymes directly reached their target site. We could show that the enzymatic 
activity is preserved by the capsules and accumulation of metabolites, psychosine in case of 
Krabbe, and Gb3 in case of Fabry, was prevented. In case of analysis of the lysosomal pH, we 
could demonstrate that high amounts of psychosine (10 µM) provoked rise of the lysosomal 
pH in WT cells, but not in KO cells. Low concentration of psychosine (2 µM) did not induce 
changes of the pH of either sort of cell. Therefore, we have shown that polymer capsules can 
be used as therapeutic carrier for delivery of enzymes, and as diagnostic reporters for 
continuous read-out of intracellular analytes such as protons. 
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